id	sid	tid	token	lemma	pos
easat-8031	1	1	edelweiss	edelweiss	PROPN
easat-8031	1	2	applied	apply	VERB
easat-8031	1	3	science	science	NOUN
easat-8031	1	4	and	and	CCONJ
easat-8031	1	5	technology	technology	NOUN
easat-8031	1	6	issn	issn	PROPN
easat-8031	1	7	:	:	PUNCT
easat-8031	1	8	2576	2576	NUM
easat-8031	1	9	-	-	SYM
easat-8031	1	10	8484	8484	NUM
easat-8031	1	11	vol	vol	NOUN
easat-8031	1	12	.	.	PROPN
easat-8031	2	1	9	9	NUM
easat-8031	2	2	,	,	PUNCT
easat-8031	2	3	no	no	INTJ
easat-8031	2	4	.	.	NOUN
easat-8031	2	5	6	6	NUM
easat-8031	2	6	,	,	PUNCT
easat-8031	2	7	1094	1094	NUM
easat-8031	2	8	-	-	SYM
easat-8031	2	9	1103	1103	NUM
easat-8031	2	10	2025	2025	NUM
easat-8031	2	11	publisher	publisher	NOUN
easat-8031	2	12	:	:	PUNCT
easat-8031	2	13	learning	learn	VERB
easat-8031	2	14	gate	gate	NOUN
easat-8031	2	15	doi	doi	PROPN
easat-8031	2	16	:	:	PUNCT
easat-8031	2	17	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	2	18	©	©	PROPN
easat-8031	2	19	2025	2025	NUM
easat-8031	2	20	by	by	ADP
easat-8031	2	21	the	the	DET
easat-8031	2	22	authors	author	NOUN
easat-8031	2	23	;	;	PUNCT
easat-8031	2	24	licensee	licensee	PROPN
easat-8031	2	25	learning	learning	NOUN
easat-8031	2	26	gate	gate	NOUN
easat-8031	3	1	©	©	PROPN
easat-8031	3	2	2025	2025	NUM
easat-8031	3	3	by	by	ADP
easat-8031	3	4	the	the	DET
easat-8031	3	5	authors	author	NOUN
easat-8031	3	6	;	;	PUNCT
easat-8031	3	7	licensee	licensee	PROPN
easat-8031	3	8	learning	learning	NOUN
easat-8031	3	9	gate	gate	NOUN
easat-8031	3	10	history	history	NOUN
easat-8031	3	11	:	:	PUNCT
easat-8031	3	12	received	receive	VERB
easat-8031	3	13	:	:	PUNCT
easat-8031	3	14	26	26	NUM
easat-8031	3	15	march	march	NOUN
easat-8031	3	16	2025	2025	NUM
easat-8031	3	17	;	;	PUNCT
easat-8031	3	18	revised	revise	VERB
easat-8031	3	19	:	:	PUNCT
easat-8031	3	20	23	23	NUM
easat-8031	3	21	may	may	PROPN
easat-8031	3	22	2025	2025	NUM
easat-8031	3	23	;	;	PUNCT
easat-8031	3	24	accepted	accept	VERB
easat-8031	3	25	:	:	PUNCT
easat-8031	3	26	26	26	NUM
easat-8031	3	27	may	may	PROPN
easat-8031	3	28	2025	2025	NUM
easat-8031	3	29	;	;	PUNCT
easat-8031	3	30	published	publish	VERB
easat-8031	3	31	:	:	PUNCT
easat-8031	3	32	13	13	NUM
easat-8031	3	33	june	june	PROPN
easat-8031	3	34	2025	2025	NUM
easat-8031	3	35	*	*	PUNCT
easat-8031	3	36	correspondence	correspondence	NOUN
easat-8031	3	37	:	:	PUNCT
easat-8031	3	38	zainab.talib@utq.edu.iq	zainab.talib@utq.edu.iq	PROPN
easat-8031	3	39	association	association	NOUN
easat-8031	3	40	of	of	ADP
easat-8031	3	41	vitamin	vitamin	NOUN
easat-8031	3	42	d3	d3	PROPN
easat-8031	3	43	deficiency	deficiency	NOUN
easat-8031	3	44	with	with	ADP
easat-8031	3	45	autoimmun	autoimmun	ADJ
easat-8031	3	46	hypothyroidism	hypothyroidism	NOUN
easat-8031	3	47	in	in	ADP
easat-8031	3	48	southern	southern	ADJ
easat-8031	3	49	iraqi	iraqi	ADJ
easat-8031	3	50	patients	patient	NOUN
easat-8031	3	51	:	:	PUNCT
easat-8031	3	52	a	a	DET
easat-8031	3	53	regional	regional	ADJ
easat-8031	3	54	study	study	NOUN
easat-8031	3	55	from	from	ADP
easat-8031	3	56	thi	thi	PROPN
easat-8031	3	57	-	-	PUNCT
easat-8031	3	58	qar	qar	PROPN
easat-8031	3	59	province	province	PROPN
easat-8031	3	60	zaeinab	zaeinab	PROPN
easat-8031	3	61	tkhadum1	tkhadum1	PROPN
easat-8031	3	62	*	*	NOUN
easat-8031	3	63	,	,	PUNCT
easat-8031	3	64	hind	hind	ADJ
easat-8031	3	65	m	m	NOUN
easat-8031	3	66	mousa2	mousa2	NOUN
easat-8031	3	67	1ministery	1ministery	NUM
easat-8031	3	68	of	of	ADP
easat-8031	3	69	health	health	PROPN
easat-8031	3	70	–	–	PUNCT
easat-8031	3	71	al	al	PROPN
easat-8031	3	72	-	-	PUNCT
easat-8031	3	73	shatraa	shatraa	NOUN
easat-8031	3	74	general	general	PROPN
easat-8031	3	75	hospital	hospital	PROPN
easat-8031	3	76	shattra	shattra	PROPN
easat-8031	3	77	,	,	PUNCT
easat-8031	3	78	iraq	iraq	PROPN
easat-8031	3	79	;	;	PUNCT
easat-8031	3	80	zainab.talib@utq.edu.iq	zainab.talib@utq.edu.iq	PROPN
easat-8031	3	81	(	(	PUNCT
easat-8031	3	82	z.t	z.t	PROPN
easat-8031	3	83	.	.	PROPN
easat-8031	3	84	)	)	PUNCT
easat-8031	3	85	.	.	PUNCT
easat-8031	4	1	2pathological	2pathological	NUM
easat-8031	4	2	analysis	analysis	NOUN
easat-8031	4	3	department	department	NOUN
easat-8031	4	4	faculty	faculty	NOUN
easat-8031	4	5	of	of	ADP
easat-8031	4	6	science	science	NOUN
easat-8031	4	7	,	,	PUNCT
easat-8031	4	8	university	university	NOUN
easat-8031	4	9	of	of	ADP
easat-8031	4	10	thi	thi	PROPN
easat-8031	4	11	-	-	PUNCT
easat-8031	4	12	qar	qar	PROPN
easat-8031	4	13	,	,	PUNCT
easat-8031	4	14	nasiriyah	nasiriyah	PROPN
easat-8031	4	15	,	,	PUNCT
easat-8031	4	16	iraq	iraq	PROPN
easat-8031	4	17	;	;	PUNCT
easat-8031	4	18	hindmousa_pa@sci.utq.edu.iq	hindmousa_pa@sci.utq.edu.iq	NOUN
easat-8031	4	19	(	(	PUNCT
easat-8031	4	20	h.m.m	h.m.m	NOUN
easat-8031	4	21	.	.	PUNCT
easat-8031	4	22	)	)	PUNCT
easat-8031	4	23	.	.	PUNCT
easat-8031	5	1	abstract	abstract	ADJ
easat-8031	5	2	:	:	PUNCT
easat-8031	5	3	autoimmune	autoimmune	ADJ
easat-8031	5	4	hypothyroidism	hypothyroidism	NOUN
easat-8031	5	5	is	be	AUX
easat-8031	5	6	immune	immune	NOUN
easat-8031	5	7	-	-	PUNCT
easat-8031	5	8	mediated	mediate	VERB
easat-8031	5	9	destruction	destruction	NOUN
easat-8031	5	10	of	of	ADP
easat-8031	5	11	thyroid	thyroid	NOUN
easat-8031	5	12	tissue	tissue	NOUN
easat-8031	5	13	.	.	PUNCT
easat-8031	6	1	emerging	emerge	VERB
easat-8031	6	2	evidence	evidence	NOUN
easat-8031	6	3	highlights	highlight	NOUN
easat-8031	6	4	d3	d3	VERB
easat-8031	6	5	immunomodulatory	immunomodulatory	ADJ
easat-8031	6	6	role	role	NOUN
easat-8031	6	7	in	in	ADP
easat-8031	6	8	autoimmune	autoimmune	ADJ
easat-8031	6	9	diseases	disease	NOUN
easat-8031	6	10	,	,	PUNCT
easat-8031	6	11	although	although	SCONJ
easat-8031	6	12	its	its	PRON
easat-8031	6	13	association	association	NOUN
easat-8031	6	14	with	with	ADP
easat-8031	6	15	thyroid	thyroid	NOUN
easat-8031	6	16	autoimmunity	autoimmunity	NOUN
easat-8031	6	17	in	in	ADP
easat-8031	6	18	iraq	iraq	PROPN
easat-8031	6	19	remains	remain	VERB
easat-8031	6	20	understudied	understudied	ADJ
easat-8031	6	21	.	.	PUNCT
easat-8031	7	1	objective	objective	NOUN
easat-8031	7	2	:	:	PUNCT
easat-8031	7	3	this	this	DET
easat-8031	7	4	study	study	NOUN
easat-8031	7	5	aimed	aim	VERB
easat-8031	7	6	to	to	PART
easat-8031	7	7	evaluate	evaluate	VERB
easat-8031	7	8	vitamin	vitamin	NOUN
easat-8031	7	9	d3	d3	PROPN
easat-8031	7	10	levels	level	NOUN
easat-8031	7	11	in	in	ADP
easat-8031	7	12	hashimoto	hashimoto	NOUN
easat-8031	7	13	’s	’s	PART
easat-8031	7	14	patients	patient	NOUN
easat-8031	7	15	compared	compare	VERB
easat-8031	7	16	to	to	ADP
easat-8031	7	17	controls	control	NOUN
easat-8031	7	18	and	and	CCONJ
easat-8031	7	19	assess	assess	VERB
easat-8031	7	20	the	the	DET
easat-8031	7	21	correlations	correlation	NOUN
easat-8031	7	22	between	between	ADP
easat-8031	7	23	vitamin	vitamin	NOUN
easat-8031	7	24	d3	d3	PROPN
easat-8031	7	25	,	,	PUNCT
easat-8031	7	26	thyrotropin	thyrotropin	NOUN
easat-8031	7	27	hormone	hormone	NOUN
easat-8031	7	28	(	(	PUNCT
easat-8031	7	29	tsh	tsh	NOUN
easat-8031	7	30	)	)	PUNCT
easat-8031	7	31	,	,	PUNCT
easat-8031	7	32	and	and	CCONJ
easat-8031	7	33	anti	anti	ADJ
easat-8031	7	34	-	-	ADJ
easat-8031	7	35	thyroid	thyroid	ADJ
easat-8031	7	36	peroxidase	peroxidase	NOUN
easat-8031	7	37	(	(	PUNCT
easat-8031	7	38	tpo	tpo	NOUN
easat-8031	7	39	-	-	PUNCT
easat-8031	7	40	ab	ab	NOUN
easat-8031	7	41	)	)	PUNCT
easat-8031	7	42	.	.	PUNCT
easat-8031	8	1	a	a	DET
easat-8031	8	2	case	case	NOUN
easat-8031	8	3	-	-	PUNCT
easat-8031	8	4	control	control	NOUN
easat-8031	8	5	study	study	NOUN
easat-8031	8	6	at	at	ADP
easat-8031	8	7	al	al	PROPN
easat-8031	8	8	-	-	PUNCT
easat-8031	8	9	refai	refai	PROPN
easat-8031	8	10	hospital	hospital	NOUN
easat-8031	8	11	and	and	CCONJ
easat-8031	8	12	al	al	PROPN
easat-8031	8	13	-	-	PUNCT
easat-8031	8	14	haboubi	haboubi	ADJ
easat-8031	8	15	teaching	teach	VERB
easat-8031	8	16	hospital/	hospital/	NUM
easat-8031	8	17	iraq	iraq	PROPN
easat-8031	8	18	comprised	comprise	VERB
easat-8031	8	19	50	50	NUM
easat-8031	8	20	hashimoto	hashimoto	NOUN
easat-8031	8	21	's	's	PART
easat-8031	8	22	patients	patient	NOUN
easat-8031	8	23	and	and	CCONJ
easat-8031	8	24	50	50	NUM
easat-8031	8	25	ageand	ageand	NOUN
easat-8031	8	26	sex	sex	NOUN
easat-8031	8	27	-	-	PUNCT
easat-8031	8	28	matched	match	VERB
easat-8031	8	29	healthy	healthy	ADJ
easat-8031	8	30	controls	control	NOUN
easat-8031	8	31	.	.	PUNCT
easat-8031	9	1	tsh	tsh	PROPN
easat-8031	9	2	,	,	PUNCT
easat-8031	9	3	tpo	tpo	NOUN
easat-8031	9	4	-	-	PUNCT
easat-8031	9	5	ab	ab	PROPN
easat-8031	9	6	,	,	PUNCT
easat-8031	9	7	and	and	CCONJ
easat-8031	9	8	25	25	NUM
easat-8031	9	9	-	-	PUNCT
easat-8031	9	10	hydroxyvitamin	hydroxyvitamin	NOUN
easat-8031	9	11	d3	d3	PROPN
easat-8031	9	12	were	be	AUX
easat-8031	9	13	assessed	assess	VERB
easat-8031	9	14	using	use	VERB
easat-8031	9	15	fluorescence	fluorescence	NOUN
easat-8031	9	16	and	and	CCONJ
easat-8031	9	17	chemiluminescence	chemiluminescence	NOUN
easat-8031	9	18	assays	assay	NOUN
easat-8031	9	19	.	.	PUNCT
easat-8031	10	1	patients	patient	NOUN
easat-8031	10	2	exhibited	exhibit	VERB
easat-8031	10	3	significantly	significantly	ADV
easat-8031	10	4	lower	low	ADJ
easat-8031	10	5	vitamin	vitamin	NOUN
easat-8031	10	6	d3	d3	PROPN
easat-8031	10	7	levels	level	NOUN
easat-8031	10	8	(	(	PUNCT
easat-8031	10	9	21.27	21.27	NUM
easat-8031	10	10	±	±	NUM
easat-8031	10	11	7.6	7.6	NUM
easat-8031	10	12	ng	ng	PROPN
easat-8031	10	13	/	/	SYM
easat-8031	10	14	ml	ml	VERB
easat-8031	10	15	)	)	PUNCT
easat-8031	10	16	compared	compare	VERB
easat-8031	10	17	to	to	ADP
easat-8031	10	18	controls	control	NOUN
easat-8031	10	19	(	(	PUNCT
easat-8031	10	20	35.45	35.45	NUM
easat-8031	10	21	±	±	NUM
easat-8031	10	22	11.8	11.8	NUM
easat-8031	10	23	ng	ng	PROPN
easat-8031	10	24	/	/	SYM
easat-8031	10	25	ml	ml	PROPN
easat-8031	10	26	;	;	PUNCT
easat-8031	10	27	p<0.01	p<0.01	PROPN
easat-8031	10	28	)	)	PUNCT
easat-8031	10	29	.	.	PUNCT
easat-8031	11	1	patients	patient	NOUN
easat-8031	11	2	had	have	AUX
easat-8031	11	3	elevated	elevate	VERB
easat-8031	11	4	tsh	tsh	NOUN
easat-8031	11	5	(	(	PUNCT
easat-8031	11	6	10.25	10.25	NUM
easat-8031	11	7	±	±	NUM
easat-8031	11	8	3.7	3.7	NUM
easat-8031	11	9	vs.	vs.	ADP
easat-8031	11	10	1.89	1.89	NUM
easat-8031	11	11	±	±	NUM
easat-8031	11	12	0.81	0.81	NUM
easat-8031	11	13	μiu	μiu	NOUN
easat-8031	11	14	/	/	SYM
easat-8031	11	15	ml	ml	NOUN
easat-8031	11	16	)	)	PUNCT
easat-8031	11	17	and	and	CCONJ
easat-8031	11	18	tpo	tpo	PROPN
easat-8031	11	19	-	-	PUNCT
easat-8031	11	20	ab	ab	PROPN
easat-8031	11	21	(	(	PUNCT
easat-8031	11	22	58.6	58.6	NUM
easat-8031	11	23	±	±	NUM
easat-8031	11	24	17.4	17.4	NUM
easat-8031	11	25	vs.	vs.	ADP
easat-8031	11	26	6.2	6.2	NUM
easat-8031	11	27	±	±	NUM
easat-8031	11	28	5.3	5.3	NUM
easat-8031	11	29	iu	iu	NOUN
easat-8031	11	30	/	/	SYM
easat-8031	11	31	ml	ml	NOUN
easat-8031	11	32	)	)	PUNCT
easat-8031	11	33	(	(	PUNCT
easat-8031	11	34	p<0.01	p<0.01	PROPN
easat-8031	11	35	)	)	PUNCT
easat-8031	11	36	.	.	PUNCT
easat-8031	12	1	weak	weak	ADJ
easat-8031	12	2	,	,	PUNCT
easat-8031	12	3	non	non	ADJ
easat-8031	12	4	-	-	ADJ
easat-8031	12	5	significant	significant	ADJ
easat-8031	12	6	negative	negative	ADJ
easat-8031	12	7	correlations	correlation	NOUN
easat-8031	12	8	were	be	AUX
easat-8031	12	9	found	find	VERB
easat-8031	12	10	between	between	ADP
easat-8031	12	11	vitamin	vitamin	NOUN
easat-8031	12	12	d3	d3	PROPN
easat-8031	12	13	and	and	CCONJ
easat-8031	12	14	tsh	tsh	NOUN
easat-8031	12	15	(	(	PUNCT
easat-8031	12	16	r	r	NOUN
easat-8031	12	17	=	=	SYM
easat-8031	12	18	-0.04	-0.04	NUM
easat-8031	12	19	)	)	PUNCT
easat-8031	12	20	and	and	CCONJ
easat-8031	12	21	tpo	tpo	PROPN
easat-8031	12	22	-	-	PUNCT
easat-8031	12	23	ab	ab	PROPN
easat-8031	12	24	(	(	PUNCT
easat-8031	12	25	r	r	NOUN
easat-8031	12	26	=	=	PUNCT
easat-8031	12	27	-0.099	-0.099	NUM
easat-8031	12	28	)	)	PUNCT
easat-8031	12	29	.	.	PUNCT
easat-8031	13	1	roc	roc	NOUN
easat-8031	13	2	analysis	analysis	NOUN
easat-8031	13	3	confirmed	confirm	VERB
easat-8031	13	4	that	that	SCONJ
easat-8031	13	5	tsh	tsh	NOUN
easat-8031	13	6	and	and	CCONJ
easat-8031	13	7	tpo	tpo	PROPN
easat-8031	13	8	-	-	PUNCT
easat-8031	13	9	ab	ab	PROPN
easat-8031	13	10	were	be	AUX
easat-8031	13	11	highly	highly	ADV
easat-8031	13	12	sensitive	sensitive	ADJ
easat-8031	13	13	biomarkers	biomarker	NOUN
easat-8031	13	14	for	for	ADP
easat-8031	13	15	hashimoto	hashimoto	NOUN
easat-8031	13	16	.	.	PUNCT
easat-8031	14	1	vitamin	vitamin	NOUN
easat-8031	14	2	d3	d3	PROPN
easat-8031	14	3	deficiency	deficiency	NOUN
easat-8031	14	4	is	be	AUX
easat-8031	14	5	strongly	strongly	ADV
easat-8031	14	6	associated	associate	VERB
easat-8031	14	7	with	with	ADP
easat-8031	14	8	autoimmune	autoimmune	ADJ
easat-8031	14	9	hypothyroidism	hypothyroidism	NOUN
easat-8031	14	10	in	in	ADP
easat-8031	14	11	southern	southern	ADJ
easat-8031	14	12	iraqi	iraqi	ADJ
easat-8031	14	13	patients	patient	NOUN
easat-8031	14	14	.	.	PUNCT
easat-8031	15	1	these	these	DET
easat-8031	15	2	findings	finding	NOUN
easat-8031	15	3	suggest	suggest	VERB
easat-8031	15	4	potential	potential	ADJ
easat-8031	15	5	therapeutic	therapeutic	ADJ
easat-8031	15	6	benefits	benefit	NOUN
easat-8031	15	7	of	of	ADP
easat-8031	15	8	vitamin	vitamin	NOUN
easat-8031	15	9	d3	d3	PROPN
easat-8031	15	10	supplementation	supplementation	NOUN
easat-8031	15	11	in	in	ADP
easat-8031	15	12	managing	manage	VERB
easat-8031	15	13	the	the	DET
easat-8031	15	14	condition	condition	NOUN
easat-8031	15	15	,	,	PUNCT
easat-8031	15	16	warranting	warrant	VERB
easat-8031	15	17	further	further	ADJ
easat-8031	15	18	clinical	clinical	ADJ
easat-8031	15	19	trials	trial	NOUN
easat-8031	15	20	.	.	PUNCT
easat-8031	16	1	keywords	keyword	NOUN
easat-8031	16	2	:	:	PUNCT
easat-8031	16	3	autoimmune	autoimmune	ADJ
easat-8031	16	4	hypothyroidism	hypothyroidism	NOUN
easat-8031	16	5	,	,	PUNCT
easat-8031	16	6	hashimoto	hashimoto	NOUN
easat-8031	16	7	’s	’s	PART
easat-8031	16	8	thyroiditis	thyroiditis	NOUN
easat-8031	16	9	,	,	PUNCT
easat-8031	16	10	tpo	tpo	NOUN
easat-8031	16	11	,	,	PUNCT
easat-8031	16	12	vitamin	vitamin	NOUN
easat-8031	16	13	d3	d3	PROPN
easat-8031	16	14	.	.	PUNCT
easat-8031	17	1	1	1	X
easat-8031	17	2	.	.	X
easat-8031	17	3	introduction	introduction	NOUN
easat-8031	17	4	hypothyroidism	hypothyroidism	NOUN
easat-8031	17	5	is	be	AUX
easat-8031	17	6	a	a	DET
easat-8031	17	7	health	health	NOUN
easat-8031	17	8	issue	issue	NOUN
easat-8031	17	9	associated	associate	VERB
easat-8031	17	10	with	with	ADP
easat-8031	17	11	an	an	DET
easat-8031	17	12	endocrine	endocrine	ADJ
easat-8031	17	13	disorder	disorder	NOUN
easat-8031	17	14	accompanied	accompany	VERB
easat-8031	17	15	by	by	ADP
easat-8031	17	16	low	low	ADJ
easat-8031	17	17	serum	serum	PROPN
easat-8031	17	18	thyroid	thyroid	PROPN
easat-8031	17	19	hormone	hormone	NOUN
easat-8031	17	20	levels	level	NOUN
easat-8031	17	21	,	,	PUNCT
easat-8031	17	22	leading	lead	VERB
easat-8031	17	23	to	to	ADP
easat-8031	17	24	a	a	DET
easat-8031	17	25	clinical	clinical	ADJ
easat-8031	17	26	spectrum	spectrum	NOUN
easat-8031	17	27	ranging	range	VERB
easat-8031	17	28	from	from	ADP
easat-8031	17	29	no	no	DET
easat-8031	17	30	signs	sign	NOUN
easat-8031	17	31	and	and	CCONJ
easat-8031	17	32	symptoms	symptom	NOUN
easat-8031	17	33	to	to	ADP
easat-8031	17	34	lifethreatening	lifethreatene	VERB
easat-8031	17	35	complications	complication	NOUN
easat-8031	17	36	[	[	X
easat-8031	17	37	1	1	NUM
easat-8031	17	38	]	]	PUNCT
easat-8031	17	39	.	.	PUNCT
easat-8031	18	1	autoimmune	autoimmune	ADJ
easat-8031	18	2	hypothyroidism	hypothyroidism	NOUN
easat-8031	18	3	,	,	PUNCT
easat-8031	18	4	or	or	CCONJ
easat-8031	18	5	hashimoto	hashimoto	NOUN
easat-8031	18	6	's	's	PART
easat-8031	18	7	disease	disease	NOUN
easat-8031	18	8	,	,	PUNCT
easat-8031	18	9	has	have	AUX
easat-8031	18	10	been	be	AUX
easat-8031	18	11	reported	report	VERB
easat-8031	18	12	to	to	PART
easat-8031	18	13	be	be	AUX
easat-8031	18	14	more	more	ADV
easat-8031	18	15	common	common	ADJ
easat-8031	18	16	than	than	ADP
easat-8031	18	17	iodine	iodine	NOUN
easat-8031	18	18	deficiency	deficiency	NOUN
easat-8031	18	19	in	in	ADP
easat-8031	18	20	areas	area	NOUN
easat-8031	18	21	with	with	ADP
easat-8031	18	22	adequate	adequate	ADJ
easat-8031	18	23	iodine	iodine	NOUN
easat-8031	18	24	intake	intake	NOUN
easat-8031	19	1	[	[	X
easat-8031	19	2	2	2	NUM
easat-8031	19	3	]	]	PUNCT
easat-8031	19	4	and	and	CCONJ
easat-8031	19	5	is	be	AUX
easat-8031	19	6	considered	consider	VERB
easat-8031	19	7	the	the	DET
easat-8031	19	8	cardinal	cardinal	ADJ
easat-8031	19	9	cause	cause	NOUN
easat-8031	19	10	of	of	ADP
easat-8031	19	11	hypothyroidism	hypothyroidism	NOUN
easat-8031	19	12	,	,	PUNCT
easat-8031	19	13	with	with	ADP
easat-8031	19	14	an	an	DET
easat-8031	19	15	incidence	incidence	NOUN
easat-8031	19	16	rate	rate	NOUN
easat-8031	19	17	of	of	ADP
easat-8031	19	18	0.3–1.5	0.3–1.5	NOUN
easat-8031	19	19	cases	case	NOUN
easat-8031	19	20	per	per	ADP
easat-8031	19	21	1,000	1,000	NUM
easat-8031	19	22	people	people	NOUN
easat-8031	19	23	in	in	ADP
easat-8031	19	24	developed	develop	VERB
easat-8031	19	25	countries	country	NOUN
easat-8031	19	26	[	[	X
easat-8031	19	27	3	3	NUM
easat-8031	19	28	]	]	PUNCT
easat-8031	19	29	.	.	PUNCT
easat-8031	20	1	women	woman	NOUN
easat-8031	20	2	are	be	AUX
easat-8031	20	3	more	more	ADV
easat-8031	20	4	susceptible	susceptible	ADJ
easat-8031	20	5	to	to	ADP
easat-8031	20	6	this	this	DET
easat-8031	20	7	disorder	disorder	NOUN
easat-8031	20	8	than	than	ADP
easat-8031	20	9	men	man	NOUN
easat-8031	20	10	,	,	PUNCT
easat-8031	20	11	and	and	CCONJ
easat-8031	20	12	its	its	PRON
easat-8031	20	13	incidence	incidence	NOUN
easat-8031	20	14	increases	increase	VERB
easat-8031	20	15	with	with	ADP
easat-8031	20	16	age	age	NOUN
easat-8031	20	17	[	[	X
easat-8031	20	18	4	4	NUM
easat-8031	20	19	]	]	PUNCT
easat-8031	20	20	.	.	PUNCT
easat-8031	21	1	pathologically	pathologically	ADV
easat-8031	21	2	,	,	PUNCT
easat-8031	21	3	hashimoto	hashimoto	NOUN
easat-8031	21	4	's	's	PART
easat-8031	21	5	disease	disease	NOUN
easat-8031	21	6	,	,	PUNCT
easat-8031	21	7	characterized	characterize	VERB
easat-8031	21	8	by	by	ADP
easat-8031	21	9	a	a	DET
easat-8031	21	10	person	person	NOUN
easat-8031	21	11	’s	’s	PART
easat-8031	21	12	immune	immune	ADJ
easat-8031	21	13	system	system	NOUN
easat-8031	21	14	,	,	PUNCT
easat-8031	21	15	produces	produce	VERB
easat-8031	21	16	lymphocytic	lymphocytic	ADJ
easat-8031	21	17	cells	cell	NOUN
easat-8031	21	18	,	,	PUNCT
easat-8031	21	19	mainly	mainly	ADV
easat-8031	21	20	t	t	X
easat-8031	21	21	helper	helper	NOUN
easat-8031	21	22	lymphocytes	lymphocyte	VERB
easat-8031	21	23	that	that	PRON
easat-8031	21	24	infiltrate	infiltrate	VERB
easat-8031	21	25	into	into	ADP
easat-8031	21	26	thyroid	thyroid	NOUN
easat-8031	21	27	gland	gland	NOUN
easat-8031	21	28	cells	cell	NOUN
easat-8031	21	29	,	,	PUNCT
easat-8031	21	30	and	and	CCONJ
easat-8031	21	31	b	b	X
easat-8031	21	32	cells	cell	NOUN
easat-8031	21	33	that	that	PRON
easat-8031	21	34	produce	produce	VERB
easat-8031	21	35	thyroid	thyroid	NOUN
easat-8031	21	36	auto	auto	NOUN
easat-8031	21	37	-	-	PUNCT
easat-8031	21	38	antibodies	antibody	NOUN
easat-8031	21	39	(	(	PUNCT
easat-8031	21	40	anti	anti	ADJ
easat-8031	21	41	-	-	NOUN
easat-8031	21	42	tpo	tpo	NOUN
easat-8031	21	43	)	)	PUNCT
easat-8031	21	44	that	that	PRON
easat-8031	21	45	attack	attack	VERB
easat-8031	21	46	the	the	DET
easat-8031	21	47	thyroid	thyroid	NOUN
easat-8031	21	48	gland	gland	NOUN
easat-8031	21	49	antigens	antigen	NOUN
easat-8031	21	50	and	and	CCONJ
easat-8031	21	51	cause	cause	VERB
easat-8031	21	52	progressive	progressive	ADJ
easat-8031	21	53	fibrosis	fibrosis	NOUN
easat-8031	21	54	,	,	PUNCT
easat-8031	21	55	which	which	PRON
easat-8031	21	56	clearly	clearly	ADV
easat-8031	21	57	reflects	reflect	VERB
easat-8031	21	58	the	the	DET
easat-8031	21	59	extent	extent	NOUN
easat-8031	21	60	of	of	ADP
easat-8031	21	61	lymphocytic	lymphocytic	ADJ
easat-8031	21	62	infiltration	infiltration	NOUN
easat-8031	21	63	within	within	ADP
easat-8031	21	64	the	the	DET
easat-8031	21	65	thyroid	thyroid	NOUN
easat-8031	21	66	gland	gland	NOUN
easat-8031	21	67	[	[	X
easat-8031	21	68	5	5	NUM
easat-8031	21	69	,	,	PUNCT
easat-8031	21	70	6	6	NUM
easat-8031	21	71	]	]	PUNCT
easat-8031	21	72	hashimoto	hashimoto	NOUN
easat-8031	21	73	's	's	PART
easat-8031	21	74	thyroid	thyroid	NOUN
easat-8031	21	75	disease	disease	NOUN
easat-8031	21	76	develops	develop	VERB
easat-8031	21	77	slowly	slowly	ADV
easat-8031	21	78	;	;	PUNCT
easat-8031	21	79	therefore	therefore	ADV
easat-8031	21	80	,	,	PUNCT
easat-8031	21	81	diagnosis	diagnosis	NOUN
easat-8031	21	82	is	be	AUX
easat-8031	21	83	often	often	ADV
easat-8031	21	84	difficult	difficult	ADJ
easat-8031	21	85	and	and	CCONJ
easat-8031	21	86	may	may	AUX
easat-8031	21	87	not	not	PART
easat-8031	21	88	occur	occur	VERB
easat-8031	21	89	until	until	ADP
easat-8031	21	90	late	late	ADV
easat-8031	21	91	in	in	ADP
easat-8031	21	92	the	the	DET
easat-8031	21	93	disease	disease	NOUN
easat-8031	21	94	course	course	NOUN
easat-8031	21	95	.	.	PUNCT
easat-8031	22	1	signs	sign	NOUN
easat-8031	22	2	and	and	CCONJ
easat-8031	22	3	symptoms	symptom	NOUN
easat-8031	22	4	,	,	PUNCT
easat-8031	22	5	along	along	ADP
easat-8031	22	6	with	with	ADP
easat-8031	22	7	blood	blood	NOUN
easat-8031	22	8	test	test	NOUN
easat-8031	22	9	results	result	NOUN
easat-8031	22	10	that	that	PRON
easat-8031	22	11	measure	measure	VERB
easat-8031	22	12	thyroid	thyroid	NOUN
easat-8031	22	13	hormones	hormone	NOUN
easat-8031	22	14	,	,	PUNCT
easat-8031	22	15	levels	level	NOUN
easat-8031	22	16	of	of	ADP
easat-8031	22	17	thyroid	thyroid	NOUN
easat-8031	22	18	-	-	PUNCT
easat-8031	22	19	stimulating	stimulate	VERB
easat-8031	22	20	hormone	hormone	NOUN
easat-8031	22	21	(	(	PUNCT
easat-8031	22	22	tsh	tsh	NOUN
easat-8031	22	23	)	)	PUNCT
easat-8031	22	24	produced	produce	VERB
easat-8031	22	25	in	in	ADP
easat-8031	22	26	the	the	DET
easat-8031	22	27	pituitary	pituitary	ADJ
easat-8031	22	28	gland	gland	NOUN
easat-8031	22	29	,	,	PUNCT
easat-8031	22	30	and	and	CCONJ
easat-8031	22	31	levels	level	NOUN
easat-8031	22	32	of	of	ADP
easat-8031	22	33	thyroid	thyroid	NOUN
easat-8031	22	34	autoantibodies	autoantibody	NOUN
easat-8031	22	35	,	,	PUNCT
easat-8031	22	36	are	be	AUX
easat-8031	22	37	used	use	VERB
easat-8031	22	38	to	to	PART
easat-8031	22	39	diagnose	diagnose	VERB
easat-8031	22	40	hashimoto	hashimoto	NOUN
easat-8031	22	41	's	's	PART
easat-8031	22	42	disease	disease	NOUN
easat-8031	22	43	[	[	X
easat-8031	22	44	7	7	NUM
easat-8031	22	45	]	]	PUNCT
easat-8031	22	46	.	.	PUNCT
easat-8031	23	1	a	a	DET
easat-8031	23	2	significant	significant	ADJ
easat-8031	23	3	role	role	NOUN
easat-8031	23	4	of	of	ADP
easat-8031	23	5	vitamin	vitamin	NOUN
easat-8031	23	6	d	d	NOUN
easat-8031	23	7	in	in	ADP
easat-8031	23	8	the	the	DET
easat-8031	23	9	progression	progression	NOUN
easat-8031	23	10	of	of	ADP
easat-8031	23	11	hashimoto	hashimoto	NOUN
easat-8031	23	12	's	's	PART
easat-8031	23	13	thyroiditis	thyroiditis	NOUN
easat-8031	23	14	has	have	AUX
easat-8031	23	15	recently	recently	ADV
easat-8031	23	16	been	be	AUX
easat-8031	23	17	pointed	point	VERB
easat-8031	23	18	out	out	ADP
easat-8031	23	19	.	.	PUNCT
easat-8031	24	1	vitamin	vitamin	NOUN
easat-8031	24	2	d	d	NOUN
easat-8031	24	3	is	be	AUX
easat-8031	24	4	https://orcid.org/0009-0005-8983-8954	https://orcid.org/0009-0005-8983-8954	ADP
easat-8031	25	1	https://orcid.org/0000-0001-8686-0703	https://orcid.org/0000-0001-8686-0703	PROPN
easat-8031	25	2	1095	1095	NUM
easat-8031	25	3	edelweiss	edelweiss	PROPN
easat-8031	25	4	applied	apply	VERB
easat-8031	25	5	science	science	NOUN
easat-8031	25	6	and	and	CCONJ
easat-8031	25	7	technology	technology	NOUN
easat-8031	25	8	issn	issn	PROPN
easat-8031	25	9	:	:	PUNCT
easat-8031	25	10	2576	2576	NUM
easat-8031	25	11	-	-	SYM
easat-8031	25	12	8484	8484	NUM
easat-8031	25	13	vol	vol	NOUN
easat-8031	25	14	.	.	PROPN
easat-8031	26	1	9	9	NUM
easat-8031	26	2	,	,	PUNCT
easat-8031	26	3	no	no	INTJ
easat-8031	26	4	.	.	NOUN
easat-8031	26	5	6	6	NUM
easat-8031	26	6	:	:	SYM
easat-8031	26	7	1094	1094	NUM
easat-8031	26	8	-	-	SYM
easat-8031	26	9	1103	1103	NUM
easat-8031	26	10	,	,	PUNCT
easat-8031	26	11	2025	2025	NUM
easat-8031	26	12	doi	doi	NOUN
easat-8031	26	13	:	:	PUNCT
easat-8031	26	14	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	26	15	©	©	PROPN
easat-8031	26	16	2025	2025	NUM
easat-8031	26	17	by	by	ADP
easat-8031	26	18	the	the	DET
easat-8031	26	19	authors	author	NOUN
easat-8031	26	20	;	;	PUNCT
easat-8031	26	21	licensee	licensee	PROPN
easat-8031	26	22	learning	learning	NOUN
easat-8031	26	23	gate	gate	NOUN
easat-8031	26	24	involved	involve	VERB
easat-8031	26	25	in	in	ADP
easat-8031	26	26	regulating	regulate	VERB
easat-8031	26	27	the	the	DET
easat-8031	26	28	calcium	calcium	NOUN
easat-8031	26	29	and	and	CCONJ
easat-8031	26	30	phosphate	phosphate	ADJ
easat-8031	26	31	balance	balance	NOUN
easat-8031	26	32	and	and	CCONJ
easat-8031	26	33	bone	bone	NOUN
easat-8031	26	34	metabolism	metabolism	NOUN
easat-8031	26	35	,	,	PUNCT
easat-8031	26	36	in	in	ADP
easat-8031	26	37	addition	addition	NOUN
easat-8031	26	38	to	to	ADP
easat-8031	26	39	maintaining	maintain	VERB
easat-8031	26	40	the	the	DET
easat-8031	26	41	balance	balance	NOUN
easat-8031	26	42	of	of	ADP
easat-8031	26	43	the	the	DET
easat-8031	26	44	immune	immune	ADJ
easat-8031	26	45	system	system	NOUN
easat-8031	26	46	,	,	PUNCT
easat-8031	26	47	which	which	PRON
easat-8031	26	48	attacks	attack	VERB
easat-8031	26	49	the	the	DET
easat-8031	26	50	thyroid	thyroid	NOUN
easat-8031	26	51	gland	gland	NOUN
easat-8031	26	52	when	when	SCONJ
easat-8031	26	53	it	it	PRON
easat-8031	26	54	is	be	AUX
easat-8031	26	55	imbalanced	imbalanced	ADJ
easat-8031	26	56	.	.	PUNCT
easat-8031	27	1	these	these	DET
easat-8031	27	2	findings	finding	NOUN
easat-8031	27	3	indicate	indicate	VERB
easat-8031	27	4	a	a	DET
easat-8031	27	5	fundamental	fundamental	ADJ
easat-8031	27	6	role	role	NOUN
easat-8031	27	7	of	of	ADP
easat-8031	27	8	vitamin	vitamin	NOUN
easat-8031	27	9	d	d	NOUN
easat-8031	27	10	in	in	ADP
easat-8031	27	11	hashimoto	hashimoto	NOUN
easat-8031	27	12	's	's	PART
easat-8031	27	13	thyroiditis	thyroiditis	NOUN
easat-8031	27	14	and	and	CCONJ
easat-8031	27	15	its	its	PRON
easat-8031	27	16	progression	progression	NOUN
easat-8031	27	17	to	to	ADP
easat-8031	27	18	hypothyroidism	hypothyroidism	NOUN
easat-8031	27	19	[	[	X
easat-8031	27	20	8	8	NUM
easat-8031	27	21	]	]	PUNCT
easat-8031	27	22	.	.	PUNCT
easat-8031	28	1	the	the	DET
easat-8031	28	2	association	association	NOUN
easat-8031	28	3	between	between	ADP
easat-8031	28	4	vitamin	vitamin	NOUN
easat-8031	28	5	d	d	NOUN
easat-8031	28	6	status	status	NOUN
easat-8031	28	7	and	and	CCONJ
easat-8031	28	8	autoimmune	autoimmune	ADJ
easat-8031	28	9	thyroid	thyroid	NOUN
easat-8031	28	10	disease	disease	NOUN
easat-8031	28	11	(	(	PUNCT
easat-8031	28	12	aitd	aitd	ADJ
easat-8031	28	13	)	)	PUNCT
easat-8031	28	14	remains	remain	VERB
easat-8031	28	15	unclear	unclear	ADJ
easat-8031	28	16	.	.	PUNCT
easat-8031	29	1	prior	prior	ADJ
easat-8031	29	2	investigations	investigation	NOUN
easat-8031	29	3	have	have	AUX
easat-8031	29	4	analyzed	analyze	VERB
easat-8031	29	5	the	the	DET
easat-8031	29	6	impact	impact	NOUN
easat-8031	29	7	of	of	ADP
easat-8031	29	8	serum	serum	NOUN
easat-8031	29	9	vitamin	vitamin	NOUN
easat-8031	29	10	d	d	NOUN
easat-8031	29	11	deficiency	deficiency	NOUN
easat-8031	29	12	on	on	ADP
easat-8031	29	13	autoimmune	autoimmune	ADJ
easat-8031	29	14	thyroid	thyroid	NOUN
easat-8031	29	15	conditions	condition	NOUN
easat-8031	29	16	[	[	X
easat-8031	29	17	9	9	NUM
easat-8031	29	18	]	]	PUNCT
easat-8031	29	19	.	.	PUNCT
easat-8031	30	1	sought	seek	VERB
easat-8031	30	2	to	to	PART
easat-8031	30	3	address	address	VERB
easat-8031	30	4	this	this	DET
easat-8031	30	5	gap	gap	NOUN
easat-8031	30	6	in	in	ADP
easat-8031	30	7	knowledge	knowledge	NOUN
easat-8031	30	8	.	.	PUNCT
easat-8031	31	1	accumulating	accumulate	VERB
easat-8031	31	2	evidence	evidence	NOUN
easat-8031	31	3	underscores	underscore	VERB
easat-8031	31	4	the	the	DET
easat-8031	31	5	immunomodulatory	immunomodulatory	ADJ
easat-8031	31	6	role	role	NOUN
easat-8031	31	7	of	of	ADP
easat-8031	31	8	vitamin	vitamin	NOUN
easat-8031	31	9	d	d	NOUN
easat-8031	31	10	in	in	ADP
easat-8031	31	11	autoimmune	autoimmune	ADJ
easat-8031	31	12	hypothyroidism	hypothyroidism	NOUN
easat-8031	31	13	,	,	PUNCT
easat-8031	31	14	with	with	ADP
easat-8031	31	15	deficiency	deficiency	NOUN
easat-8031	31	16	implicated	implicate	VERB
easat-8031	31	17	in	in	ADP
easat-8031	31	18	elevated	elevated	ADJ
easat-8031	31	19	prevalence	prevalence	NOUN
easat-8031	31	20	rates	rate	NOUN
easat-8031	31	21	of	of	ADP
easat-8031	31	22	thyroid	thyroid	NOUN
easat-8031	31	23	autoimmunity	autoimmunity	NOUN
easat-8031	31	24	across	across	ADP
easat-8031	31	25	diverse	diverse	ADJ
easat-8031	31	26	demographic	demographic	ADJ
easat-8031	31	27	cohorts	cohort	NOUN
easat-8031	31	28	,	,	PUNCT
easat-8031	31	29	such	such	ADJ
easat-8031	31	30	as	as	ADP
easat-8031	31	31	pediatric	pediatric	ADJ
easat-8031	31	32	,	,	PUNCT
easat-8031	31	33	adolescent	adolescent	ADJ
easat-8031	31	34	,	,	PUNCT
easat-8031	31	35	and	and	CCONJ
easat-8031	31	36	obese	obese	ADJ
easat-8031	31	37	populations	population	NOUN
easat-8031	31	38	[	[	X
easat-8031	31	39	10	10	NUM
easat-8031	31	40	]	]	PUNCT
easat-8031	31	41	.	.	PUNCT
easat-8031	32	1	although	although	SCONJ
easat-8031	32	2	the	the	DET
easat-8031	32	3	interplay	interplay	NOUN
easat-8031	32	4	between	between	ADP
easat-8031	32	5	vitamin	vitamin	NOUN
easat-8031	32	6	d	d	NOUN
easat-8031	32	7	and	and	CCONJ
easat-8031	32	8	aitd	aitd	ADJ
easat-8031	32	9	has	have	AUX
easat-8031	32	10	garnered	garner	VERB
easat-8031	32	11	increasing	increase	VERB
easat-8031	32	12	attention	attention	NOUN
easat-8031	32	13	,	,	PUNCT
easat-8031	32	14	the	the	DET
easat-8031	32	15	underlying	underlying	ADJ
easat-8031	32	16	pathophysiological	pathophysiological	ADJ
easat-8031	32	17	mechanisms	mechanism	NOUN
easat-8031	32	18	remain	remain	VERB
easat-8031	32	19	unclear	unclear	ADJ
easat-8031	32	20	.	.	PUNCT
easat-8031	33	1	initial	initial	ADJ
easat-8031	33	2	explorations	exploration	NOUN
easat-8031	33	3	were	be	AUX
easat-8031	33	4	exemplified	exemplify	VERB
easat-8031	33	5	by	by	ADP
easat-8031	33	6	a	a	DET
easat-8031	33	7	comparative	comparative	ADJ
easat-8031	33	8	analysis	analysis	NOUN
easat-8031	33	9	of	of	ADP
easat-8031	33	10	serum	serum	NOUN
easat-8031	33	11	25	25	NUM
easat-8031	33	12	-	-	PUNCT
easat-8031	33	13	hydroxyvitamin	hydroxyvitamin	NOUN
easat-8031	33	14	d	d	NOUN
easat-8031	33	15	(	(	PUNCT
easat-8031	33	16	25(oh)d	25(oh)d	NOUN
easat-8031	33	17	)	)	PUNCT
easat-8031	33	18	concentrations	concentration	NOUN
easat-8031	33	19	in	in	ADP
easat-8031	33	20	patients	patient	NOUN
easat-8031	33	21	with	with	ADP
easat-8031	33	22	hashimoto	hashimoto	NOUN
easat-8031	33	23	’s	’s	PART
easat-8031	33	24	thyroiditis	thyroiditis	NOUN
easat-8031	33	25	versus	versus	ADP
easat-8031	33	26	healthy	healthy	ADJ
easat-8031	33	27	controls	control	NOUN
easat-8031	33	28	[	[	X
easat-8031	33	29	11	11	NUM
easat-8031	33	30	,	,	PUNCT
easat-8031	33	31	12	12	NUM
easat-8031	33	32	]	]	PUNCT
easat-8031	33	33	.	.	PUNCT
easat-8031	34	1	according	accord	VERB
easat-8031	34	2	to	to	ADP
easat-8031	34	3	what	what	PRON
easat-8031	34	4	was	be	AUX
easat-8031	34	5	explained	explain	VERB
easat-8031	34	6	above	above	ADV
easat-8031	34	7	,	,	PUNCT
easat-8031	34	8	vitamin	vitamin	NOUN
easat-8031	34	9	d	d	NOUN
easat-8031	34	10	deficiency	deficiency	NOUN
easat-8031	34	11	is	be	AUX
easat-8031	34	12	increasingly	increasingly	ADV
easat-8031	34	13	recognized	recognize	VERB
easat-8031	34	14	as	as	ADP
easat-8031	34	15	a	a	DET
easat-8031	34	16	factor	factor	NOUN
easat-8031	34	17	in	in	ADP
easat-8031	34	18	various	various	ADJ
easat-8031	34	19	autoimmune	autoimmune	ADJ
easat-8031	34	20	diseases	disease	NOUN
easat-8031	34	21	.	.	PUNCT
easat-8031	35	1	investigating	investigate	VERB
easat-8031	35	2	its	its	PRON
easat-8031	35	3	potential	potential	ADJ
easat-8031	35	4	role	role	NOUN
easat-8031	35	5	in	in	ADP
easat-8031	35	6	autoimmune	autoimmune	ADJ
easat-8031	35	7	hypothyroidism	hypothyroidism	NOUN
easat-8031	35	8	can	can	AUX
easat-8031	35	9	enhance	enhance	VERB
easat-8031	35	10	our	our	PRON
easat-8031	35	11	understanding	understanding	NOUN
easat-8031	35	12	of	of	ADP
easat-8031	35	13	disease	disease	NOUN
easat-8031	35	14	mechanisms	mechanism	NOUN
easat-8031	35	15	and	and	CCONJ
easat-8031	35	16	progression	progression	NOUN
easat-8031	35	17	;	;	PUNCT
easat-8031	35	18	therefore	therefore	ADV
easat-8031	35	19	,	,	PUNCT
easat-8031	35	20	the	the	DET
easat-8031	35	21	present	present	ADJ
easat-8031	35	22	study	study	NOUN
easat-8031	35	23	was	be	AUX
easat-8031	35	24	undertaken	undertake	VERB
easat-8031	35	25	to	to	PART
easat-8031	35	26	estimate	estimate	VERB
easat-8031	35	27	the	the	DET
easat-8031	35	28	levels	level	NOUN
easat-8031	35	29	of	of	ADP
easat-8031	35	30	tsh	tsh	NOUN
easat-8031	35	31	and	and	CCONJ
easat-8031	35	32	tpo	tpo	NOUN
easat-8031	35	33	-	-	PUNCT
easat-8031	35	34	ab	ab	PROPN
easat-8031	35	35	in	in	ADP
easat-8031	35	36	the	the	DET
easat-8031	35	37	context	context	NOUN
easat-8031	35	38	of	of	ADP
easat-8031	35	39	vitamin	vitamin	NOUN
easat-8031	35	40	d	d	NOUN
easat-8031	35	41	in	in	ADP
easat-8031	35	42	autoimmune	autoimmune	ADJ
easat-8031	35	43	hashimoto	hashimoto	NOUN
easat-8031	35	44	’s	’s	PART
easat-8031	35	45	patients	patient	NOUN
easat-8031	35	46	in	in	ADP
easat-8031	35	47	the	the	DET
easat-8031	35	48	thi	thi	PROPN
easat-8031	35	49	-	-	PUNCT
easat-8031	35	50	qar	qar	PROPN
easat-8031	35	51	province	province	NOUN
easat-8031	35	52	and	and	CCONJ
easat-8031	35	53	their	their	PRON
easat-8031	35	54	role	role	NOUN
easat-8031	35	55	in	in	ADP
easat-8031	35	56	the	the	DET
easat-8031	35	57	prognosis	prognosis	NOUN
easat-8031	35	58	of	of	ADP
easat-8031	35	59	this	this	DET
easat-8031	35	60	disease	disease	NOUN
easat-8031	35	61	.	.	PUNCT
easat-8031	36	1	2	2	X
easat-8031	36	2	.	.	X
easat-8031	36	3	subjects	subject	NOUN
easat-8031	36	4	and	and	CCONJ
easat-8031	36	5	methods	method	NOUN
easat-8031	36	6	this	this	DET
easat-8031	36	7	case	case	NOUN
easat-8031	36	8	-	-	PUNCT
easat-8031	36	9	control	control	NOUN
easat-8031	36	10	study	study	NOUN
easat-8031	36	11	was	be	AUX
easat-8031	36	12	conducted	conduct	VERB
easat-8031	36	13	between	between	ADP
easat-8031	36	14	september	september	PROPN
easat-8031	36	15	and	and	CCONJ
easat-8031	36	16	december	december	PROPN
easat-8031	36	17	2023	2023	NUM
easat-8031	36	18	at	at	ADP
easat-8031	36	19	al	al	PROPN
easat-8031	36	20	-	-	PUNCT
easat-8031	36	21	rifai	rifai	PROPN
easat-8031	36	22	general	general	ADJ
easat-8031	36	23	hospital	hospital	NOUN
easat-8031	36	24	and	and	CCONJ
easat-8031	36	25	al	al	PROPN
easat-8031	36	26	-	-	PUNCT
easat-8031	36	27	haboubi	haboubi	ADJ
easat-8031	36	28	teaching	teaching	NOUN
easat-8031	36	29	hospital	hospital	NOUN
easat-8031	36	30	in	in	ADP
easat-8031	36	31	thi	thi	PROPN
easat-8031	36	32	-	-	PUNCT
easat-8031	36	33	qar	qar	PROPN
easat-8031	36	34	governorate	governorate	NOUN
easat-8031	36	35	,	,	PUNCT
easat-8031	36	36	iraq	iraq	PROPN
easat-8031	36	37	.	.	PUNCT
easat-8031	37	1	a	a	DET
easat-8031	37	2	total	total	NOUN
easat-8031	37	3	of	of	ADP
easat-8031	37	4	100	100	NUM
easat-8031	37	5	iraqi	iraqi	ADJ
easat-8031	37	6	participants	participant	NOUN
easat-8031	37	7	aged	age	VERB
easat-8031	37	8	18–60	18–60	NUM
easat-8031	37	9	years	year	NOUN
easat-8031	37	10	were	be	AUX
easat-8031	37	11	enrolled	enrol	VERB
easat-8031	37	12	,	,	PUNCT
easat-8031	37	13	comprising	comprise	VERB
easat-8031	37	14	50	50	NUM
easat-8031	37	15	patients	patient	NOUN
easat-8031	37	16	diagnosed	diagnose	VERB
easat-8031	37	17	with	with	ADP
easat-8031	37	18	autoimmune	autoimmune	ADJ
easat-8031	37	19	hypothyroidism	hypothyroidism	NOUN
easat-8031	37	20	(	(	PUNCT
easat-8031	37	21	hashimoto	hashimoto	NOUN
easat-8031	37	22	thyroiditis	thyroiditis	NOUN
easat-8031	37	23	)	)	PUNCT
easat-8031	37	24	and	and	CCONJ
easat-8031	37	25	50	50	NUM
easat-8031	37	26	ageand	ageand	NOUN
easat-8031	37	27	sex	sex	NOUN
easat-8031	37	28	-	-	PUNCT
easat-8031	37	29	matched	match	VERB
easat-8031	37	30	healthy	healthy	ADJ
easat-8031	37	31	controls	control	NOUN
easat-8031	37	32	.	.	PUNCT
easat-8031	38	1	patients	patient	NOUN
easat-8031	38	2	were	be	AUX
easat-8031	38	3	recruited	recruit	VERB
easat-8031	38	4	from	from	ADP
easat-8031	38	5	endocrinology	endocrinology	NOUN
easat-8031	38	6	outpatient	outpatient	NOUN
easat-8031	38	7	clinics	clinic	NOUN
easat-8031	38	8	,	,	PUNCT
easat-8031	38	9	while	while	SCONJ
easat-8031	38	10	controls	control	NOUN
easat-8031	38	11	were	be	AUX
easat-8031	38	12	selected	select	VERB
easat-8031	38	13	from	from	ADP
easat-8031	38	14	individuals	individual	NOUN
easat-8031	38	15	attending	attend	VERB
easat-8031	38	16	routine	routine	ADJ
easat-8031	38	17	health	health	NOUN
easat-8031	38	18	checkups	checkup	NOUN
easat-8031	38	19	with	with	ADP
easat-8031	38	20	no	no	DET
easat-8031	38	21	history	history	NOUN
easat-8031	38	22	of	of	ADP
easat-8031	38	23	thyroid	thyroid	NOUN
easat-8031	38	24	disorders	disorder	NOUN
easat-8031	38	25	,	,	PUNCT
easat-8031	38	26	autoimmune	autoimmune	ADJ
easat-8031	38	27	diseases	disease	NOUN
easat-8031	38	28	,	,	PUNCT
easat-8031	38	29	or	or	CCONJ
easat-8031	38	30	chronic	chronic	ADJ
easat-8031	38	31	illnesses	illness	NOUN
easat-8031	38	32	.	.	PUNCT
easat-8031	39	1	inclusion	inclusion	NOUN
easat-8031	39	2	and	and	CCONJ
easat-8031	39	3	exclusion	exclusion	NOUN
easat-8031	39	4	criteria	criterion	NOUN
easat-8031	39	5	,	,	PUNCT
easat-8031	39	6	patients	patient	NOUN
easat-8031	39	7	:	:	PUNCT
easat-8031	39	8	diagnosis	diagnosis	NOUN
easat-8031	39	9	of	of	ADP
easat-8031	39	10	autoimmune	autoimmune	ADJ
easat-8031	39	11	hypothyroidism	hypothyroidism	NOUN
easat-8031	39	12	was	be	AUX
easat-8031	39	13	confirmed	confirm	VERB
easat-8031	39	14	by	by	ADP
easat-8031	39	15	elevated	elevated	ADJ
easat-8031	39	16	(	(	PUNCT
easat-8031	39	17	tsh	tsh	NOUN
easat-8031	39	18	>	>	SYM
easat-8031	39	19	4.2	4.2	NUM
easat-8031	39	20	μiu	μiu	NOUN
easat-8031	39	21	/	/	SYM
easat-8031	39	22	ml	ml	NOUN
easat-8031	39	23	)	)	PUNCT
easat-8031	39	24	,	,	PUNCT
easat-8031	39	25	reduced	reduce	VERB
easat-8031	39	26	free	free	ADJ
easat-8031	39	27	thyroxine	thyroxine	NOUN
easat-8031	39	28	(	(	PUNCT
easat-8031	39	29	ft4	ft4	NOUN
easat-8031	39	30	<	<	X
easat-8031	39	31	0.8	0.8	NUM
easat-8031	39	32	ng	ng	PROPN
easat-8031	39	33	/	/	SYM
easat-8031	39	34	dl	dl	PROPN
easat-8031	39	35	)	)	PUNCT
easat-8031	39	36	,	,	PUNCT
easat-8031	39	37	and	and	CCONJ
easat-8031	39	38	positivity	positivity	NOUN
easat-8031	39	39	for	for	ADP
easat-8031	39	40	anti	anti	ADJ
easat-8031	39	41	-	-	ADJ
easat-8031	39	42	thyroid	thyroid	ADJ
easat-8031	39	43	peroxidase	peroxidase	NOUN
easat-8031	39	44	antibodies	antibodie	VERB
easat-8031	39	45	(	(	PUNCT
easat-8031	39	46	anti	anti	ADJ
easat-8031	39	47	-	-	ADJ
easat-8031	39	48	tpo	tpo	NOUN
easat-8031	39	49	>	>	X
easat-8031	39	50	35	35	NUM
easat-8031	39	51	iu	iu	NOUN
easat-8031	39	52	/	/	SYM
easat-8031	39	53	ml	ml	NOUN
easat-8031	39	54	)	)	PUNCT
easat-8031	39	55	.	.	PUNCT
easat-8031	40	1	exclusion	exclusion	NOUN
easat-8031	40	2	criteria	criterion	NOUN
easat-8031	40	3	were	be	AUX
easat-8031	40	4	pregnancy	pregnancy	NOUN
easat-8031	40	5	,	,	PUNCT
easat-8031	40	6	recent	recent	ADJ
easat-8031	40	7	thyroid	thyroid	NOUN
easat-8031	40	8	surgery	surgery	NOUN
easat-8031	40	9	,	,	PUNCT
easat-8031	40	10	iodine	iodine	NOUN
easat-8031	40	11	contrast	contrast	NOUN
easat-8031	40	12	exposure	exposure	NOUN
easat-8031	40	13	,	,	PUNCT
easat-8031	40	14	or	or	CCONJ
easat-8031	40	15	concurrent	concurrent	ADJ
easat-8031	40	16	autoimmune	autoimmune	ADJ
easat-8031	40	17	conditions	condition	NOUN
easat-8031	40	18	(	(	PUNCT
easat-8031	40	19	e.g.	e.g.	ADV
easat-8031	40	20	,	,	PUNCT
easat-8031	40	21	type	type	NOUN
easat-8031	40	22	1	1	NUM
easat-8031	40	23	diabetes	diabetes	NOUN
easat-8031	40	24	,	,	PUNCT
easat-8031	40	25	lupus	lupus	NOUN
easat-8031	40	26	)	)	PUNCT
easat-8031	40	27	.	.	PUNCT
easat-8031	41	1	controls	control	NOUN
easat-8031	41	2	:	:	PUNCT
easat-8031	41	3	individuals	individual	NOUN
easat-8031	41	4	with	with	ADP
easat-8031	41	5	normal	normal	ADJ
easat-8031	41	6	thyroid	thyroid	NOUN
easat-8031	41	7	function	function	NOUN
easat-8031	41	8	(	(	PUNCT
easat-8031	41	9	tsh	tsh	NOUN
easat-8031	41	10	0.4–4.0	0.4–4.0	X
easat-8031	41	11	μiu	μiu	PROPN
easat-8031	41	12	/	/	SYM
easat-8031	41	13	ml	ml	PROPN
easat-8031	41	14	,	,	PUNCT
easat-8031	41	15	ft4	ft4	PROPN
easat-8031	41	16	0.8–1.8	0.8–1.8	PROPN
easat-8031	41	17	ng	ng	PROPN
easat-8031	41	18	/	/	SYM
easat-8031	41	19	dl	dl	PROPN
easat-8031	41	20	)	)	PUNCT
easat-8031	41	21	,	,	PUNCT
easat-8031	41	22	negative	negative	ADJ
easat-8031	41	23	anti	anti	ADJ
easat-8031	41	24	-	-	ADJ
easat-8031	41	25	tpo	tpo	NOUN
easat-8031	41	26	antibodies	antibodie	VERB
easat-8031	41	27	(	(	PUNCT
easat-8031	41	28	<	<	X
easat-8031	41	29	35	35	NUM
easat-8031	41	30	iu	iu	NOUN
easat-8031	41	31	/	/	SYM
easat-8031	41	32	ml	ml	NOUN
easat-8031	41	33	)	)	PUNCT
easat-8031	41	34	,	,	PUNCT
easat-8031	41	35	and	and	CCONJ
easat-8031	41	36	no	no	DET
easat-8031	41	37	family	family	NOUN
easat-8031	41	38	history	history	NOUN
easat-8031	41	39	of	of	ADP
easat-8031	41	40	autoimmune	autoimmune	ADJ
easat-8031	41	41	thyroid	thyroid	NOUN
easat-8031	41	42	disease	disease	NOUN
easat-8031	41	43	.	.	PUNCT
easat-8031	42	1	venous	venous	ADJ
easat-8031	42	2	blood	blood	NOUN
easat-8031	42	3	samples	sample	NOUN
easat-8031	42	4	(	(	PUNCT
easat-8031	42	5	5	5	NUM
easat-8031	42	6	ml	ml	NOUN
easat-8031	42	7	)	)	PUNCT
easat-8031	42	8	were	be	AUX
easat-8031	42	9	drawn	draw	VERB
easat-8031	42	10	from	from	ADP
easat-8031	42	11	all	all	DET
easat-8031	42	12	participants	participant	NOUN
easat-8031	42	13	after	after	ADP
easat-8031	42	14	a	a	DET
easat-8031	42	15	12	12	NUM
easat-8031	42	16	-	-	PUNCT
easat-8031	42	17	hour	hour	NOUN
easat-8031	42	18	fast	fast	ADV
easat-8031	42	19	.	.	PUNCT
easat-8031	43	1	serum	serum	NOUN
easat-8031	43	2	was	be	AUX
easat-8031	43	3	separated	separate	VERB
easat-8031	43	4	via	via	ADP
easat-8031	43	5	centrifugation	centrifugation	NOUN
easat-8031	43	6	at	at	ADP
easat-8031	43	7	3,000	3,000	NUM
easat-8031	43	8	rpm	rpm	NOUN
easat-8031	43	9	for	for	ADP
easat-8031	43	10	10	10	NUM
easat-8031	43	11	min	min	NOUN
easat-8031	43	12	,	,	PUNCT
easat-8031	43	13	aliquoted	aliquote	VERB
easat-8031	43	14	into	into	ADP
easat-8031	43	15	sterile	sterile	ADJ
easat-8031	43	16	cryovials	cryovial	NOUN
easat-8031	43	17	,	,	PUNCT
easat-8031	43	18	and	and	CCONJ
easat-8031	43	19	stored	store	VERB
easat-8031	43	20	at	at	ADP
easat-8031	43	21	−20	−20	NOUN
easat-8031	43	22	°	°	ADP
easat-8031	43	23	c	c	NOUN
easat-8031	43	24	.	.	PUNCT
easat-8031	44	1	to	to	PART
easat-8031	44	2	minimize	minimize	VERB
easat-8031	44	3	degradation	degradation	NOUN
easat-8031	44	4	,	,	PUNCT
easat-8031	44	5	samples	sample	NOUN
easat-8031	44	6	were	be	AUX
easat-8031	44	7	analyzed	analyze	VERB
easat-8031	44	8	within	within	ADP
easat-8031	44	9	four	four	NUM
easat-8031	44	10	weeks	week	NOUN
easat-8031	44	11	of	of	ADP
easat-8031	44	12	collection	collection	NOUN
easat-8031	44	13	to	to	PART
easat-8031	44	14	avoid	avoid	VERB
easat-8031	44	15	freezethaw	freezethaw	ADJ
easat-8031	44	16	cycles	cycle	NOUN
easat-8031	44	17	.	.	PUNCT
easat-8031	45	1	2.1	2.1	NUM
easat-8031	45	2	.	.	PUNCT
easat-8031	46	1	laboratory	laboratory	NOUN
easat-8031	46	2	assays	assay	NOUN
easat-8031	46	3	thyroid	thyroid	VERB
easat-8031	46	4	function	function	NOUN
easat-8031	46	5	tests	test	NOUN
easat-8031	46	6	,	,	PUNCT
easat-8031	46	7	including	include	VERB
easat-8031	46	8	"	"	PUNCT
easat-8031	46	9	thyroid	thyroid	NOUN
easat-8031	46	10	stimulating	stimulate	VERB
easat-8031	46	11	hormone	hormone	NOUN
easat-8031	46	12	(	(	PUNCT
easat-8031	46	13	tsh	tsh	NOUN
easat-8031	46	14	)	)	PUNCT
easat-8031	46	15	,	,	PUNCT
easat-8031	46	16	triiodothyronine	triiodothyronine	ADJ
easat-8031	46	17	hormone	hormone	NOUN
easat-8031	46	18	(	(	PUNCT
easat-8031	46	19	t3	t3	PROPN
easat-8031	46	20	)	)	PUNCT
easat-8031	46	21	,	,	PUNCT
easat-8031	46	22	and	and	CCONJ
easat-8031	46	23	thyroxine	thyroxine	NOUN
easat-8031	46	24	hormone	hormone	NOUN
easat-8031	46	25	(	(	PUNCT
easat-8031	46	26	t4	t4	PROPN
easat-8031	46	27	)	)	PUNCT
easat-8031	46	28	,	,	PUNCT
easat-8031	46	29	”	"	PUNCT
easat-8031	46	30	were	be	AUX
easat-8031	46	31	performed	perform	VERB
easat-8031	46	32	utilizing	utilize	VERB
easat-8031	46	33	afias-10	afias-10	NOUN
easat-8031	46	34	apparatus	apparatus	NOUN
easat-8031	46	35	'	'	PART
easat-8031	46	36	automated	automate	VERB
easat-8031	46	37	fluorescence	fluorescence	NOUN
easat-8031	46	38	immunoassay	immunoassay	PROPN
easat-8031	46	39	.	.	PUNCT
easat-8031	47	1	anti	anti	ADJ
easat-8031	47	2	-	-	ADJ
easat-8031	47	3	tpo	tpo	ADJ
easat-8031	47	4	antibody	antibody	NOUN
easat-8031	47	5	and	and	CCONJ
easat-8031	47	6	25	25	NUM
easat-8031	47	7	-	-	PUNCT
easat-8031	47	8	hydroxyvitamin	hydroxyvitamin	NOUN
easat-8031	47	9	d	d	NOUN
easat-8031	47	10	(	(	PUNCT
easat-8031	47	11	25[oh]d	25[oh]d	ADJ
easat-8031	47	12	)	)	PUNCT
easat-8031	47	13	levels	level	NOUN
easat-8031	47	14	were	be	AUX
easat-8031	47	15	measured	measure	VERB
easat-8031	47	16	using	use	VERB
easat-8031	47	17	a	a	DET
easat-8031	47	18	cobas	cobas	ADJ
easat-8031	47	19	e411	e411	PROPN
easat-8031	47	20	chemiluminescence	chemiluminescence	NOUN
easat-8031	47	21	immunoassay	immunoassay	NOUN
easat-8031	47	22	(	(	PUNCT
easat-8031	47	23	roche	roche	NOUN
easat-8031	47	24	diagnostics	diagnostic	NOUN
easat-8031	47	25	,	,	PUNCT
easat-8031	47	26	germany	germany	PROPN
easat-8031	47	27	)	)	PUNCT
easat-8031	47	28	.	.	PUNCT
easat-8031	48	1	2.2	2.2	NUM
easat-8031	48	2	.	.	PUNCT
easat-8031	49	1	statistical	statistical	ADJ
easat-8031	49	2	analysis	analysis	NOUN
easat-8031	49	3	data	datum	NOUN
easat-8031	49	4	were	be	AUX
easat-8031	49	5	analyzed	analyze	VERB
easat-8031	49	6	using	use	VERB
easat-8031	49	7	spss	spss	PROPN
easat-8031	49	8	version	version	NOUN
easat-8031	49	9	26	26	NUM
easat-8031	49	10	.	.	PUNCT
easat-8031	50	1	continuous	continuous	ADJ
easat-8031	50	2	variables	variable	NOUN
easat-8031	50	3	are	be	AUX
easat-8031	50	4	expressed	express	VERB
easat-8031	50	5	as	as	ADP
easat-8031	50	6	mean	mean	NOUN
easat-8031	50	7	±	±	NUM
easat-8031	50	8	standard	standard	ADJ
easat-8031	50	9	deviation	deviation	NOUN
easat-8031	50	10	(	(	PUNCT
easat-8031	50	11	sd	sd	NOUN
easat-8031	50	12	)	)	PUNCT
easat-8031	50	13	and	and	CCONJ
easat-8031	50	14	compared	compare	VERB
easat-8031	50	15	using	use	VERB
easat-8031	50	16	independent	independent	ADJ
easat-8031	50	17	student	student	NOUN
easat-8031	50	18	’s	’s	PART
easat-8031	50	19	t	t	PROPN
easat-8031	50	20	-	-	PUNCT
easat-8031	50	21	tests	test	NOUN
easat-8031	50	22	(	(	PUNCT
easat-8031	50	23	assuming	assume	VERB
easat-8031	50	24	normality	normality	NOUN
easat-8031	50	25	,	,	PUNCT
easat-8031	50	26	confirmed	confirm	VERB
easat-8031	50	27	by	by	ADP
easat-8031	50	28	shapiro	shapiro	PROPN
easat-8031	50	29	-	-	PUNCT
easat-8031	50	30	wilk	wilk	NOUN
easat-8031	50	31	tests	test	NOUN
easat-8031	50	32	)	)	PUNCT
easat-8031	50	33	.	.	PUNCT
easat-8031	51	1	categorical	categorical	ADJ
easat-8031	51	2	variables	variable	NOUN
easat-8031	51	3	(	(	PUNCT
easat-8031	51	4	e.g.	e.g.	ADV
easat-8031	51	5	,	,	PUNCT
easat-8031	51	6	sex	sex	NOUN
easat-8031	51	7	and	and	CCONJ
easat-8031	51	8	anti	anti	ADJ
easat-8031	51	9	-	-	ADJ
easat-8031	51	10	tpo	tpo	ADJ
easat-8031	51	11	positivity	positivity	NOUN
easat-8031	51	12	)	)	PUNCT
easat-8031	51	13	and	and	CCONJ
easat-8031	51	14	pearson	pearson	PROPN
easat-8031	51	15	’s	’s	PART
easat-8031	51	16	correlation	correlation	NOUN
easat-8031	51	17	coefficient	coefficient	NOUN
easat-8031	51	18	(	(	PUNCT
easat-8031	51	19	r	r	NOUN
easat-8031	51	20	)	)	PUNCT
easat-8031	51	21	were	be	AUX
easat-8031	51	22	used	use	VERB
easat-8031	51	23	to	to	PART
easat-8031	51	24	assess	assess	VERB
easat-8031	51	25	the	the	DET
easat-8031	51	26	relationships	relationship	NOUN
easat-8031	51	27	between	between	ADP
easat-8031	51	28	vitamin	vitamin	NOUN
easat-8031	51	29	d	d	PROPN
easat-8031	51	30	,	,	PUNCT
easat-8031	51	31	tsh	tsh	NOUN
easat-8031	51	32	,	,	PUNCT
easat-8031	51	33	and	and	CCONJ
easat-8031	51	34	anti	anti	ADJ
easat-8031	51	35	-	-	NOUN
easat-8031	51	36	tpo	tpo	NOUN
easat-8031	51	37	.	.	PUNCT
easat-8031	52	1	receiver	receiver	PROPN
easat-8031	52	2	1096	1096	NUM
easat-8031	52	3	edelweiss	edelweiss	PROPN
easat-8031	52	4	applied	apply	VERB
easat-8031	52	5	science	science	NOUN
easat-8031	52	6	and	and	CCONJ
easat-8031	52	7	technology	technology	NOUN
easat-8031	52	8	issn	issn	PROPN
easat-8031	52	9	:	:	PUNCT
easat-8031	52	10	2576	2576	NUM
easat-8031	52	11	-	-	SYM
easat-8031	52	12	8484	8484	NUM
easat-8031	52	13	vol	vol	NOUN
easat-8031	52	14	.	.	PROPN
easat-8031	53	1	9	9	NUM
easat-8031	53	2	,	,	PUNCT
easat-8031	53	3	no	no	INTJ
easat-8031	53	4	.	.	NOUN
easat-8031	53	5	6	6	NUM
easat-8031	53	6	:	:	SYM
easat-8031	53	7	1094	1094	NUM
easat-8031	53	8	-	-	SYM
easat-8031	53	9	1103	1103	NUM
easat-8031	53	10	,	,	PUNCT
easat-8031	53	11	2025	2025	NUM
easat-8031	53	12	doi	doi	NOUN
easat-8031	53	13	:	:	PUNCT
easat-8031	53	14	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	53	15	©	©	PROPN
easat-8031	53	16	2025	2025	NUM
easat-8031	53	17	by	by	ADP
easat-8031	53	18	the	the	DET
easat-8031	53	19	authors	author	NOUN
easat-8031	53	20	;	;	PUNCT
easat-8031	53	21	licensee	licensee	PROPN
easat-8031	53	22	learning	learn	VERB
easat-8031	53	23	gate	gate	NOUN
easat-8031	53	24	operating	operate	VERB
easat-8031	53	25	characteristic	characteristic	NOUN
easat-8031	53	26	(	(	PUNCT
easat-8031	53	27	roc	roc	PROPN
easat-8031	53	28	)	)	PUNCT
easat-8031	53	29	curves	curve	NOUN
easat-8031	53	30	were	be	AUX
easat-8031	53	31	used	use	VERB
easat-8031	53	32	to	to	PART
easat-8031	53	33	evaluate	evaluate	VERB
easat-8031	53	34	diagnostic	diagnostic	ADJ
easat-8031	53	35	accuracy	accuracy	NOUN
easat-8031	53	36	.	.	PUNCT
easat-8031	54	1	statistical	statistical	ADJ
easat-8031	54	2	significance	significance	NOUN
easat-8031	54	3	was	be	AUX
easat-8031	54	4	set	set	VERB
easat-8031	54	5	at	at	ADP
easat-8031	54	6	p	p	NOUN
easat-8031	54	7	<	<	X
easat-8031	54	8	0.05	0.05	NUM
easat-8031	54	9	.	.	PUNCT
easat-8031	55	1	2.3	2.3	NUM
easat-8031	55	2	.	.	PUNCT
easat-8031	56	1	ethical	ethical	ADJ
easat-8031	56	2	considerations	consideration	NOUN
easat-8031	56	3	the	the	DET
easat-8031	56	4	study	study	NOUN
easat-8031	56	5	protocol	protocol	NOUN
easat-8031	56	6	was	be	AUX
easat-8031	56	7	approved	approve	VERB
easat-8031	56	8	by	by	ADP
easat-8031	56	9	the	the	DET
easat-8031	56	10	iraqi	iraqi	PROPN
easat-8031	56	11	ministry	ministry	PROPN
easat-8031	56	12	of	of	ADP
easat-8031	56	13	health	health	PROPN
easat-8031	56	14	(	(	PUNCT
easat-8031	56	15	document	document	NOUN
easat-8031	56	16	no	no	INTJ
easat-8031	56	17	.	.	NOUN
easat-8031	56	18	2024/255	2024/255	NUM
easat-8031	56	19	)	)	PUNCT
easat-8031	56	20	,	,	PUNCT
easat-8031	56	21	and	and	CCONJ
easat-8031	56	22	adhered	adhere	VERB
easat-8031	56	23	to	to	ADP
easat-8031	56	24	the	the	DET
easat-8031	56	25	declaration	declaration	NOUN
easat-8031	56	26	of	of	ADP
easat-8031	56	27	helsinki	helsinki	PROPN
easat-8031	56	28	.	.	PUNCT
easat-8031	57	1	written	write	VERB
easat-8031	57	2	informed	informed	ADJ
easat-8031	57	3	consent	consent	NOUN
easat-8031	57	4	was	be	AUX
easat-8031	57	5	obtained	obtain	VERB
easat-8031	57	6	from	from	ADP
easat-8031	57	7	all	all	DET
easat-8031	57	8	the	the	DET
easat-8031	57	9	participants	participant	NOUN
easat-8031	57	10	.	.	PUNCT
easat-8031	58	1	confidentiality	confidentiality	NOUN
easat-8031	58	2	was	be	AUX
easat-8031	58	3	maintained	maintain	VERB
easat-8031	58	4	by	by	ADP
easat-8031	58	5	anonymizing	anonymizing	NOUN
easat-8031	58	6	data	datum	NOUN
easat-8031	58	7	,	,	PUNCT
easat-8031	58	8	and	and	CCONJ
easat-8031	58	9	participants	participant	NOUN
easat-8031	58	10	received	receive	VERB
easat-8031	58	11	no	no	DET
easat-8031	58	12	financial	financial	ADJ
easat-8031	58	13	compensation	compensation	NOUN
easat-8031	58	14	.	.	PUNCT
easat-8031	59	1	3	3	X
easat-8031	59	2	.	.	NOUN
easat-8031	59	3	results	result	VERB
easat-8031	59	4	a	a	DET
easat-8031	59	5	description	description	NOUN
easat-8031	59	6	of	of	ADP
easat-8031	59	7	the	the	DET
easat-8031	59	8	investigated	investigate	VERB
easat-8031	59	9	groups	group	NOUN
easat-8031	59	10	according	accord	VERB
easat-8031	59	11	to	to	ADP
easat-8031	59	12	sex	sex	NOUN
easat-8031	59	13	is	be	AUX
easat-8031	59	14	shown	show	VERB
easat-8031	59	15	in	in	ADP
easat-8031	59	16	figure	figure	NOUN
easat-8031	59	17	(	(	PUNCT
easat-8031	59	18	1	1	NUM
easat-8031	59	19	)	)	PUNCT
easat-8031	59	20	.	.	PUNCT
easat-8031	60	1	this	this	DET
easat-8031	60	2	study	study	NOUN
easat-8031	60	3	included	include	VERB
easat-8031	60	4	100	100	NUM
easat-8031	60	5	individuals	individual	NOUN
easat-8031	60	6	classified	classify	VERB
easat-8031	60	7	into	into	ADP
easat-8031	60	8	two	two	NUM
easat-8031	60	9	categories	category	NOUN
easat-8031	60	10	:	:	PUNCT
easat-8031	60	11	the	the	DET
easat-8031	60	12	first	first	ADJ
easat-8031	60	13	category	category	NOUN
easat-8031	60	14	included	include	VERB
easat-8031	60	15	50	50	NUM
easat-8031	60	16	individuals	individual	NOUN
easat-8031	60	17	suffering	suffer	VERB
easat-8031	60	18	from	from	ADP
easat-8031	60	19	autoimmune	autoimmune	ADJ
easat-8031	60	20	hypothyroidism	hypothyroidism	NOUN
easat-8031	60	21	[	[	PUNCT
easat-8031	60	22	16	16	NUM
easat-8031	60	23	males	male	NOUN
easat-8031	60	24	and	and	CCONJ
easat-8031	60	25	34	34	NUM
easat-8031	60	26	females	female	NOUN
easat-8031	60	27	]	]	PUNCT
easat-8031	60	28	and	and	CCONJ
easat-8031	60	29	the	the	DET
easat-8031	60	30	second	second	ADJ
easat-8031	60	31	was	be	AUX
easat-8031	60	32	healthy	healthy	ADJ
easat-8031	60	33	people	people	NOUN
easat-8031	60	34	as	as	ADP
easat-8031	60	35	a	a	DET
easat-8031	60	36	control	control	NOUN
easat-8031	60	37	that	that	PRON
easat-8031	60	38	included	include	VERB
easat-8031	60	39	50	50	NUM
easat-8031	60	40	individuals	individual	NOUN
easat-8031	60	41	[	[	PUNCT
easat-8031	60	42	15	15	NUM
easat-8031	60	43	males	male	NOUN
easat-8031	60	44	and	and	CCONJ
easat-8031	60	45	35	35	NUM
easat-8031	60	46	females	female	NOUN
easat-8031	60	47	]	]	PUNCT
easat-8031	60	48	.	.	PUNCT
easat-8031	61	1	the	the	DET
easat-8031	61	2	majority	majority	NOUN
easat-8031	61	3	of	of	ADP
easat-8031	61	4	patients	patient	NOUN
easat-8031	61	5	participating	participate	VERB
easat-8031	61	6	in	in	ADP
easat-8031	61	7	the	the	DET
easat-8031	61	8	study	study	NOUN
easat-8031	61	9	were	be	AUX
easat-8031	61	10	female	female	ADJ
easat-8031	61	11	(	(	PUNCT
easat-8031	61	12	68	68	NUM
easat-8031	61	13	%	%	NOUN
easat-8031	61	14	)	)	PUNCT
easat-8031	61	15	compared	compare	VERB
easat-8031	61	16	to	to	ADP
easat-8031	61	17	males	male	NOUN
easat-8031	61	18	(	(	PUNCT
easat-8031	61	19	32	32	NUM
easat-8031	61	20	%	%	NOUN
easat-8031	61	21	)	)	PUNCT
easat-8031	61	22	,	,	PUNCT
easat-8031	61	23	and	and	CCONJ
easat-8031	61	24	the	the	DET
easat-8031	61	25	female	female	NOUN
easat-8031	61	26	-	-	PUNCT
easat-8031	61	27	to	to	ADP
easat-8031	61	28	-	-	PUNCT
easat-8031	61	29	male	male	NOUN
easat-8031	61	30	ratio	ratio	NOUN
easat-8031	61	31	was	be	AUX
easat-8031	61	32	2.13:1	2.13:1	NUM
easat-8031	61	33	.	.	PUNCT
easat-8031	62	1	figure	figure	NOUN
easat-8031	62	2	1	1	NUM
easat-8031	62	3	.	.	PUNCT
easat-8031	63	1	represent	represent	VERB
easat-8031	63	2	the	the	DET
easat-8031	63	3	prevalence	prevalence	NOUN
easat-8031	63	4	of	of	ADP
easat-8031	63	5	hashimoto	hashimoto	NOUN
easat-8031	63	6	’s	’s	PART
easat-8031	63	7	disease	disease	NOUN
easat-8031	63	8	in	in	ADP
easat-8031	63	9	women	woman	NOUN
easat-8031	63	10	compared	compare	VERB
easat-8031	63	11	to	to	ADP
easat-8031	63	12	men	man	NOUN
easat-8031	63	13	.	.	PUNCT
easat-8031	64	1	thyroid	thyroid	NOUN
easat-8031	64	2	hormone	hormone	NOUN
easat-8031	64	3	values	value	NOUN
easat-8031	64	4	were	be	AUX
easat-8031	64	5	estimated	estimate	VERB
easat-8031	64	6	to	to	PART
easat-8031	64	7	diagnose	diagnose	VERB
easat-8031	64	8	patients	patient	NOUN
easat-8031	64	9	with	with	ADP
easat-8031	64	10	hypothyroidism	hypothyroidism	NOUN
easat-8031	64	11	,	,	PUNCT
easat-8031	64	12	and	and	CCONJ
easat-8031	64	13	tpo	tpo	NOUN
easat-8031	64	14	antibody	antibody	NOUN
easat-8031	64	15	values	value	NOUN
easat-8031	64	16	were	be	AUX
easat-8031	64	17	used	use	VERB
easat-8031	64	18	to	to	PART
easat-8031	64	19	confirm	confirm	VERB
easat-8031	64	20	autoimmune	autoimmune	ADJ
easat-8031	64	21	hypothyroidism	hypothyroidism	NOUN
easat-8031	64	22	,	,	PUNCT
easat-8031	64	23	as	as	SCONJ
easat-8031	64	24	listed	list	VERB
easat-8031	64	25	in	in	ADP
easat-8031	64	26	table	table	NOUN
easat-8031	64	27	1	1	NUM
easat-8031	64	28	.	.	PUNCT
easat-8031	65	1	the	the	DET
easat-8031	65	2	results	result	NOUN
easat-8031	65	3	showed	show	VERB
easat-8031	65	4	that	that	SCONJ
easat-8031	65	5	the	the	DET
easat-8031	65	6	positivity	positivity	NOUN
easat-8031	65	7	rate	rate	NOUN
easat-8031	65	8	of	of	ADP
easat-8031	65	9	the	the	DET
easat-8031	65	10	tpo	tpo	NOUN
easat-8031	65	11	antibody	antibody	NOUN
easat-8031	65	12	was	be	AUX
easat-8031	65	13	37/50	37/50	NUM
easat-8031	65	14	(	(	PUNCT
easat-8031	65	15	74	74	NUM
easat-8031	65	16	%	%	NOUN
easat-8031	65	17	)	)	PUNCT
easat-8031	65	18	in	in	ADP
easat-8031	65	19	patients	patient	NOUN
easat-8031	65	20	.	.	PUNCT
easat-8031	66	1	only	only	ADV
easat-8031	66	2	two	two	NUM
easat-8031	66	3	healthy	healthy	ADJ
easat-8031	66	4	individuals	individual	NOUN
easat-8031	66	5	were	be	AUX
easat-8031	66	6	positive	positive	ADJ
easat-8031	66	7	for	for	SCONJ
easat-8031	66	8	the	the	DET
easat-8031	66	9	tpo	tpo	NOUN
easat-8031	66	10	antibody	antibody	NOUN
easat-8031	66	11	2/50	2/50	NUM
easat-8031	66	12	(	(	PUNCT
easat-8031	66	13	4	4	NUM
easat-8031	66	14	%	%	NOUN
easat-8031	66	15	)	)	PUNCT
easat-8031	66	16	,	,	PUNCT
easat-8031	66	17	and	and	CCONJ
easat-8031	66	18	the	the	DET
easat-8031	66	19	tpo	tpo	NOUN
easat-8031	66	20	-	-	PUNCT
easat-8031	66	21	abs	ab	NOUN
easat-8031	66	22	mean	mean	VERB
easat-8031	66	23	values	value	NOUN
easat-8031	66	24	were	be	AUX
easat-8031	66	25	higher	high	ADJ
easat-8031	66	26	in	in	ADP
easat-8031	66	27	patients	patient	NOUN
easat-8031	66	28	than	than	ADP
easat-8031	66	29	in	in	ADP
easat-8031	66	30	healthy	healthy	ADJ
easat-8031	66	31	individuals	individual	NOUN
easat-8031	66	32	.	.	PUNCT
easat-8031	67	1	according	accord	VERB
easat-8031	67	2	to	to	ADP
easat-8031	67	3	the	the	DET
easat-8031	67	4	levels	level	NOUN
easat-8031	67	5	of	of	ADP
easat-8031	67	6	vitamin	vitamin	NOUN
easat-8031	67	7	d	d	NOUN
easat-8031	67	8	in	in	ADP
easat-8031	67	9	the	the	DET
easat-8031	67	10	studied	study	VERB
easat-8031	67	11	groups	group	NOUN
easat-8031	67	12	,	,	PUNCT
easat-8031	67	13	patients	patient	NOUN
easat-8031	67	14	had	have	VERB
easat-8031	67	15	reduced	reduce	VERB
easat-8031	67	16	levels	level	NOUN
easat-8031	67	17	compared	compare	VERB
easat-8031	67	18	with	with	ADP
easat-8031	67	19	healthy	healthy	ADJ
easat-8031	67	20	individuals	individual	NOUN
easat-8031	67	21	.	.	PUNCT
easat-8031	68	1	table	table	NOUN
easat-8031	68	2	1	1	NUM
easat-8031	68	3	.	.	PUNCT
easat-8031	68	4	represent	represent	VERB
easat-8031	68	5	the	the	DET
easat-8031	68	6	means	mean	NOUN
easat-8031	68	7	of	of	ADP
easat-8031	68	8	levels	level	NOUN
easat-8031	68	9	of	of	ADP
easat-8031	68	10	thyroids	thyroid	NOUN
easat-8031	68	11	hormones	hormone	NOUN
easat-8031	68	12	,	,	PUNCT
easat-8031	68	13	vitamin	vitamin	NOUN
easat-8031	68	14	d	d	PROPN
easat-8031	68	15	,	,	PUNCT
easat-8031	68	16	tpo	tpo	NOUN
easat-8031	68	17	-	-	PUNCT
easat-8031	68	18	abs	ab	NOUN
easat-8031	68	19	,	,	PUNCT
easat-8031	68	20	and	and	CCONJ
easat-8031	68	21	bml	bml	PROPN
easat-8031	68	22	of	of	ADP
easat-8031	68	23	the	the	DET
easat-8031	68	24	patients	patient	NOUN
easat-8031	68	25	group	group	NOUN
easat-8031	68	26	compared	compare	VERB
easat-8031	68	27	to	to	ADP
easat-8031	68	28	control	control	NOUN
easat-8031	68	29	group	group	NOUN
easat-8031	68	30	using	use	VERB
easat-8031	68	31	t	t	NOUN
easat-8031	68	32	-	-	PUNCT
easat-8031	68	33	test	test	NOUN
easat-8031	68	34	.	.	PUNCT
easat-8031	69	1	p	p	NOUN
easat-8031	69	2	value	value	NOUN
easat-8031	69	3	t	t	PROPN
easat-8031	69	4	test	test	NOUN
easat-8031	69	5	control	control	PROPN
easat-8031	69	6	mean±	mean±	PROPN
easat-8031	69	7	sd	sd	ADP
easat-8031	69	8	patients	patient	NOUN
easat-8031	69	9	mean±	mean±	PROPN
easat-8031	69	10	sd	sd	ADP
easat-8031	69	11	parameters	parameter	NOUN
easat-8031	69	12	0.00	0.00	NUM
easat-8031	69	13	*	*	SYM
easat-8031	69	14	*	*	PUNCT
easat-8031	69	15	15.3	15.3	NUM
easat-8031	69	16	1.89±	1.89±	NOUN
easat-8031	69	17	0.81	0.81	NUM
easat-8031	69	18	10.25±3.7	10.25±3.7	NUM
easat-8031	69	19	tsh	tsh	ADP
easat-8031	69	20	0.00	0.00	NUM
easat-8031	69	21	*	*	NOUN
easat-8031	69	22	*	*	PUNCT
easat-8031	69	23	-13	-13	PUNCT
easat-8031	69	24	.	.	PUNCT
easat-8031	70	1	66	66	NUM
easat-8031	71	1	66.02	66.02	NUM
easat-8031	71	2	±19.5	±19.5	NUM
easat-8031	71	3	25.73±7.28	25.73±7.28	NUM
easat-8031	71	4	t4	t4	PROPN
easat-8031	71	5	0.01	0.01	NUM
easat-8031	71	6	*	*	PROPN
easat-8031	71	7	*	*	PUNCT
easat-8031	71	8	-8.001	-8.001	PUNCT
easat-8031	71	9	2.39±0.6	2.39±0.6	NUM
easat-8031	71	10	1.51±	1.51±	NOUN
easat-8031	71	11	0.5	0.5	NUM
easat-8031	71	12	t3	t3	NOUN
easat-8031	71	13	0.01	0.01	NUM
easat-8031	71	14	*	*	PUNCT
easat-8031	71	15	*	*	X
easat-8031	71	16	20.4	20.4	NUM
easat-8031	71	17	6.2±5.3	6.2±5.3	NUM
easat-8031	71	18	58.6±17.4	58.6±17.4	NUM
easat-8031	71	19	tpo	tpo	NOUN
easat-8031	71	20	-	-	PUNCT
easat-8031	71	21	abs	ab	VERB
easat-8031	71	22	0.01	0.01	NUM
easat-8031	71	23	*	*	PUNCT
easat-8031	71	24	*	*	PUNCT
easat-8031	72	1	-7.4	-7.4	PUNCT
easat-8031	72	2	35.45±11.8	35.45±11.8	NUM
easat-8031	73	1	21.27±7.6	21.27±7.6	NUM
easat-8031	73	2	vd	vd	NOUN
easat-8031	73	3	0.01	0.01	NUM
easat-8031	73	4	*	*	PUNCT
easat-8031	73	5	*	*	PUNCT
easat-8031	73	6	7.32	7.32	NUM
easat-8031	73	7	24.4±1.8	24.4±1.8	NUM
easat-8031	73	8	28.3±3.3	28.3±3.3	NUM
easat-8031	73	9	bmi	bmi	NOUN
easat-8031	73	10	0	0	NUM
easat-8031	73	11	5	5	NUM
easat-8031	73	12	10	10	NUM
easat-8031	73	13	15	15	NUM
easat-8031	73	14	20	20	NUM
easat-8031	73	15	25	25	NUM
easat-8031	73	16	30	30	NUM
easat-8031	73	17	35	35	NUM
easat-8031	73	18	patients	patient	NOUN
easat-8031	73	19	healthy	healthy	ADJ
easat-8031	73	20	male	male	NOUN
easat-8031	73	21	16	16	NUM
easat-8031	73	22	15	15	NUM
easat-8031	73	23	female	female	ADJ
easat-8031	73	24	34	34	NUM
easat-8031	73	25	35	35	NUM
easat-8031	73	26	1097	1097	NUM
easat-8031	73	27	edelweiss	edelweiss	PROPN
easat-8031	73	28	applied	apply	VERB
easat-8031	73	29	science	science	NOUN
easat-8031	73	30	and	and	CCONJ
easat-8031	73	31	technology	technology	NOUN
easat-8031	73	32	issn	issn	PROPN
easat-8031	73	33	:	:	PUNCT
easat-8031	73	34	2576	2576	NUM
easat-8031	73	35	-	-	SYM
easat-8031	73	36	8484	8484	NUM
easat-8031	73	37	vol	vol	NOUN
easat-8031	73	38	.	.	PROPN
easat-8031	73	39	9	9	NUM
easat-8031	73	40	,	,	PUNCT
easat-8031	73	41	no	no	INTJ
easat-8031	73	42	.	.	NOUN
easat-8031	73	43	6	6	NUM
easat-8031	73	44	:	:	SYM
easat-8031	73	45	1094	1094	NUM
easat-8031	73	46	-	-	SYM
easat-8031	73	47	1103	1103	NUM
easat-8031	73	48	,	,	PUNCT
easat-8031	73	49	2025	2025	NUM
easat-8031	73	50	doi	doi	NOUN
easat-8031	73	51	:	:	PUNCT
easat-8031	73	52	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	73	53	©	©	PROPN
easat-8031	73	54	2025	2025	NUM
easat-8031	73	55	by	by	ADP
easat-8031	73	56	the	the	DET
easat-8031	73	57	authors	author	NOUN
easat-8031	73	58	;	;	PUNCT
easat-8031	73	59	licensee	licensee	PROPN
easat-8031	73	60	learning	learning	PROPN
easat-8031	73	61	gate	gate	PROPN
easat-8031	73	62	pearson	pearson	PROPN
easat-8031	73	63	's	's	PART
easat-8031	73	64	correlation	correlation	NOUN
easat-8031	73	65	showed	show	VERB
easat-8031	73	66	a	a	DET
easat-8031	73	67	non	non	ADJ
easat-8031	73	68	-	-	ADJ
easat-8031	73	69	significant	significant	ADJ
easat-8031	73	70	negative	negative	ADJ
easat-8031	73	71	association	association	NOUN
easat-8031	73	72	between	between	ADP
easat-8031	73	73	vitamin	vitamin	NOUN
easat-8031	73	74	d	d	NOUN
easat-8031	73	75	and	and	CCONJ
easat-8031	73	76	tsh	tsh	NOUN
easat-8031	73	77	and	and	CCONJ
easat-8031	73	78	anti	anti	ADJ
easat-8031	73	79	-	-	ADJ
easat-8031	73	80	tpo	tpo	NOUN
easat-8031	73	81	levels	level	NOUN
easat-8031	73	82	.	.	PUNCT
easat-8031	74	1	figures	figure	NOUN
easat-8031	74	2	(	(	PUNCT
easat-8031	74	3	2	2	NUM
easat-8031	74	4	)	)	PUNCT
easat-8031	74	5	and	and	CCONJ
easat-8031	74	6	(	(	PUNCT
easat-8031	74	7	3	3	NUM
easat-8031	74	8	)	)	PUNCT
easat-8031	74	9	.	.	PUNCT
easat-8031	75	1	figure	figure	NOUN
easat-8031	75	2	2	2	NUM
easat-8031	75	3	.	.	PUNCT
easat-8031	75	4	represent	represent	VERB
easat-8031	75	5	an	an	DET
easat-8031	75	6	inverse	inverse	NOUN
easat-8031	75	7	relationship	relationship	NOUN
easat-8031	75	8	between	between	ADP
easat-8031	75	9	tsh	tsh	PROPN
easat-8031	75	10	&	&	CCONJ
easat-8031	75	11	vitamin	vitamin	PROPN
easat-8031	75	12	d	d	PROPN
easat-8031	75	13	levels	level	NOUN
easat-8031	75	14	was	be	AUX
easat-8031	75	15	identified	identify	VERB
easat-8031	75	16	in	in	ADP
easat-8031	75	17	patients	patient	NOUN
easat-8031	75	18	group	group	NOUN
easat-8031	75	19	using	use	VERB
easat-8031	75	20	pearson	pearson	PROPN
easat-8031	75	21	’s	’s	PART
easat-8031	75	22	correlation	correlation	NOUN
easat-8031	75	23	coefficient	coefficient	NOUN
easat-8031	75	24	.	.	PUNCT
easat-8031	76	1	1098	1098	NUM
easat-8031	76	2	edelweiss	edelweiss	PROPN
easat-8031	76	3	applied	apply	VERB
easat-8031	76	4	science	science	NOUN
easat-8031	76	5	and	and	CCONJ
easat-8031	76	6	technology	technology	NOUN
easat-8031	76	7	issn	issn	PROPN
easat-8031	76	8	:	:	PUNCT
easat-8031	76	9	2576	2576	NUM
easat-8031	76	10	-	-	SYM
easat-8031	76	11	8484	8484	NUM
easat-8031	76	12	vol	vol	NOUN
easat-8031	76	13	.	.	PROPN
easat-8031	77	1	9	9	NUM
easat-8031	77	2	,	,	PUNCT
easat-8031	77	3	no	no	INTJ
easat-8031	77	4	.	.	NOUN
easat-8031	77	5	6	6	NUM
easat-8031	77	6	:	:	SYM
easat-8031	77	7	1094	1094	NUM
easat-8031	77	8	-	-	SYM
easat-8031	77	9	1103	1103	NUM
easat-8031	77	10	,	,	PUNCT
easat-8031	77	11	2025	2025	NUM
easat-8031	77	12	doi	doi	NOUN
easat-8031	77	13	:	:	PUNCT
easat-8031	77	14	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	77	15	©	©	PROPN
easat-8031	77	16	2025	2025	NUM
easat-8031	77	17	by	by	ADP
easat-8031	77	18	the	the	DET
easat-8031	77	19	authors	author	NOUN
easat-8031	77	20	;	;	PUNCT
easat-8031	77	21	licensee	licensee	PROPN
easat-8031	77	22	learning	learn	VERB
easat-8031	77	23	gate	gate	PROPN
easat-8031	77	24	figure	figure	NOUN
easat-8031	77	25	3	3	NUM
easat-8031	77	26	.	.	PUNCT
easat-8031	77	27	represent	represent	VERB
easat-8031	77	28	an	an	DET
easat-8031	77	29	inverse	inverse	NOUN
easat-8031	77	30	relationship	relationship	NOUN
easat-8031	77	31	between	between	ADP
easat-8031	77	32	tpoabs&vitamin	tpoabs&vitamin	PROPN
easat-8031	77	33	d	d	PROPN
easat-8031	77	34	levels	level	NOUN
easat-8031	77	35	was	be	AUX
easat-8031	77	36	identified	identify	VERB
easat-8031	77	37	in	in	ADP
easat-8031	77	38	patients	patient	NOUN
easat-8031	77	39	group	group	NOUN
easat-8031	77	40	using	use	VERB
easat-8031	77	41	pearson	pearson	PROPN
easat-8031	77	42	’s	’s	PART
easat-8031	77	43	correlation	correlation	NOUN
easat-8031	77	44	coefficient	coefficient	NOUN
easat-8031	77	45	.	.	PUNCT
easat-8031	78	1	the	the	DET
easat-8031	78	2	results	result	NOUN
easat-8031	78	3	of	of	ADP
easat-8031	78	4	roc	roc	PROPN
easat-8031	78	5	listed	list	VERB
easat-8031	78	6	in	in	ADP
easat-8031	78	7	tables	table	NOUN
easat-8031	78	8	(	(	PUNCT
easat-8031	78	9	2	2	NUM
easat-8031	78	10	)	)	PUNCT
easat-8031	78	11	and	and	CCONJ
easat-8031	78	12	(	(	PUNCT
easat-8031	78	13	3	3	X
easat-8031	78	14	)	)	PUNCT
easat-8031	78	15	demonstrate	demonstrate	VERB
easat-8031	78	16	the	the	DET
easat-8031	78	17	calculated	calculate	VERB
easat-8031	78	18	results	result	NOUN
easat-8031	78	19	for	for	ADP
easat-8031	78	20	testing	test	VERB
easat-8031	78	21	the	the	DET
easat-8031	78	22	selected	select	VERB
easat-8031	78	23	variables	variable	NOUN
easat-8031	78	24	as	as	ADV
easat-8031	78	25	well	well	ADV
easat-8031	78	26	as	as	ADP
easat-8031	78	27	to	to	PART
easat-8031	78	28	reveal	reveal	VERB
easat-8031	78	29	the	the	DET
easat-8031	78	30	validity	validity	NOUN
easat-8031	78	31	of	of	ADP
easat-8031	78	32	these	these	DET
easat-8031	78	33	biomarkers	biomarker	NOUN
easat-8031	78	34	in	in	ADP
easat-8031	78	35	diagnosing	diagnose	VERB
easat-8031	78	36	hashimoto	hashimoto	NOUN
easat-8031	78	37	’s	’s	PART
easat-8031	78	38	disease	disease	NOUN
easat-8031	78	39	figures	figure	VERB
easat-8031	78	40	4	4	NUM
easat-8031	78	41	and	and	CCONJ
easat-8031	78	42	5	5	NUM
easat-8031	78	43	.	.	NOUN
easat-8031	78	44	table	table	NOUN
easat-8031	78	45	2	2	NUM
easat-8031	78	46	.	.	PUNCT
easat-8031	78	47	represent	represent	VERB
easat-8031	78	48	the	the	DET
easat-8031	78	49	calculated	calculate	VERB
easat-8031	78	50	results	result	NOUN
easat-8031	78	51	for	for	ADP
easat-8031	78	52	testing	test	VERB
easat-8031	78	53	anti	anti	ADJ
easat-8031	78	54	-	-	NOUN
easat-8031	78	55	tpo	tpo	NOUN
easat-8031	78	56	and	and	CCONJ
easat-8031	78	57	tsh	tsh	NOUN
easat-8031	78	58	using	use	VERB
easat-8031	78	59	roc	roc	PROPN
easat-8031	78	60	test	test	NOUN
easat-8031	78	61	for	for	ADP
easat-8031	78	62	patient	patient	ADJ
easat-8031	78	63	and	and	CCONJ
easat-8031	78	64	healthy	healthy	ADJ
easat-8031	78	65	subjects	subject	NOUN
easat-8031	78	66	.	.	PUNCT
easat-8031	79	1	area	area	NOUN
easat-8031	79	2	under	under	ADP
easat-8031	79	3	the	the	DET
easat-8031	79	4	curve	curve	NOUN
easat-8031	79	5	test	test	NOUN
easat-8031	79	6	result	result	NOUN
easat-8031	79	7	variables	variable	NOUN
easat-8031	79	8	area	area	NOUN
easat-8031	79	9	std	std	PROPN
easat-8031	79	10	.	.	PUNCT
easat-8031	79	11	error	error	NOUN
easat-8031	79	12	asymptotic	asymptotic	ADJ
easat-8031	79	13	sig	sig	NOUN
easat-8031	79	14	.	.	PUNCT
easat-8031	80	1	asymptotic	asymptotic	ADJ
easat-8031	80	2	95	95	NUM
easat-8031	80	3	%	%	NOUN
easat-8031	80	4	confidence	confidence	NOUN
easat-8031	80	5	interval	interval	NOUN
easat-8031	80	6	lower	lower	ADV
easat-8031	80	7	bound	bind	VERB
easat-8031	80	8	upper	upper	ADJ
easat-8031	80	9	bound	bind	VERB
easat-8031	80	10	tpo	tpo	NOUN
easat-8031	80	11	.980	.980	NUM
easat-8031	81	1	0.011	0.011	NUM
easat-8031	81	2	0.000	0.000	NUM
easat-8031	81	3	0.959	0.959	NUM
easat-8031	81	4	1.000	1.000	NUM
easat-8031	81	5	tsh	tsh	NOUN
easat-8031	81	6	1.000	1.000	NUM
easat-8031	81	7	0.000	0.000	NUM
easat-8031	81	8	0.000	0.000	NUM
easat-8031	81	9	1.000	1.000	NUM
easat-8031	81	10	1.000	1.000	NUM
easat-8031	81	11	the	the	DET
easat-8031	81	12	results	result	NOUN
easat-8031	81	13	indicated	indicate	VERB
easat-8031	81	14	that	that	SCONJ
easat-8031	81	15	autoantibodies	autoantibody	NOUN
easat-8031	81	16	to	to	ADP
easat-8031	81	17	thyroperoxidase(anti	thyroperoxidase(anti	PROPN
easat-8031	81	18	-	-	NOUN
easat-8031	81	19	tpo	tpo	NOUN
easat-8031	81	20	)	)	PUNCT
easat-8031	81	21	and	and	CCONJ
easat-8031	81	22	tsh	tsh	NOUN
easat-8031	81	23	have	have	VERB
easat-8031	81	24	the	the	DET
easat-8031	81	25	most	most	ADV
easat-8031	81	26	sensitive	sensitive	ADJ
easat-8031	81	27	and	and	CCONJ
easat-8031	81	28	specific	specific	ADJ
easat-8031	81	29	values	value	NOUN
easat-8031	81	30	,	,	PUNCT
easat-8031	81	31	making	make	VERB
easat-8031	81	32	them	they	PRON
easat-8031	81	33	the	the	DET
easat-8031	81	34	best	good	ADJ
easat-8031	81	35	biomarkers	biomarker	NOUN
easat-8031	81	36	for	for	ADP
easat-8031	81	37	detecting	detect	VERB
easat-8031	81	38	hashimoto	hashimoto	NOUN
easat-8031	81	39	’s	’s	PART
easat-8031	81	40	disease	disease	NOUN
easat-8031	81	41	.	.	PUNCT
easat-8031	82	1	anti	anti	ADJ
easat-8031	82	2	-	-	ADJ
easat-8031	82	3	tpo	tpo	ADJ
easat-8031	82	4	levels	level	NOUN
easat-8031	82	5	1099	1099	NUM
easat-8031	82	6	edelweiss	edelweiss	PROPN
easat-8031	82	7	applied	apply	VERB
easat-8031	82	8	science	science	NOUN
easat-8031	82	9	and	and	CCONJ
easat-8031	82	10	technology	technology	NOUN
easat-8031	82	11	issn	issn	PROPN
easat-8031	82	12	:	:	PUNCT
easat-8031	82	13	2576	2576	NUM
easat-8031	82	14	-	-	SYM
easat-8031	82	15	8484	8484	NUM
easat-8031	82	16	vol	vol	NOUN
easat-8031	82	17	.	.	PROPN
easat-8031	83	1	9	9	NUM
easat-8031	83	2	,	,	PUNCT
easat-8031	83	3	no	no	INTJ
easat-8031	83	4	.	.	NOUN
easat-8031	83	5	6	6	NUM
easat-8031	83	6	:	:	SYM
easat-8031	83	7	1094	1094	NUM
easat-8031	83	8	-	-	SYM
easat-8031	83	9	1103	1103	NUM
easat-8031	83	10	,	,	PUNCT
easat-8031	83	11	2025	2025	NUM
easat-8031	83	12	doi	doi	NOUN
easat-8031	83	13	:	:	PUNCT
easat-8031	83	14	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	83	15	©	©	PROPN
easat-8031	83	16	2025	2025	NUM
easat-8031	83	17	by	by	ADP
easat-8031	83	18	the	the	DET
easat-8031	83	19	authors	author	NOUN
easat-8031	83	20	;	;	PUNCT
easat-8031	83	21	licensee	licensee	PROPN
easat-8031	83	22	learning	learn	VERB
easat-8031	83	23	gate	gate	NOUN
easat-8031	83	24	figure	figure	NOUN
easat-8031	83	25	4	4	NUM
easat-8031	83	26	.	.	PUNCT
easat-8031	83	27	receiver	receiver	ADJ
easat-8031	83	28	operator	operator	NOUN
easat-8031	83	29	characteristic	characteristic	ADJ
easat-8031	83	30	curve	curve	NOUN
easat-8031	83	31	analysis	analysis	NOUN
easat-8031	83	32	of	of	ADP
easat-8031	83	33	tsh	tsh	NOUN
easat-8031	83	34	&	&	CCONJ
easat-8031	83	35	anti	anti	NOUN
easat-8031	83	36	-	-	NOUN
easat-8031	83	37	tpo	tpo	NOUN
easat-8031	83	38	for	for	ADP
easat-8031	83	39	the	the	DET
easat-8031	83	40	calculation	calculation	NOUN
easat-8031	83	41	a	a	DET
easat-8031	83	42	possible	possible	ADJ
easat-8031	83	43	diagnostic	diagnostic	ADJ
easat-8031	83	44	cut	cut	NOUN
easat-8031	83	45	-	-	PUNCT
easat-8031	83	46	off	off	ADP
easat-8031	83	47	value	value	NOUN
easat-8031	83	48	in	in	ADP
easat-8031	83	49	patients	patient	NOUN
easat-8031	83	50	and	and	CCONJ
easat-8031	83	51	healthy	healthy	ADJ
easat-8031	83	52	(	(	PUNCT
easat-8031	83	53	tsh	tsh	NOUN
easat-8031	83	54	cut	cut	NOUN
easat-8031	83	55	off	off	ADP
easat-8031	83	56	<	<	X
easat-8031	83	57	4.2	4.2	NUM
easat-8031	83	58	sensitivity	sensitivity	NOUN
easat-8031	83	59	100	100	NUM
easat-8031	83	60	%	%	NOUN
easat-8031	83	61	,	,	PUNCT
easat-8031	83	62	specifity	specifity	NOUN
easat-8031	83	63	100	100	NUM
easat-8031	83	64	%	%	NOUN
easat-8031	83	65	,	,	PUNCT
easat-8031	83	66	anti	anti	ADJ
easat-8031	83	67	-	-	ADJ
easat-8031	83	68	tpo	tpo	NOUN
easat-8031	83	69	cut	cut	VERB
easat-8031	83	70	off	off	ADP
easat-8031	83	71	<	<	X
easat-8031	83	72	9.5	9.5	NUM
easat-8031	83	73	,	,	PUNCT
easat-8031	83	74	sensitivity	sensitivity	NOUN
easat-8031	83	75	100	100	NUM
easat-8031	83	76	%	%	NOUN
easat-8031	83	77	,	,	PUNCT
easat-8031	83	78	specifity	specifity	NOUN
easat-8031	83	79	0.92	0.92	NUM
easat-8031	83	80	%	%	NOUN
easat-8031	83	81	)	)	PUNCT
easat-8031	83	82	.	.	PUNCT
easat-8031	84	1	while	while	SCONJ
easat-8031	84	2	,	,	PUNCT
easat-8031	84	3	the	the	DET
easat-8031	84	4	results	result	NOUN
easat-8031	84	5	of	of	ADP
easat-8031	84	6	roc	roc	PROPN
easat-8031	84	7	test	test	NOUN
easat-8031	84	8	for	for	ADP
easat-8031	84	9	vitamin	vitamin	NOUN
easat-8031	84	10	d	d	NOUN
easat-8031	84	11	demonstrated	demonstrate	VERB
easat-8031	84	12	that	that	SCONJ
easat-8031	84	13	the	the	DET
easat-8031	84	14	computed	computed	ADJ
easat-8031	84	15	area	area	NOUN
easat-8031	84	16	under	under	ADP
easat-8031	84	17	the	the	DET
easat-8031	84	18	curve	curve	NOUN
easat-8031	84	19	is	be	AUX
easat-8031	84	20	0.759	0.759	NUM
easat-8031	84	21	,	,	PUNCT
easat-8031	84	22	reflecting	reflect	VERB
easat-8031	84	23	a	a	DET
easat-8031	84	24	fair	fair	ADJ
easat-8031	84	25	level	level	NOUN
easat-8031	84	26	of	of	ADP
easat-8031	84	27	discrimination	discrimination	NOUN
easat-8031	84	28	for	for	ADP
easat-8031	84	29	vitamin	vitamin	NOUN
easat-8031	84	30	d	d	NOUN
easat-8031	84	31	in	in	ADP
easat-8031	84	32	hypothyroid	hypothyroid	ADJ
easat-8031	84	33	diseases	disease	NOUN
easat-8031	84	34	,	,	PUNCT
easat-8031	84	35	but	but	CCONJ
easat-8031	84	36	not	not	PART
easat-8031	84	37	conclusive	conclusive	ADJ
easat-8031	84	38	,	,	PUNCT
easat-8031	84	39	with	with	ADP
easat-8031	84	40	fair	fair	ADJ
easat-8031	84	41	sensitivity	sensitivity	NOUN
easat-8031	84	42	and	and	CCONJ
easat-8031	84	43	specificity	specificity	NOUN
easat-8031	84	44	table	table	NOUN
easat-8031	84	45	3	3	NUM
easat-8031	84	46	.	.	PUNCT
easat-8031	84	47	table	table	NOUN
easat-8031	84	48	3	3	NUM
easat-8031	84	49	.	.	PUNCT
easat-8031	84	50	represent	represent	VERB
easat-8031	84	51	the	the	DET
easat-8031	84	52	calculated	calculate	VERB
easat-8031	84	53	results	result	NOUN
easat-8031	84	54	for	for	ADP
easat-8031	84	55	testing	test	VERB
easat-8031	84	56	vitamin	vitamin	NOUN
easat-8031	84	57	d	d	NOUN
easat-8031	84	58	using	use	VERB
easat-8031	84	59	roc	roc	PROPN
easat-8031	84	60	test	test	NOUN
easat-8031	84	61	for	for	ADP
easat-8031	84	62	patient	patient	ADJ
easat-8031	84	63	and	and	CCONJ
easat-8031	84	64	healthy	healthy	ADJ
easat-8031	84	65	subjects	subject	NOUN
easat-8031	84	66	.	.	PUNCT
easat-8031	85	1	area	area	NOUN
easat-8031	85	2	under	under	ADP
easat-8031	85	3	the	the	DET
easat-8031	85	4	curve	curve	NOUN
easat-8031	85	5	test	test	NOUN
easat-8031	85	6	result	result	NOUN
easat-8031	85	7	variables	variable	NOUN
easat-8031	85	8	area	area	NOUN
easat-8031	85	9	std	std	PROPN
easat-8031	85	10	.	.	PUNCT
easat-8031	85	11	error	error	NOUN
easat-8031	85	12	asymptotic	asymptotic	ADJ
easat-8031	85	13	sig	sig	NOUN
easat-8031	85	14	.	.	PUNCT
easat-8031	86	1	asymptotic	asymptotic	ADJ
easat-8031	86	2	95	95	NUM
easat-8031	86	3	%	%	NOUN
easat-8031	86	4	confidence	confidence	NOUN
easat-8031	86	5	interval	interval	NOUN
easat-8031	86	6	lower	lower	ADV
easat-8031	86	7	bound	bind	VERB
easat-8031	86	8	upper	upper	ADJ
easat-8031	86	9	bound	bind	VERB
easat-8031	86	10	vitamin	vitamin	NOUN
easat-8031	86	11	d	d	ADP
easat-8031	86	12	0.759	0.759	NUM
easat-8031	86	13	0.048	0.048	NUM
easat-8031	86	14	0	0	NUM
easat-8031	86	15	0.664	0.664	NUM
easat-8031	86	16	0.854	0.854	NUM
easat-8031	86	17	1100	1100	NUM
easat-8031	86	18	edelweiss	edelweiss	PROPN
easat-8031	86	19	applied	apply	VERB
easat-8031	86	20	science	science	NOUN
easat-8031	86	21	and	and	CCONJ
easat-8031	86	22	technology	technology	NOUN
easat-8031	86	23	issn	issn	PROPN
easat-8031	86	24	:	:	PUNCT
easat-8031	86	25	2576	2576	NUM
easat-8031	86	26	-	-	SYM
easat-8031	86	27	8484	8484	NUM
easat-8031	86	28	vol	vol	NOUN
easat-8031	86	29	.	.	PROPN
easat-8031	87	1	9	9	NUM
easat-8031	87	2	,	,	PUNCT
easat-8031	87	3	no	no	INTJ
easat-8031	87	4	.	.	NOUN
easat-8031	87	5	6	6	NUM
easat-8031	87	6	:	:	SYM
easat-8031	87	7	1094	1094	NUM
easat-8031	87	8	-	-	SYM
easat-8031	87	9	1103	1103	NUM
easat-8031	87	10	,	,	PUNCT
easat-8031	87	11	2025	2025	NUM
easat-8031	87	12	doi	doi	NOUN
easat-8031	87	13	:	:	PUNCT
easat-8031	87	14	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	87	15	©	©	PROPN
easat-8031	87	16	2025	2025	NUM
easat-8031	87	17	by	by	ADP
easat-8031	87	18	the	the	DET
easat-8031	87	19	authors	author	NOUN
easat-8031	87	20	;	;	PUNCT
easat-8031	87	21	licensee	licensee	PROPN
easat-8031	87	22	learning	learn	VERB
easat-8031	87	23	gate	gate	PROPN
easat-8031	87	24	figure	figure	NOUN
easat-8031	87	25	5	5	NUM
easat-8031	87	26	.	.	PUNCT
easat-8031	87	27	receiver	receiver	ADJ
easat-8031	87	28	operator	operator	NOUN
easat-8031	87	29	characteristic	characteristic	ADJ
easat-8031	87	30	curve	curve	NOUN
easat-8031	87	31	analysis	analysis	NOUN
easat-8031	87	32	of	of	ADP
easat-8031	87	33	vitamin	vitamin	NOUN
easat-8031	87	34	d	d	NOUN
easat-8031	87	35	for	for	ADP
easat-8031	87	36	the	the	DET
easat-8031	87	37	calculation	calculation	NOUN
easat-8031	87	38	a	a	DET
easat-8031	87	39	possible	possible	ADJ
easat-8031	87	40	diagnostic	diagnostic	ADJ
easat-8031	87	41	cutoff	cutoff	NOUN
easat-8031	87	42	value	value	NOUN
easat-8031	87	43	in	in	ADP
easat-8031	87	44	patients	patient	NOUN
easat-8031	87	45	and	and	CCONJ
easat-8031	87	46	healthy(vitamin	healthy(vitamin	PROPN
easat-8031	87	47	d	d	PROPN
easat-8031	87	48	cut	cut	VERB
easat-8031	87	49	off	off	ADP
easat-8031	87	50	<	<	X
easat-8031	87	51	24.59	24.59	NUM
easat-8031	87	52	sensitivity	sensitivity	NOUN
easat-8031	87	53	70	70	NUM
easat-8031	87	54	%	%	NOUN
easat-8031	87	55	,	,	PUNCT
easat-8031	87	56	specifity	specifity	NOUN
easat-8031	87	57	74	74	NUM
easat-8031	87	58	%	%	NOUN
easat-8031	87	59	)	)	PUNCT
easat-8031	87	60	.	.	PUNCT
easat-8031	88	1	4	4	X
easat-8031	88	2	.	.	X
easat-8031	88	3	discussion	discussion	NOUN
easat-8031	88	4	hashimoto	hashimoto	NOUN
easat-8031	88	5	thyroiditis	thyroiditis	NOUN
easat-8031	88	6	.	.	PUNCT
easat-8031	88	7	is	be	AUX
easat-8031	88	8	an	an	DET
easat-8031	88	9	immune	immune	NOUN
easat-8031	88	10	-	-	PUNCT
easat-8031	88	11	mediated	mediate	VERB
easat-8031	88	12	injury	injury	NOUN
easat-8031	88	13	that	that	PRON
easat-8031	88	14	affects	affect	VERB
easat-8031	88	15	the	the	DET
easat-8031	88	16	thyroid	thyroid	NOUN
easat-8031	88	17	gland	gland	NOUN
easat-8031	88	18	,	,	PUNCT
easat-8031	88	19	and	and	CCONJ
easat-8031	88	20	women	woman	NOUN
easat-8031	88	21	appear	appear	VERB
easat-8031	88	22	to	to	PART
easat-8031	88	23	be	be	AUX
easat-8031	88	24	more	more	ADV
easat-8031	88	25	susceptible	susceptible	ADJ
easat-8031	88	26	to	to	ADP
easat-8031	88	27	it	it	PRON
easat-8031	88	28	geetha	geetha	PROPN
easat-8031	88	29	,	,	PUNCT
easat-8031	88	30	et	et	PROPN
easat-8031	88	31	al	al	PROPN
easat-8031	88	32	.	.	PUNCT
easat-8031	89	1	[	[	X
easat-8031	89	2	5	5	NUM
easat-8031	89	3	]	]	PUNCT
easat-8031	89	4	.	.	PUNCT
easat-8031	90	1	the	the	DET
easat-8031	90	2	current	current	ADJ
easat-8031	90	3	data	datum	NOUN
easat-8031	90	4	agree	agree	VERB
easat-8031	90	5	with	with	ADP
easat-8031	90	6	a	a	DET
easat-8031	90	7	local	local	ADJ
easat-8031	90	8	study	study	NOUN
easat-8031	90	9	in	in	ADP
easat-8031	90	10	thiqar	thiqar	VERB
easat-8031	90	11	province	province	NOUN
easat-8031	90	12	that	that	PRON
easat-8031	90	13	referred	refer	VERB
easat-8031	90	14	women	woman	NOUN
easat-8031	90	15	who	who	PRON
easat-8031	90	16	were	be	AUX
easat-8031	90	17	more	more	ADV
easat-8031	90	18	susceptible	susceptible	ADJ
easat-8031	90	19	to	to	ADP
easat-8031	90	20	hypothyroidism	hypothyroidism	NOUN
easat-8031	90	21	and	and	CCONJ
easat-8031	90	22	hyperthyroidism	hyperthyroidism	NOUN
easat-8031	90	23	[	[	X
easat-8031	90	24	13	13	NUM
easat-8031	90	25	]	]	PUNCT
easat-8031	90	26	.	.	PUNCT
easat-8031	91	1	the	the	DET
easat-8031	91	2	interpretation	interpretation	NOUN
easat-8031	91	3	of	of	ADP
easat-8031	91	4	prevalence	prevalence	NOUN
easat-8031	91	5	thyroid	thyroid	NOUN
easat-8031	91	6	problems	problem	NOUN
easat-8031	91	7	among	among	ADP
easat-8031	91	8	females	female	NOUN
easat-8031	91	9	,	,	PUNCT
easat-8031	91	10	it	it	PRON
easat-8031	91	11	may	may	AUX
easat-8031	91	12	be	be	AUX
easat-8031	91	13	due	due	ADJ
easat-8031	91	14	to	to	ADP
easat-8031	91	15	an	an	DET
easat-8031	91	16	imbalance	imbalance	NOUN
easat-8031	91	17	of	of	ADP
easat-8031	91	18	female	female	ADJ
easat-8031	91	19	sex	sex	NOUN
easat-8031	91	20	hormones	hormone	NOUN
easat-8031	91	21	,	,	PUNCT
easat-8031	91	22	especially	especially	ADV
easat-8031	91	23	estrogen	estrogen	NOUN
easat-8031	91	24	,	,	PUNCT
easat-8031	91	25	that	that	SCONJ
easat-8031	91	26	increases	increase	VERB
easat-8031	91	27	during	during	ADP
easat-8031	91	28	puberty	puberty	NOUN
easat-8031	91	29	and	and	CCONJ
easat-8031	91	30	pregnancy	pregnancy	NOUN
easat-8031	91	31	in	in	ADP
easat-8031	91	32	women	woman	NOUN
easat-8031	91	33	,	,	PUNCT
easat-8031	91	34	and	and	CCONJ
easat-8031	91	35	the	the	DET
easat-8031	91	36	inactivation	inactivation	NOUN
easat-8031	91	37	of	of	ADP
easat-8031	91	38	the	the	DET
easat-8031	91	39	x	x	ADJ
easat-8031	91	40	chromosome	chromosome	NOUN
easat-8031	91	41	in	in	ADP
easat-8031	91	42	the	the	DET
easat-8031	91	43	thyroid	thyroid	NOUN
easat-8031	91	44	gland	gland	NOUN
easat-8031	91	45	and	and	CCONJ
easat-8031	91	46	immune	immune	ADJ
easat-8031	91	47	system	system	NOUN
easat-8031	91	48	,	,	PUNCT
easat-8031	91	49	which	which	PRON
easat-8031	91	50	in	in	ADP
easat-8031	91	51	turn	turn	NOUN
easat-8031	91	52	predisposes	predispose	VERB
easat-8031	91	53	women	woman	NOUN
easat-8031	91	54	to	to	ADP
easat-8031	91	55	autoimmune	autoimmune	ADJ
easat-8031	91	56	thyroiditis	thyroiditis	NOUN
easat-8031	91	57	[	[	X
easat-8031	91	58	14	14	NUM
easat-8031	91	59	]	]	PUNCT
easat-8031	91	60	.	.	PUNCT
easat-8031	92	1	females	female	NOUN
easat-8031	92	2	disproportionately	disproportionately	ADV
easat-8031	92	3	carry	carry	VERB
easat-8031	92	4	high	high	ADJ
easat-8031	92	5	-	-	PUNCT
easat-8031	92	6	risk	risk	NOUN
easat-8031	92	7	hla	hla	NOUN
easat-8031	92	8	alleles	allele	NOUN
easat-8031	92	9	(	(	PUNCT
easat-8031	92	10	e.g.	e.g.	ADV
easat-8031	92	11	,	,	PUNCT
easat-8031	92	12	hla	hla	PROPN
easat-8031	92	13	-	-	PUNCT
easat-8031	92	14	dr3	dr3	PROPN
easat-8031	92	15	and	and	CCONJ
easat-8031	92	16	hla	hla	PROPN
easat-8031	92	17	-	-	PUNCT
easat-8031	92	18	dr4	dr4	PROPN
easat-8031	92	19	)	)	PUNCT
easat-8031	92	20	linked	link	VERB
easat-8031	92	21	to	to	PART
easat-8031	92	22	thyroid	thyroid	VERB
easat-8031	92	23	autoimmunity	autoimmunity	NOUN
easat-8031	92	24	.	.	PUNCT
easat-8031	93	1	these	these	DET
easat-8031	93	2	alleles	allele	NOUN
easat-8031	93	3	enhance	enhance	VERB
easat-8031	93	4	antigen	antigen	X
easat-8031	93	5	1101	1101	NUM
easat-8031	93	6	edelweiss	edelweiss	PROPN
easat-8031	93	7	applied	apply	VERB
easat-8031	93	8	science	science	NOUN
easat-8031	93	9	and	and	CCONJ
easat-8031	93	10	technology	technology	NOUN
easat-8031	93	11	issn	issn	PROPN
easat-8031	93	12	:	:	PUNCT
easat-8031	93	13	2576	2576	NUM
easat-8031	93	14	-	-	SYM
easat-8031	93	15	8484	8484	NUM
easat-8031	93	16	vol	vol	NOUN
easat-8031	93	17	.	.	PROPN
easat-8031	94	1	9	9	NUM
easat-8031	94	2	,	,	PUNCT
easat-8031	94	3	no	no	INTJ
easat-8031	94	4	.	.	NOUN
easat-8031	94	5	6	6	NUM
easat-8031	94	6	:	:	SYM
easat-8031	94	7	1094	1094	NUM
easat-8031	94	8	-	-	SYM
easat-8031	94	9	1103	1103	NUM
easat-8031	94	10	,	,	PUNCT
easat-8031	94	11	2025	2025	NUM
easat-8031	94	12	doi	doi	NOUN
easat-8031	94	13	:	:	PUNCT
easat-8031	94	14	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	94	15	©	©	PROPN
easat-8031	94	16	2025	2025	NUM
easat-8031	94	17	by	by	ADP
easat-8031	94	18	the	the	DET
easat-8031	94	19	authors	author	NOUN
easat-8031	94	20	;	;	PUNCT
easat-8031	94	21	licensee	licensee	PROPN
easat-8031	94	22	learning	learn	VERB
easat-8031	94	23	gate	gate	NOUN
easat-8031	94	24	presentation	presentation	NOUN
easat-8031	94	25	of	of	ADP
easat-8031	94	26	tpo	tpo	PROPN
easat-8031	94	27	and	and	CCONJ
easat-8031	94	28	thyroglobulin	thyroglobulin	PROPN
easat-8031	94	29	fragments	fragment	VERB
easat-8031	94	30	to	to	ADP
easat-8031	94	31	t	t	NOUN
easat-8031	94	32	cells	cell	NOUN
easat-8031	94	33	[	[	X
easat-8031	94	34	15	15	NUM
easat-8031	94	35	]	]	PUNCT
easat-8031	94	36	.	.	PUNCT
easat-8031	95	1	females	female	NOUN
easat-8031	95	2	exhibit	exhibit	VERB
easat-8031	95	3	stronger	strong	ADJ
easat-8031	95	4	innate	innate	ADJ
easat-8031	95	5	and	and	CCONJ
easat-8031	95	6	adaptive	adaptive	ADJ
easat-8031	95	7	immune	immune	ADJ
easat-8031	95	8	responses	response	NOUN
easat-8031	95	9	,	,	PUNCT
easat-8031	95	10	increasing	increase	VERB
easat-8031	95	11	both	both	DET
easat-8031	95	12	pathogen	pathogen	NOUN
easat-8031	95	13	defense	defense	NOUN
easat-8031	95	14	and	and	CCONJ
easat-8031	95	15	self	self	NOUN
easat-8031	95	16	-	-	PUNCT
easat-8031	95	17	reactivity	reactivity	NOUN
easat-8031	95	18	risk	risk	NOUN
easat-8031	95	19	.	.	PUNCT
easat-8031	96	1	women	woman	NOUN
easat-8031	96	2	with	with	ADP
easat-8031	96	3	autoimmune	autoimmune	ADJ
easat-8031	96	4	thyroid	thyroid	NOUN
easat-8031	96	5	disease	disease	NOUN
easat-8031	96	6	show	show	VERB
easat-8031	96	7	elevated	elevate	VERB
easat-8031	96	8	th17	th17	PROPN
easat-8031	96	9	cells	cell	NOUN
easat-8031	96	10	and	and	CCONJ
easat-8031	96	11	reduced	reduce	VERB
easat-8031	96	12	regulatory	regulatory	ADJ
easat-8031	96	13	t	t	NOUN
easat-8031	96	14	cells	cell	NOUN
easat-8031	96	15	,	,	PUNCT
easat-8031	96	16	an	an	DET
easat-8031	96	17	imbalance	imbalance	NOUN
easat-8031	96	18	exacerbated	exacerbate	VERB
easat-8031	96	19	by	by	ADP
easat-8031	96	20	estrogen	estrogen	NOUN
easat-8031	97	1	[	[	X
easat-8031	97	2	16	16	NUM
easat-8031	97	3	]	]	PUNCT
easat-8031	97	4	.	.	PUNCT
easat-8031	98	1	thyroid	thyroid	NOUN
easat-8031	98	2	hormone	hormone	NOUN
easat-8031	98	3	levels	level	NOUN
easat-8031	98	4	were	be	AUX
easat-8031	98	5	estimated	estimate	VERB
easat-8031	98	6	to	to	PART
easat-8031	98	7	diagnose	diagnose	VERB
easat-8031	98	8	hypothyroidism	hypothyroidism	NOUN
easat-8031	98	9	.	.	PUNCT
easat-8031	99	1	the	the	DET
easat-8031	99	2	increased	increase	VERB
easat-8031	99	3	tsh	tsh	NOUN
easat-8031	99	4	levels	level	NOUN
easat-8031	99	5	in	in	ADP
easat-8031	99	6	patients	patient	NOUN
easat-8031	99	7	with	with	ADP
easat-8031	99	8	hypothyroidism	hypothyroidism	NOUN
easat-8031	99	9	compared	compare	VERB
easat-8031	99	10	to	to	ADP
easat-8031	99	11	healthy	healthy	ADJ
easat-8031	99	12	controls	control	NOUN
easat-8031	99	13	were	be	AUX
easat-8031	99	14	consistent	consistent	ADJ
easat-8031	99	15	with	with	ADP
easat-8031	99	16	the	the	DET
easat-8031	99	17	findings	finding	NOUN
easat-8031	99	18	of	of	ADP
easat-8031	99	19	other	other	ADJ
easat-8031	99	20	studies	study	NOUN
easat-8031	99	21	mousa	mousa	VERB
easat-8031	99	22	and	and	CCONJ
easat-8031	99	23	zoori	zoori	PRON
easat-8031	100	1	[	[	X
easat-8031	100	2	13	13	NUM
easat-8031	100	3	]	]	PUNCT
easat-8031	100	4	and	and	CCONJ
easat-8031	100	5	ameen	ameen	NOUN
easat-8031	100	6	,	,	PUNCT
easat-8031	100	7	et	et	PROPN
easat-8031	100	8	al	al	PROPN
easat-8031	100	9	.	.	PUNCT
easat-8031	101	1	[	[	X
easat-8031	101	2	17	17	NUM
easat-8031	101	3	]	]	PUNCT
easat-8031	101	4	.	.	PUNCT
easat-8031	102	1	these	these	DET
easat-8031	102	2	high	high	ADJ
easat-8031	102	3	levels	level	NOUN
easat-8031	102	4	of	of	ADP
easat-8031	102	5	tsh	tsh	NOUN
easat-8031	102	6	in	in	ADP
easat-8031	102	7	patients	patient	NOUN
easat-8031	102	8	with	with	ADP
easat-8031	102	9	hypothyroidism	hypothyroidism	NOUN
easat-8031	102	10	may	may	AUX
easat-8031	102	11	be	be	AUX
easat-8031	102	12	a	a	DET
easat-8031	102	13	result	result	NOUN
easat-8031	102	14	of	of	ADP
easat-8031	102	15	the	the	DET
easat-8031	102	16	pituitary	pituitary	ADJ
easat-8031	102	17	gland	gland	NOUN
easat-8031	102	18	releasing	release	VERB
easat-8031	102	19	more	more	ADJ
easat-8031	102	20	tsh	tsh	NOUN
easat-8031	102	21	in	in	ADP
easat-8031	102	22	an	an	DET
easat-8031	102	23	attempt	attempt	NOUN
easat-8031	102	24	to	to	PART
easat-8031	102	25	induce	induce	VERB
easat-8031	102	26	the	the	DET
easat-8031	102	27	thyroid	thyroid	NOUN
easat-8031	102	28	gland	gland	NOUN
easat-8031	102	29	to	to	PART
easat-8031	102	30	increase	increase	VERB
easat-8031	102	31	the	the	DET
easat-8031	102	32	production	production	NOUN
easat-8031	102	33	of	of	ADP
easat-8031	102	34	more	more	ADJ
easat-8031	102	35	of	of	ADP
easat-8031	102	36	the	the	DET
easat-8031	102	37	low	low	ADJ
easat-8031	102	38	thyroid	thyroid	NOUN
easat-8031	102	39	hormones	hormone	NOUN
easat-8031	102	40	(	(	PUNCT
easat-8031	102	41	t3	t3	PROPN
easat-8031	102	42	,	,	PUNCT
easat-8031	102	43	t4	t4	PROPN
easat-8031	102	44	)	)	PUNCT
easat-8031	102	45	,	,	PUNCT
easat-8031	102	46	which	which	PRON
easat-8031	102	47	appeared	appear	VERB
easat-8031	102	48	low	low	ADJ
easat-8031	102	49	in	in	ADP
easat-8031	102	50	patients	patient	NOUN
easat-8031	102	51	compared	compare	VERB
easat-8031	102	52	to	to	ADP
easat-8031	102	53	controls	control	NOUN
easat-8031	102	54	in	in	ADP
easat-8031	102	55	the	the	DET
easat-8031	102	56	current	current	ADJ
easat-8031	102	57	study	study	NOUN
easat-8031	102	58	.	.	PUNCT
easat-8031	103	1	this	this	PRON
easat-8031	103	2	is	be	AUX
easat-8031	103	3	consistent	consistent	ADJ
easat-8031	103	4	with	with	ADP
easat-8031	103	5	the	the	DET
easat-8031	103	6	findings	finding	NOUN
easat-8031	103	7	of	of	ADP
easat-8031	103	8	several	several	ADJ
easat-8031	103	9	studies	study	NOUN
easat-8031	103	10	that	that	PRON
easat-8031	103	11	have	have	AUX
easat-8031	103	12	indicated	indicate	VERB
easat-8031	103	13	low	low	ADJ
easat-8031	103	14	thyroid	thyroid	NOUN
easat-8031	103	15	hormone	hormone	NOUN
easat-8031	103	16	levels	level	NOUN
easat-8031	103	17	in	in	ADP
easat-8031	103	18	patients	patient	NOUN
easat-8031	103	19	with	with	ADP
easat-8031	103	20	hypothyroidism	hypothyroidism	NOUN
easat-8031	103	21	.	.	PUNCT
easat-8031	104	1	these	these	PRON
easat-8031	104	2	approve	approve	VERB
easat-8031	104	3	the	the	DET
easat-8031	104	4	criteria	criterion	NOUN
easat-8031	104	5	used	use	VERB
easat-8031	104	6	to	to	PART
easat-8031	104	7	diagnose	diagnose	VERB
easat-8031	104	8	hypothyroidism	hypothyroidism	NOUN
easat-8031	104	9	and	and	CCONJ
easat-8031	104	10	align	align	VERB
easat-8031	104	11	with	with	ADP
easat-8031	104	12	those	those	PRON
easat-8031	104	13	reported	report	VERB
easat-8031	104	14	in	in	ADP
easat-8031	104	15	studies	study	NOUN
easat-8031	104	16	of	of	ADP
easat-8031	104	17	thyroid	thyroid	NOUN
easat-8031	104	18	hormone	hormone	NOUN
easat-8031	104	19	levels	level	NOUN
easat-8031	104	20	in	in	ADP
easat-8031	104	21	patients	patient	NOUN
easat-8031	104	22	with	with	ADP
easat-8031	104	23	hypothyroidism	hypothyroidism	NOUN
easat-8031	104	24	[	[	X
easat-8031	104	25	18	18	NUM
easat-8031	104	26	,	,	PUNCT
easat-8031	104	27	19	19	NUM
easat-8031	104	28	]	]	PUNCT
easat-8031	104	29	the	the	DET
easat-8031	104	30	tpo	tpo	NOUN
easat-8031	104	31	antibody	antibody	NOUN
easat-8031	104	32	values	value	NOUN
easat-8031	104	33	were	be	AUX
easat-8031	104	34	used	use	VERB
easat-8031	104	35	to	to	PART
easat-8031	104	36	confirm	confirm	VERB
easat-8031	104	37	autoimmune	autoimmune	ADJ
easat-8031	104	38	hypothyroidism	hypothyroidism	NOUN
easat-8031	104	39	.	.	PUNCT
easat-8031	105	1	the	the	DET
easat-8031	105	2	highly	highly	ADV
easat-8031	105	3	positivity	positivity	NOUN
easat-8031	105	4	mean	mean	NOUN
easat-8031	105	5	of	of	ADP
easat-8031	105	6	tpo	tpo	NOUN
easat-8031	105	7	antibody	antibody	VERB
easat-8031	105	8	in	in	ADP
easat-8031	105	9	patients	patient	NOUN
easat-8031	105	10	compare	compare	VERB
easat-8031	105	11	to	to	ADP
easat-8031	105	12	healthy	healthy	ADJ
easat-8031	105	13	groups	group	NOUN
easat-8031	105	14	with	with	ADP
easat-8031	105	15	significant	significant	ADJ
easat-8031	105	16	difference	difference	NOUN
easat-8031	105	17	,	,	PUNCT
easat-8031	105	18	compatible	compatible	ADJ
easat-8031	105	19	with	with	ADP
easat-8031	105	20	the	the	DET
easat-8031	105	21	fact	fact	NOUN
easat-8031	105	22	recorded	record	VERB
easat-8031	105	23	by	by	ADP
easat-8031	105	24	previous	previous	ADJ
easat-8031	105	25	studies	study	NOUN
easat-8031	105	26	that	that	PRON
easat-8031	105	27	referred	refer	VERB
easat-8031	105	28	that	that	SCONJ
easat-8031	105	29	the	the	DET
easat-8031	105	30	cardinal	cardinal	ADJ
easat-8031	105	31	sign	sign	NOUN
easat-8031	105	32	of	of	ADP
easat-8031	105	33	the	the	DET
easat-8031	105	34	autoimmune	autoimmune	ADJ
easat-8031	105	35	hypothyroidism	hypothyroidism	NOUN
easat-8031	105	36	is	be	AUX
easat-8031	105	37	the	the	DET
easat-8031	105	38	auto	auto	NOUN
easat-8031	105	39	-	-	PUNCT
easat-8031	105	40	antibodies	antibody	NOUN
easat-8031	105	41	found	find	VERB
easat-8031	105	42	against	against	ADP
easat-8031	105	43	thyroid	thyroid	NOUN
easat-8031	105	44	peroxidase	peroxidase	NOUN
easat-8031	105	45	"	"	PUNCT
easat-8031	105	46	tpoab	tpoab	PROPN
easat-8031	105	47	"	"	PUNCT
easat-8031	105	48	in	in	ADP
easat-8031	105	49	thyroid	thyroid	NOUN
easat-8031	105	50	[	[	X
easat-8031	105	51	15	15	NUM
easat-8031	105	52	]	]	PUNCT
easat-8031	105	53	.	.	PUNCT
easat-8031	106	1	according	accord	VERB
easat-8031	106	2	to	to	ADP
easat-8031	106	3	the	the	DET
easat-8031	106	4	levels	level	NOUN
easat-8031	106	5	of	of	ADP
easat-8031	106	6	vitamin	vitamin	NOUN
easat-8031	106	7	d	d	NOUN
easat-8031	106	8	in	in	ADP
easat-8031	106	9	the	the	DET
easat-8031	106	10	studied	study	VERB
easat-8031	106	11	groups	group	NOUN
easat-8031	106	12	,	,	PUNCT
easat-8031	106	13	patients	patient	NOUN
easat-8031	106	14	had	have	VERB
easat-8031	106	15	reduced	reduce	VERB
easat-8031	106	16	levels	level	NOUN
easat-8031	106	17	compared	compare	VERB
easat-8031	106	18	with	with	ADP
easat-8031	106	19	healthy	healthy	ADJ
easat-8031	106	20	people	people	NOUN
easat-8031	106	21	,	,	PUNCT
easat-8031	106	22	corroborating	corroborate	VERB
easat-8031	106	23	prior	prior	ADJ
easat-8031	106	24	observations	observation	NOUN
easat-8031	106	25	of	of	ADP
easat-8031	106	26	vitamin	vitamin	NOUN
easat-8031	106	27	d	d	NOUN
easat-8031	106	28	insufficiency	insufficiency	NOUN
easat-8031	106	29	in	in	ADP
easat-8031	106	30	autoimmune	autoimmune	ADJ
easat-8031	106	31	thyroid	thyroid	NOUN
easat-8031	106	32	pathologies	pathology	NOUN
easat-8031	106	33	.	.	PUNCT
easat-8031	107	1	cross	cross	ADJ
easat-8031	107	2	-	-	ADJ
easat-8031	107	3	sectional	sectional	ADJ
easat-8031	107	4	and	and	CCONJ
easat-8031	107	5	case	case	NOUN
easat-8031	107	6	-	-	PUNCT
easat-8031	107	7	control	control	NOUN
easat-8031	107	8	studies	study	NOUN
easat-8031	107	9	across	across	ADP
easat-8031	107	10	diverse	diverse	ADJ
easat-8031	107	11	populations	population	NOUN
easat-8031	107	12	revealed	reveal	VERB
easat-8031	107	13	a	a	DET
easat-8031	107	14	pronounced	pronounced	ADJ
easat-8031	107	15	disparity	disparity	NOUN
easat-8031	107	16	,	,	PUNCT
easat-8031	107	17	with	with	ADP
easat-8031	107	18	ht	ht	PROPN
easat-8031	107	19	cohorts	cohort	NOUN
easat-8031	107	20	exhibiting	exhibit	VERB
easat-8031	107	21	median	median	ADJ
easat-8031	107	22	25(oh)d	25(oh)d	NUM
easat-8031	107	23	levels	level	NOUN
easat-8031	107	24	20–40	20–40	NUM
easat-8031	107	25	%	%	NOUN
easat-8031	107	26	lower	low	ADJ
easat-8031	107	27	than	than	ADP
easat-8031	107	28	matched	matched	ADJ
easat-8031	107	29	controls	control	NOUN
easat-8031	107	30	and	and	CCONJ
easat-8031	107	31	deficiency	deficiency	NOUN
easat-8031	107	32	prevalence	prevalence	NOUN
easat-8031	107	33	(	(	PUNCT
easat-8031	107	34	<	<	X
easat-8031	107	35	20	20	NUM
easat-8031	107	36	ng	ng	PROPN
easat-8031	107	37	/	/	SYM
easat-8031	107	38	ml	ml	NOUN
easat-8031	107	39	)	)	PUNCT
easat-8031	107	40	exceeding	exceed	VERB
easat-8031	107	41	70	70	NUM
easat-8031	107	42	%	%	NOUN
easat-8031	107	43	in	in	ADP
easat-8031	107	44	the	the	DET
easat-8031	107	45	affected	affected	ADJ
easat-8031	107	46	groups	group	NOUN
easat-8031	107	47	.	.	PUNCT
easat-8031	108	1	regional	regional	ADJ
easat-8031	108	2	investigations	investigation	NOUN
easat-8031	108	3	highlight	highlight	VERB
easat-8031	108	4	this	this	DET
easat-8031	108	5	trend	trend	NOUN
easat-8031	108	6	even	even	ADV
easat-8031	108	7	in	in	ADP
easat-8031	108	8	high	high	ADJ
easat-8031	108	9	-	-	PUNCT
easat-8031	108	10	insolation	insolation	NOUN
easat-8031	108	11	regions	region	NOUN
easat-8031	108	12	:	:	PUNCT
easat-8031	108	13	middle	middle	ADJ
easat-8031	108	14	eastern	eastern	ADJ
easat-8031	108	15	studies	study	NOUN
easat-8031	108	16	reported	report	VERB
easat-8031	108	17	mean	mean	VERB
easat-8031	108	18	25(oh)d	25(oh)d	NUM
easat-8031	108	19	values	value	NOUN
easat-8031	108	20	of	of	ADP
easat-8031	108	21	9.37±15.2	9.37±15.2	NUM
easat-8031	108	22	ng	ng	PROPN
easat-8031	108	23	/	/	SYM
easat-8031	108	24	ml	ml	NOUN
easat-8031	108	25	in	in	ADP
easat-8031	108	26	ht	ht	PROPN
easat-8031	108	27	patients	patient	NOUN
easat-8031	108	28	versus	versus	ADP
easat-8031	108	29	11.95±28.1	11.95±28.1	NUM
easat-8031	108	30	ng	ng	PROPN
easat-8031	108	31	/	/	SYM
easat-8031	108	32	ml	ml	X
easat-8031	108	33	in	in	ADP
easat-8031	108	34	controls	control	NOUN
easat-8031	108	35	(	(	PUNCT
easat-8031	108	36	p<0.01	p<0.01	PROPN
easat-8031	108	37	)	)	PUNCT
easat-8031	108	38	.	.	PUNCT
easat-8031	109	1	these	these	DET
easat-8031	109	2	findings	finding	NOUN
easat-8031	109	3	align	align	VERB
easat-8031	109	4	with	with	ADP
easat-8031	109	5	meta	meta	ADJ
easat-8031	109	6	-	-	PUNCT
easat-8031	109	7	analytic	analytic	ADJ
easat-8031	109	8	evidence	evidence	NOUN
easat-8031	109	9	(	(	PUNCT
easat-8031	109	10	or=2.89	or=2.89	ADV
easat-8031	109	11	,	,	PUNCT
easat-8031	109	12	95	95	NUM
easat-8031	109	13	%	%	NOUN
easat-8031	109	14	ci	ci	NOUN
easat-8031	109	15	:	:	PUNCT
easat-8031	109	16	1.92–4.35	1.92–4.35	NUM
easat-8031	109	17	for	for	ADP
easat-8031	109	18	deficiency	deficiency	NOUN
easat-8031	109	19	risk	risk	NOUN
easat-8031	109	20	in	in	ADP
easat-8031	109	21	ht	ht	PROPN
easat-8031	109	22	)	)	PUNCT
easat-8031	109	23	and	and	CCONJ
easat-8031	109	24	support	support	VERB
easat-8031	109	25	the	the	DET
easat-8031	109	26	putative	putative	ADJ
easat-8031	109	27	role	role	NOUN
easat-8031	109	28	of	of	ADP
easat-8031	109	29	vitamin	vitamin	NOUN
easat-8031	109	30	d	d	NOUN
easat-8031	109	31	in	in	ADP
easat-8031	109	32	modulating	modulate	VERB
easat-8031	109	33	thyroid	thyroid	NOUN
easat-8031	109	34	autoimmunity	autoimmunity	NOUN
easat-8031	109	35	through	through	ADP
easat-8031	109	36	vdr	vdr	NOUN
easat-8031	109	37	-	-	PUNCT
easat-8031	109	38	mediated	mediate	VERB
easat-8031	109	39	cytokine	cytokine	NOUN
easat-8031	109	40	regulation	regulation	NOUN
easat-8031	109	41	.	.	PUNCT
easat-8031	110	1	mechanistic	mechanistic	ADJ
easat-8031	110	2	studies	study	NOUN
easat-8031	110	3	posit	posit	VERB
easat-8031	110	4	that	that	SCONJ
easat-8031	110	5	suboptimal	suboptimal	ADJ
easat-8031	110	6	25(oh)d	25(oh)d	NUM
easat-8031	110	7	levels	level	NOUN
easat-8031	110	8	(	(	PUNCT
easat-8031	110	9	<	<	X
easat-8031	110	10	30	30	NUM
easat-8031	110	11	ng	ng	NOUN
easat-8031	110	12	/	/	SYM
easat-8031	110	13	ml	ml	PROPN
easat-8031	110	14	)	)	PUNCT
easat-8031	110	15	may	may	AUX
easat-8031	110	16	impair	impair	VERB
easat-8031	110	17	t	t	PROPN
easat-8031	110	18	-	-	PUNCT
easat-8031	110	19	regulatory	regulatory	ADJ
easat-8031	110	20	cell	cell	NOUN
easat-8031	110	21	function	function	NOUN
easat-8031	110	22	,	,	PUNCT
easat-8031	110	23	potentially	potentially	ADV
easat-8031	110	24	exacerbating	exacerbate	VERB
easat-8031	110	25	thyrocyte	thyrocyte	NOUN
easat-8031	110	26	destruction	destruction	NOUN
easat-8031	110	27	in	in	ADP
easat-8031	110	28	genetically	genetically	ADV
easat-8031	110	29	susceptible	susceptible	ADJ
easat-8031	110	30	individuals	individual	NOUN
easat-8031	110	31	[	[	X
easat-8031	110	32	20	20	NUM
easat-8031	110	33	-	-	SYM
easat-8031	110	34	23	23	NUM
easat-8031	110	35	]	]	PUNCT
easat-8031	110	36	.	.	PUNCT
easat-8031	111	1	these	these	DET
easat-8031	111	2	disparities	disparity	NOUN
easat-8031	111	3	persisted	persist	VERB
easat-8031	111	4	even	even	ADV
easat-8031	111	5	after	after	ADP
easat-8031	111	6	adjusting	adjust	VERB
easat-8031	111	7	for	for	ADP
easat-8031	111	8	variables	variable	NOUN
easat-8031	111	9	such	such	ADJ
easat-8031	111	10	as	as	ADP
easat-8031	111	11	age	age	NOUN
easat-8031	111	12	,	,	PUNCT
easat-8031	111	13	sex	sex	NOUN
easat-8031	111	14	,	,	PUNCT
easat-8031	111	15	and	and	CCONJ
easat-8031	111	16	body	body	NOUN
easat-8031	111	17	mass	mass	PROPN
easat-8031	111	18	index	index	NOUN
easat-8031	111	19	,	,	PUNCT
easat-8031	111	20	suggesting	suggest	VERB
easat-8031	111	21	an	an	DET
easat-8031	111	22	intrinsic	intrinsic	ADJ
easat-8031	111	23	link	link	NOUN
easat-8031	111	24	between	between	ADP
easat-8031	111	25	hypovitaminosis	hypovitaminosis	NOUN
easat-8031	111	26	d	d	PROPN
easat-8031	111	27	and	and	CCONJ
easat-8031	111	28	autoimmune	autoimmune	ADJ
easat-8031	111	29	thyroid	thyroid	NOUN
easat-8031	111	30	dysfunction	dysfunction	NOUN
easat-8031	111	31	.	.	PUNCT
easat-8031	112	1	the	the	DET
easat-8031	112	2	mechanistic	mechanistic	ADJ
easat-8031	112	3	interplay	interplay	NOUN
easat-8031	112	4	between	between	ADP
easat-8031	112	5	vitamin	vitamin	NOUN
easat-8031	112	6	d	d	NOUN
easat-8031	112	7	status	status	NOUN
easat-8031	112	8	and	and	CCONJ
easat-8031	112	9	thyroid	thyroid	NOUN
easat-8031	112	10	autoimmunity	autoimmunity	NOUN
easat-8031	112	11	extends	extend	VERB
easat-8031	112	12	beyond	beyond	ADP
easat-8031	112	13	simple	simple	ADJ
easat-8031	112	14	deficiency	deficiency	NOUN
easat-8031	112	15	.	.	PUNCT
easat-8031	113	1	observational	observational	ADJ
easat-8031	113	2	studies	study	NOUN
easat-8031	113	3	noted	note	VERB
easat-8031	113	4	inverse	inverse	ADJ
easat-8031	113	5	correlations	correlation	NOUN
easat-8031	113	6	between	between	ADP
easat-8031	113	7	25(oh)d	25(oh)d	NOUN
easat-8031	113	8	levels	level	NOUN
easat-8031	113	9	and	and	CCONJ
easat-8031	113	10	tpoab	tpoab	PROPN
easat-8031	113	11	titers	titer	NOUN
easat-8031	113	12	,	,	PUNCT
easat-8031	113	13	where	where	SCONJ
easat-8031	113	14	every	every	DET
easat-8031	113	15	1	1	NUM
easat-8031	113	16	ng	ng	NOUN
easat-8031	113	17	/	/	SYM
easat-8031	113	18	ml	ml	NOUN
easat-8031	113	19	increase	increase	NOUN
easat-8031	113	20	in	in	ADP
easat-8031	113	21	vitamin	vitamin	NOUN
easat-8031	113	22	d	d	NOUN
easat-8031	113	23	corresponds	correspond	VERB
easat-8031	113	24	to	to	ADP
easat-8031	113	25	measurable	measurable	ADJ
easat-8031	113	26	reductions	reduction	NOUN
easat-8031	113	27	in	in	ADP
easat-8031	113	28	autoimmune	autoimmune	ADJ
easat-8031	113	29	activity	activity	NOUN
easat-8031	114	1	[	[	X
easat-8031	114	2	23	23	NUM
easat-8031	114	3	,	,	PUNCT
easat-8031	114	4	24	24	NUM
easat-8031	114	5	]	]	PUNCT
easat-8031	114	6	.	.	PUNCT
easat-8031	115	1	regarding	regard	VERB
easat-8031	115	2	the	the	DET
easat-8031	115	3	relationship	relationship	NOUN
easat-8031	115	4	between	between	ADP
easat-8031	115	5	auto	auto	NOUN
easat-8031	115	6	-	-	PUNCT
easat-8031	115	7	hypothyroidism	hypothyroidism	NOUN
easat-8031	115	8	and	and	CCONJ
easat-8031	115	9	vitamin	vitamin	NOUN
easat-8031	115	10	d	d	PROPN
easat-8031	115	11	,	,	PUNCT
easat-8031	115	12	pearson	pearson	PROPN
easat-8031	115	13	's	's	PART
easat-8031	115	14	correlation	correlation	NOUN
easat-8031	115	15	showed	show	VERB
easat-8031	115	16	a	a	DET
easat-8031	115	17	negative	negative	ADJ
easat-8031	115	18	non	non	ADJ
easat-8031	115	19	-	-	ADJ
easat-8031	115	20	significant	significant	ADJ
easat-8031	115	21	association	association	NOUN
easat-8031	115	22	between	between	ADP
easat-8031	115	23	vitamin	vitamin	NOUN
easat-8031	115	24	d	d	NOUN
easat-8031	115	25	and	and	CCONJ
easat-8031	115	26	tsh	tsh	NOUN
easat-8031	115	27	and	and	CCONJ
easat-8031	115	28	anti	anti	ADJ
easat-8031	115	29	-	-	ADJ
easat-8031	115	30	tpo	tpo	ADJ
easat-8031	115	31	levels	level	NOUN
easat-8031	115	32	,	,	PUNCT
easat-8031	115	33	suggesting	suggest	VERB
easat-8031	115	34	that	that	SCONJ
easat-8031	115	35	vitamin	vitamin	NOUN
easat-8031	115	36	d	d	NOUN
easat-8031	115	37	deficiency	deficiency	NOUN
easat-8031	115	38	leads	lead	VERB
easat-8031	115	39	to	to	ADP
easat-8031	115	40	elevated	elevated	ADJ
easat-8031	115	41	tsh	tsh	NOUN
easat-8031	115	42	and	and	CCONJ
easat-8031	115	43	autoantibody	autoantibody	ADJ
easat-8031	115	44	levels	level	NOUN
easat-8031	115	45	.	.	PUNCT
easat-8031	116	1	this	this	DET
easat-8031	116	2	result	result	NOUN
easat-8031	116	3	is	be	AUX
easat-8031	116	4	in	in	ADP
easat-8031	116	5	line	line	NOUN
easat-8031	116	6	with	with	ADP
easat-8031	116	7	the	the	DET
easat-8031	116	8	iraqi	iraqi	ADJ
easat-8031	116	9	study	study	NOUN
easat-8031	116	10	by	by	ADP
easat-8031	116	11	raeef	raeef	PROPN
easat-8031	116	12	et	et	PROPN
easat-8031	116	13	al	al	PROPN
easat-8031	116	14	.	.	PROPN
easat-8031	116	15	,	,	PUNCT
easat-8031	116	16	who	who	PRON
easat-8031	116	17	found	find	VERB
easat-8031	116	18	the	the	DET
easat-8031	116	19	same	same	ADJ
easat-8031	116	20	negative	negative	ADJ
easat-8031	116	21	correlation	correlation	NOUN
easat-8031	116	22	between	between	ADP
easat-8031	116	23	vitamin	vitamin	NOUN
easat-8031	116	24	d	d	NOUN
easat-8031	116	25	blood	blood	NOUN
easat-8031	116	26	levels	level	NOUN
easat-8031	116	27	and	and	CCONJ
easat-8031	116	28	tsh	tsh	NOUN
easat-8031	116	29	and	and	CCONJ
easat-8031	116	30	anti	anti	ADJ
easat-8031	116	31	-	-	ADJ
easat-8031	116	32	tpo	tpo	ADJ
easat-8031	116	33	levels	level	NOUN
easat-8031	116	34	,	,	PUNCT
easat-8031	116	35	and	and	CCONJ
easat-8031	116	36	other	other	ADJ
easat-8031	116	37	studies	study	NOUN
easat-8031	116	38	in	in	ADP
easat-8031	116	39	egypt	egypt	PROPN
easat-8031	116	40	figures	figure	NOUN
easat-8031	116	41	(	(	PUNCT
easat-8031	116	42	2)(3	2)(3	NUM
easat-8031	116	43	)	)	PUNCT
easat-8031	117	1	[	[	X
easat-8031	117	2	25	25	NUM
easat-8031	117	3	,	,	PUNCT
easat-8031	117	4	26	26	NUM
easat-8031	117	5	]	]	PUNCT
easat-8031	117	6	.	.	PUNCT
easat-8031	118	1	body	body	NOUN
easat-8031	118	2	mass	mass	PROPN
easat-8031	118	3	index	index	NOUN
easat-8031	118	4	(	(	PUNCT
easat-8031	118	5	bmi	bmi	PROPN
easat-8031	118	6	)	)	PUNCT
easat-8031	118	7	has	have	AUX
easat-8031	118	8	also	also	ADV
easat-8031	118	9	been	be	AUX
easat-8031	118	10	associated	associate	VERB
easat-8031	118	11	with	with	ADP
easat-8031	118	12	hypothyroidism	hypothyroidism	NOUN
easat-8031	118	13	.	.	PUNCT
easat-8031	119	1	the	the	DET
easat-8031	119	2	results	result	NOUN
easat-8031	119	3	revealed	reveal	VERB
easat-8031	119	4	a	a	DET
easat-8031	119	5	significant	significant	ADJ
easat-8031	119	6	increase	increase	NOUN
easat-8031	119	7	in	in	ADP
easat-8031	119	8	the	the	DET
easat-8031	119	9	mean	mean	ADJ
easat-8031	119	10	bmi	bmi	NOUN
easat-8031	119	11	in	in	ADP
easat-8031	119	12	patients	patient	NOUN
easat-8031	119	13	with	with	ADP
easat-8031	119	14	hypothyroidism	hypothyroidism	NOUN
easat-8031	119	15	compared	compare	VERB
easat-8031	119	16	to	to	ADP
easat-8031	119	17	that	that	PRON
easat-8031	119	18	in	in	ADP
easat-8031	119	19	the	the	DET
easat-8031	119	20	healthy	healthy	ADJ
easat-8031	119	21	control	control	NOUN
easat-8031	119	22	group	group	NOUN
easat-8031	119	23	.	.	PUNCT
easat-8031	120	1	this	this	PRON
easat-8031	120	2	aligns	align	VERB
easat-8031	120	3	with	with	ADP
easat-8031	120	4	the	the	DET
easat-8031	120	5	results	result	NOUN
easat-8031	120	6	in	in	ADP
easat-8031	120	7	[	[	X
easat-8031	120	8	11	11	NUM
easat-8031	120	9	]	]	PUNCT
easat-8031	120	10	.	.	PUNCT
easat-8031	121	1	this	this	PRON
easat-8031	121	2	is	be	AUX
easat-8031	121	3	consistent	consistent	ADJ
easat-8031	121	4	with	with	ADP
easat-8031	121	5	the	the	DET
easat-8031	121	6	fact	fact	NOUN
easat-8031	121	7	that	that	SCONJ
easat-8031	121	8	hypothyroidism	hypothyroidism	NOUN
easat-8031	121	9	is	be	AUX
easat-8031	121	10	linked	link	VERB
easat-8031	121	11	to	to	ADP
easat-8031	121	12	a	a	DET
easat-8031	121	13	lower	low	ADJ
easat-8031	121	14	metabolic	metabolic	NOUN
easat-8031	121	15	rate	rate	NOUN
easat-8031	121	16	,	,	PUNCT
easat-8031	121	17	higher	high	ADJ
easat-8031	121	18	bmi	bmi	NOUN
easat-8031	121	19	,	,	PUNCT
easat-8031	121	20	and	and	CCONJ
easat-8031	121	21	greater	great	ADJ
easat-8031	121	22	prevalence	prevalence	NOUN
easat-8031	121	23	of	of	ADP
easat-8031	121	24	obesity	obesity	NOUN
easat-8031	121	25	,	,	PUNCT
easat-8031	121	26	suggesting	suggest	VERB
easat-8031	121	27	that	that	SCONJ
easat-8031	121	28	subclinical	subclinical	ADJ
easat-8031	121	29	hypothyroidism	hypothyroidism	NOUN
easat-8031	121	30	is	be	AUX
easat-8031	121	31	associated	associate	VERB
easat-8031	121	32	with	with	ADP
easat-8031	121	33	significant	significant	ADJ
easat-8031	121	34	changes	change	NOUN
easat-8031	121	35	in	in	ADP
easat-8031	121	36	body	body	NOUN
easat-8031	121	37	weight	weight	NOUN
easat-8031	121	38	and	and	CCONJ
easat-8031	121	39	is	be	AUX
easat-8031	121	40	considered	consider	VERB
easat-8031	121	41	a	a	DET
easat-8031	121	42	risk	risk	NOUN
easat-8031	121	43	factor	factor	NOUN
easat-8031	121	44	for	for	ADP
easat-8031	121	45	overweight	overweight	NOUN
easat-8031	121	46	and	and	CCONJ
easat-8031	121	47	obesity	obesity	NOUN
easat-8031	121	48	[	[	X
easat-8031	121	49	27	27	NUM
easat-8031	121	50	]	]	PUNCT
easat-8031	121	51	the	the	DET
easat-8031	121	52	data	datum	NOUN
easat-8031	121	53	were	be	AUX
easat-8031	121	54	also	also	ADV
easat-8031	121	55	subjected	subject	VERB
easat-8031	121	56	to	to	ADP
easat-8031	121	57	roc	roc	PROPN
easat-8031	121	58	curve	curve	NOUN
easat-8031	121	59	analysis	analysis	NOUN
easat-8031	121	60	to	to	PART
easat-8031	121	61	assess	assess	VERB
easat-8031	121	62	the	the	DET
easat-8031	121	63	validity	validity	NOUN
easat-8031	121	64	and	and	CCONJ
easat-8031	121	65	effectiveness	effectiveness	NOUN
easat-8031	121	66	of	of	ADP
easat-8031	121	67	these	these	DET
easat-8031	121	68	diagnostic	diagnostic	ADJ
easat-8031	121	69	criteria	criterion	NOUN
easat-8031	121	70	for	for	ADP
easat-8031	121	71	detecting	detect	VERB
easat-8031	121	72	hashimoto	hashimoto	NOUN
easat-8031	121	73	's	's	PART
easat-8031	121	74	thyroiditis	thyroiditis	NOUN
easat-8031	121	75	in	in	ADP
easat-8031	121	76	the	the	DET
easat-8031	121	77	thi	thi	PROPN
easat-8031	121	78	-	-	PUNCT
easat-8031	121	79	qar	qar	PROPN
easat-8031	121	80	.	.	PUNCT
easat-8031	122	1	roc	roc	NOUN
easat-8031	122	2	analysis	analysis	NOUN
easat-8031	122	3	confirmed	confirm	VERB
easat-8031	122	4	the	the	DET
easat-8031	122	5	validity	validity	NOUN
easat-8031	122	6	of	of	ADP
easat-8031	122	7	these	these	DET
easat-8031	122	8	markers	marker	NOUN
easat-8031	122	9	for	for	ADP
easat-8031	122	10	detecting	detect	VERB
easat-8031	122	11	hashimoto	hashimoto	NOUN
easat-8031	122	12	's	's	PART
easat-8031	122	13	thyroiditis	thyroiditis	NOUN
easat-8031	122	14	.	.	PUNCT
easat-8031	123	1	1102	1102	NUM
easat-8031	123	2	edelweiss	edelweiss	PROPN
easat-8031	123	3	applied	apply	VERB
easat-8031	123	4	science	science	NOUN
easat-8031	123	5	and	and	CCONJ
easat-8031	123	6	technology	technology	NOUN
easat-8031	123	7	issn	issn	PROPN
easat-8031	123	8	:	:	PUNCT
easat-8031	123	9	2576	2576	NUM
easat-8031	123	10	-	-	SYM
easat-8031	123	11	8484	8484	NUM
easat-8031	123	12	vol	vol	NOUN
easat-8031	123	13	.	.	PROPN
easat-8031	124	1	9	9	NUM
easat-8031	124	2	,	,	PUNCT
easat-8031	124	3	no	no	INTJ
easat-8031	124	4	.	.	NOUN
easat-8031	124	5	6	6	NUM
easat-8031	124	6	:	:	SYM
easat-8031	124	7	1094	1094	NUM
easat-8031	124	8	-	-	SYM
easat-8031	124	9	1103	1103	NUM
easat-8031	124	10	,	,	PUNCT
easat-8031	124	11	2025	2025	NUM
easat-8031	124	12	doi	doi	NOUN
easat-8031	124	13	:	:	PUNCT
easat-8031	124	14	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	124	15	©	©	PROPN
easat-8031	124	16	2025	2025	NUM
easat-8031	124	17	by	by	ADP
easat-8031	124	18	the	the	DET
easat-8031	124	19	authors	author	NOUN
easat-8031	124	20	;	;	PUNCT
easat-8031	124	21	licensee	licensee	PROPN
easat-8031	124	22	learning	learning	NOUN
easat-8031	124	23	gate	gate	VERB
easat-8031	124	24	the	the	DET
easat-8031	124	25	results	result	NOUN
easat-8031	124	26	indicated	indicate	VERB
easat-8031	124	27	that	that	SCONJ
easat-8031	124	28	autoantibodies	autoantibody	NOUN
easat-8031	124	29	to	to	PART
easat-8031	124	30	thyroperoxidase	thyroperoxidase	VERB
easat-8031	124	31	(	(	PUNCT
easat-8031	124	32	anti	anti	ADJ
easat-8031	124	33	-	-	NOUN
easat-8031	124	34	tpo	tpo	NOUN
easat-8031	124	35	)	)	PUNCT
easat-8031	124	36	and	and	CCONJ
easat-8031	124	37	tsh	tsh	NOUN
easat-8031	124	38	have	have	VERB
easat-8031	124	39	the	the	DET
easat-8031	124	40	most	most	ADV
easat-8031	124	41	sensitive	sensitive	ADJ
easat-8031	124	42	and	and	CCONJ
easat-8031	124	43	specific	specific	ADJ
easat-8031	124	44	values	value	NOUN
easat-8031	124	45	,	,	PUNCT
easat-8031	124	46	making	make	VERB
easat-8031	124	47	them	they	PRON
easat-8031	124	48	the	the	DET
easat-8031	124	49	best	good	ADJ
easat-8031	124	50	biomarkers	biomarker	NOUN
easat-8031	124	51	to	to	PART
easat-8031	124	52	detect	detect	VERB
easat-8031	124	53	hashimoto	hashimoto	NOUN
easat-8031	124	54	’s	’s	PART
easat-8031	124	55	disease	disease	NOUN
easat-8031	124	56	,	,	PUNCT
easat-8031	124	57	in	in	ADP
easat-8031	124	58	line	line	NOUN
easat-8031	124	59	with	with	ADP
easat-8031	124	60	ameen	ameen	PROPN
easat-8031	124	61	,	,	PUNCT
easat-8031	124	62	et	et	PROPN
easat-8031	124	63	al	al	PROPN
easat-8031	124	64	.	.	PUNCT
easat-8031	125	1	[	[	X
easat-8031	125	2	28	28	NUM
easat-8031	125	3	]	]	PUNCT
easat-8031	125	4	.	.	PUNCT
easat-8031	126	1	the	the	DET
easat-8031	126	2	high	high	ADJ
easat-8031	126	3	levels	level	NOUN
easat-8031	126	4	of	of	ADP
easat-8031	126	5	tsh	tsh	ADJ
easat-8031	126	6	and	and	CCONJ
easat-8031	126	7	anti	anti	NOUN
easat-8031	126	8	-	-	NOUN
easat-8031	126	9	tpo	tpo	NOUN
easat-8031	126	10	in	in	ADP
easat-8031	126	11	patients	patient	NOUN
easat-8031	126	12	compared	compare	VERB
easat-8031	126	13	to	to	ADP
easat-8031	126	14	controls	control	NOUN
easat-8031	126	15	and	and	CCONJ
easat-8031	126	16	the	the	DET
easat-8031	126	17	roc	roc	PROPN
easat-8031	126	18	curve	curve	NOUN
easat-8031	126	19	result	result	NOUN
easat-8031	126	20	confirmed	confirm	VERB
easat-8031	126	21	the	the	DET
easat-8031	126	22	validity	validity	NOUN
easat-8031	126	23	of	of	ADP
easat-8031	126	24	these	these	DET
easat-8031	126	25	parameters	parameter	NOUN
easat-8031	126	26	as	as	ADP
easat-8031	126	27	exceptional	exceptional	ADJ
easat-8031	126	28	biomarkers	biomarker	NOUN
easat-8031	126	29	for	for	ADP
easat-8031	126	30	the	the	DET
easat-8031	126	31	detection	detection	NOUN
easat-8031	126	32	of	of	ADP
easat-8031	126	33	hashimoto	hashimoto	NOUN
easat-8031	126	34	's	's	PART
easat-8031	126	35	disease	disease	NOUN
easat-8031	126	36	,	,	PUNCT
easat-8031	126	37	which	which	PRON
easat-8031	126	38	is	be	AUX
easat-8031	126	39	usually	usually	ADV
easat-8031	126	40	not	not	PART
easat-8031	126	41	detected	detect	VERB
easat-8031	126	42	until	until	SCONJ
easat-8031	126	43	advanced	advanced	ADJ
easat-8031	126	44	stages	stage	NOUN
easat-8031	126	45	are	be	AUX
easat-8031	126	46	associated	associate	VERB
easat-8031	126	47	with	with	ADP
easat-8031	126	48	significant	significant	ADJ
easat-8031	126	49	thyroid	thyroid	NOUN
easat-8031	126	50	damage	damage	NOUN
easat-8031	126	51	.	.	PUNCT
easat-8031	127	1	from	from	ADP
easat-8031	127	2	the	the	DET
easat-8031	127	3	other	other	ADJ
easat-8031	127	4	hand	hand	NOUN
easat-8031	127	5	,	,	PUNCT
easat-8031	127	6	the	the	DET
easat-8031	127	7	roc	roc	PROPN
easat-8031	127	8	analysis	analysis	NOUN
easat-8031	127	9	result	result	NOUN
easat-8031	127	10	for	for	ADP
easat-8031	127	11	vitamin	vitamin	NOUN
easat-8031	127	12	d	d	NOUN
easat-8031	127	13	showed	show	VERB
easat-8031	127	14	that	that	SCONJ
easat-8031	127	15	the	the	DET
easat-8031	127	16	sensitivity	sensitivity	NOUN
easat-8031	127	17	and	and	CCONJ
easat-8031	127	18	specificity	specificity	NOUN
easat-8031	127	19	are	be	AUX
easat-8031	127	20	not	not	PART
easat-8031	127	21	high	high	ADJ
easat-8031	127	22	enough	enough	ADV
easat-8031	127	23	to	to	PART
easat-8031	127	24	use	use	VERB
easat-8031	127	25	this	this	DET
easat-8031	127	26	marker	marker	NOUN
easat-8031	127	27	as	as	ADP
easat-8031	127	28	a	a	DET
easat-8031	127	29	standalone	standalone	ADJ
easat-8031	127	30	diagnostic	diagnostic	ADJ
easat-8031	127	31	test	test	NOUN
easat-8031	127	32	this	this	DET
easat-8031	127	33	finding	find	VERB
easat-8031	127	34	consistent	consistent	ADJ
easat-8031	127	35	with	with	ADP
easat-8031	127	36	iqbal	iqbal	PROPN
easat-8031	127	37	and	and	CCONJ
easat-8031	127	38	samanje	samanje	PROPN
easat-8031	128	1	[	[	X
easat-8031	128	2	29	29	NUM
easat-8031	128	3	]	]	PUNCT
easat-8031	128	4	.	.	PUNCT
easat-8031	129	1	instead	instead	ADV
easat-8031	129	2	,	,	PUNCT
easat-8031	129	3	it	it	PRON
easat-8031	129	4	is	be	AUX
easat-8031	129	5	recommended	recommend	VERB
easat-8031	129	6	to	to	PART
easat-8031	129	7	use	use	VERB
easat-8031	129	8	it	it	PRON
easat-8031	129	9	as	as	ADP
easat-8031	129	10	a	a	DET
easat-8031	129	11	supportive	supportive	ADJ
easat-8031	129	12	tool	tool	NOUN
easat-8031	129	13	alongside	alongside	ADP
easat-8031	129	14	other	other	ADJ
easat-8031	129	15	clinical	clinical	ADJ
easat-8031	129	16	or	or	CCONJ
easat-8031	129	17	laboratory	laboratory	NOUN
easat-8031	129	18	indicators	indicator	NOUN
easat-8031	129	19	.	.	PUNCT
easat-8031	130	1	5	5	X
easat-8031	130	2	.	.	X
easat-8031	130	3	conclusions	conclusion	NOUN
easat-8031	130	4	this	this	DET
easat-8031	130	5	study	study	NOUN
easat-8031	130	6	elucidates	elucidate	VERB
easat-8031	130	7	that	that	SCONJ
easat-8031	130	8	vitamin	vitamin	NOUN
easat-8031	130	9	d	d	NOUN
easat-8031	130	10	deficiency	deficiency	NOUN
easat-8031	130	11	in	in	ADP
easat-8031	130	12	patients	patient	NOUN
easat-8031	130	13	aligns	align	VERB
easat-8031	130	14	with	with	ADP
easat-8031	130	15	emerging	emerge	VERB
easat-8031	130	16	evidence	evidence	NOUN
easat-8031	130	17	linking	link	VERB
easat-8031	130	18	hypovitaminosis	hypovitaminosis	NOUN
easat-8031	130	19	d	d	NOUN
easat-8031	130	20	to	to	PART
easat-8031	130	21	thyroid	thyroid	VERB
easat-8031	130	22	autoimmunity	autoimmunity	NOUN
easat-8031	130	23	,	,	PUNCT
easat-8031	130	24	potentially	potentially	ADV
easat-8031	130	25	exacerbating	exacerbate	VERB
easat-8031	130	26	immune	immune	ADJ
easat-8031	130	27	dysregulation	dysregulation	NOUN
easat-8031	130	28	through	through	ADP
easat-8031	130	29	impaired	impair	VERB
easat-8031	130	30	t	t	NOUN
easat-8031	130	31	cell	cell	NOUN
easat-8031	130	32	modulation	modulation	NOUN
easat-8031	130	33	.	.	PUNCT
easat-8031	131	1	while	while	SCONJ
easat-8031	131	2	the	the	DET
easat-8031	131	3	weak	weak	ADJ
easat-8031	131	4	negative	negative	ADJ
easat-8031	131	5	correlations	correlation	NOUN
easat-8031	131	6	between	between	ADP
easat-8031	131	7	vitamin	vitamin	NOUN
easat-8031	131	8	d	d	NOUN
easat-8031	131	9	and	and	CCONJ
easat-8031	131	10	tsh	tsh	NOUN
easat-8031	131	11	/	/	SYM
easat-8031	131	12	antitpo	antitpo	NOUN
easat-8031	131	13	were	be	AUX
easat-8031	131	14	not	not	PART
easat-8031	131	15	statistically	statistically	ADV
easat-8031	131	16	significant	significant	ADJ
easat-8031	131	17	,	,	PUNCT
easat-8031	131	18	they	they	PRON
easat-8031	131	19	underscore	underscore	VERB
easat-8031	131	20	a	a	DET
easat-8031	131	21	plausible	plausible	ADJ
easat-8031	131	22	pathophysiological	pathophysiological	ADJ
easat-8031	131	23	interplay	interplay	NOUN
easat-8031	131	24	,	,	PUNCT
easat-8031	131	25	warranting	warrant	VERB
easat-8031	131	26	further	further	ADJ
easat-8031	131	27	exploration	exploration	NOUN
easat-8031	131	28	.	.	PUNCT
easat-8031	132	1	additionally	additionally	ADV
easat-8031	132	2	,	,	PUNCT
easat-8031	132	3	the	the	DET
easat-8031	132	4	association	association	NOUN
easat-8031	132	5	between	between	ADP
easat-8031	132	6	higher	high	ADJ
easat-8031	132	7	bmi	bmi	NOUN
easat-8031	132	8	and	and	CCONJ
easat-8031	132	9	hypothyroidism	hypothyroidism	NOUN
easat-8031	132	10	highlights	highlight	VERB
easat-8031	132	11	the	the	DET
easat-8031	132	12	metabolic	metabolic	NOUN
easat-8031	132	13	implications	implication	NOUN
easat-8031	132	14	of	of	ADP
easat-8031	132	15	thyroid	thyroid	NOUN
easat-8031	132	16	dysfunction	dysfunction	NOUN
easat-8031	132	17	.	.	PUNCT
easat-8031	133	1	finally	finally	ADV
easat-8031	133	2	,	,	PUNCT
easat-8031	133	3	understanding	understand	VERB
easat-8031	133	4	how	how	SCONJ
easat-8031	133	5	vitamin	vitamin	NOUN
easat-8031	133	6	d	d	NOUN
easat-8031	133	7	insufficiency	insufficiency	NOUN
easat-8031	133	8	affects	affect	VERB
easat-8031	133	9	all	all	DET
easat-8031	133	10	the	the	DET
easat-8031	133	11	parameters	parameter	NOUN
easat-8031	133	12	associated	associate	VERB
easat-8031	133	13	with	with	ADP
easat-8031	133	14	hashimoto	hashimoto	NOUN
easat-8031	133	15	's	's	PART
easat-8031	133	16	disease	disease	NOUN
easat-8031	133	17	opens	open	VERB
easat-8031	133	18	the	the	DET
easat-8031	133	19	way	way	NOUN
easat-8031	133	20	for	for	ADP
easat-8031	133	21	new	new	ADJ
easat-8031	133	22	therapeutic	therapeutic	ADJ
easat-8031	133	23	strategies	strategy	NOUN
easat-8031	133	24	,	,	PUNCT
easat-8031	133	25	including	include	VERB
easat-8031	133	26	the	the	DET
easat-8031	133	27	use	use	NOUN
easat-8031	133	28	of	of	ADP
easat-8031	133	29	vitamin	vitamin	NOUN
easat-8031	133	30	d	d	NOUN
easat-8031	133	31	supplements	supplement	NOUN
easat-8031	133	32	as	as	ADP
easat-8031	133	33	part	part	NOUN
easat-8031	133	34	of	of	ADP
easat-8031	133	35	the	the	DET
easat-8031	133	36	management	management	NOUN
easat-8031	133	37	of	of	ADP
easat-8031	133	38	this	this	DET
easat-8031	133	39	disease	disease	NOUN
easat-8031	133	40	.	.	PUNCT
easat-8031	134	1	transparency	transparency	NOUN
easat-8031	134	2	:	:	PUNCT
easat-8031	134	3	the	the	DET
easat-8031	134	4	authors	author	NOUN
easat-8031	134	5	confirm	confirm	VERB
easat-8031	134	6	that	that	SCONJ
easat-8031	134	7	the	the	DET
easat-8031	134	8	manuscript	manuscript	NOUN
easat-8031	134	9	is	be	AUX
easat-8031	134	10	an	an	DET
easat-8031	134	11	honest	honest	ADJ
easat-8031	134	12	,	,	PUNCT
easat-8031	134	13	accurate	accurate	ADJ
easat-8031	134	14	,	,	PUNCT
easat-8031	134	15	and	and	CCONJ
easat-8031	134	16	transparent	transparent	ADJ
easat-8031	134	17	account	account	NOUN
easat-8031	134	18	of	of	ADP
easat-8031	134	19	the	the	DET
easat-8031	134	20	study	study	NOUN
easat-8031	134	21	;	;	PUNCT
easat-8031	134	22	that	that	SCONJ
easat-8031	134	23	no	no	DET
easat-8031	134	24	vital	vital	ADJ
easat-8031	134	25	features	feature	NOUN
easat-8031	134	26	of	of	ADP
easat-8031	134	27	the	the	DET
easat-8031	134	28	study	study	NOUN
easat-8031	134	29	have	have	AUX
easat-8031	134	30	been	be	AUX
easat-8031	134	31	omitted	omit	VERB
easat-8031	134	32	;	;	PUNCT
easat-8031	134	33	and	and	CCONJ
easat-8031	134	34	that	that	SCONJ
easat-8031	134	35	any	any	DET
easat-8031	134	36	discrepancies	discrepancy	NOUN
easat-8031	134	37	from	from	ADP
easat-8031	134	38	the	the	DET
easat-8031	134	39	study	study	NOUN
easat-8031	134	40	as	as	SCONJ
easat-8031	134	41	planned	plan	VERB
easat-8031	134	42	have	have	AUX
easat-8031	134	43	been	be	AUX
easat-8031	134	44	explained	explain	VERB
easat-8031	134	45	.	.	PUNCT
easat-8031	135	1	this	this	DET
easat-8031	135	2	study	study	NOUN
easat-8031	135	3	followed	follow	VERB
easat-8031	135	4	all	all	DET
easat-8031	135	5	ethical	ethical	ADJ
easat-8031	135	6	practices	practice	NOUN
easat-8031	135	7	during	during	ADP
easat-8031	135	8	writing	writing	NOUN
easat-8031	135	9	.	.	PUNCT
easat-8031	136	1	acknowledgement	acknowledgement	NOUN
easat-8031	136	2	:	:	PUNCT
easat-8031	136	3	we	we	PRON
easat-8031	136	4	are	be	AUX
easat-8031	136	5	grateful	grateful	ADJ
easat-8031	136	6	to	to	ADP
easat-8031	136	7	the	the	DET
easat-8031	136	8	al	al	PROPN
easat-8031	136	9	-	-	PUNCT
easat-8031	136	10	rifai	rifai	PROPN
easat-8031	136	11	general	general	ADJ
easat-8031	136	12	hospital	hospital	NOUN
easat-8031	136	13	and	and	CCONJ
easat-8031	136	14	al	al	PROPN
easat-8031	136	15	-	-	PUNCT
easat-8031	136	16	haboubi	haboubi	ADJ
easat-8031	136	17	teaching	teaching	NOUN
easat-8031	136	18	hospital	hospital	NOUN
easat-8031	136	19	,	,	PUNCT
easat-8031	136	20	as	as	ADV
easat-8031	136	21	well	well	ADV
easat-8031	136	22	as	as	ADP
easat-8031	136	23	several	several	ADJ
easat-8031	136	24	private	private	ADJ
easat-8031	136	25	clinics	clinic	NOUN
easat-8031	136	26	in	in	ADP
easat-8031	136	27	thi	thi	AUX
easat-8031	136	28	qar	qar	PROPN
easat-8031	136	29	governorate	governorate	PROPN
easat-8031	136	30	,	,	PUNCT
easat-8031	136	31	and	and	CCONJ
easat-8031	136	32	to	to	ADP
easat-8031	136	33	the	the	DET
easat-8031	136	34	healthy	healthy	ADJ
easat-8031	136	35	volunteer	volunteer	NOUN
easat-8031	136	36	’s	’s	PART
easat-8031	136	37	people	people	NOUN
easat-8031	136	38	who	who	PRON
easat-8031	136	39	provided	provide	VERB
easat-8031	136	40	us	we	PRON
easat-8031	136	41	with	with	ADP
easat-8031	136	42	samples	sample	NOUN
easat-8031	136	43	.	.	PUNCT
easat-8031	137	1	thanks	thank	NOUN
easat-8031	137	2	and	and	CCONJ
easat-8031	137	3	gratitude	gratitude	NOUN
easat-8031	137	4	extend	extend	NOUN
easat-8031	137	5	to	to	ADP
easat-8031	137	6	the	the	DET
easat-8031	137	7	department	department	NOUN
easat-8031	137	8	of	of	ADP
easat-8031	137	9	pathological	pathological	ADJ
easat-8031	137	10	analysis	analysis	NOUN
easat-8031	137	11	,	,	PUNCT
easat-8031	137	12	in	in	ADP
easat-8031	137	13	university	university	NOUN
easat-8031	137	14	of	of	ADP
easat-8031	137	15	thiqar	thiqar	VERB
easat-8031	137	16	.	.	PUNCT
easat-8031	138	1	copyright	copyright	NOUN
easat-8031	138	2	:	:	PUNCT
easat-8031	138	3	©	©	PROPN
easat-8031	138	4	2025	2025	NUM
easat-8031	138	5	by	by	ADP
easat-8031	138	6	the	the	DET
easat-8031	138	7	authors	author	NOUN
easat-8031	138	8	.	.	PUNCT
easat-8031	139	1	this	this	DET
easat-8031	139	2	open	open	ADJ
easat-8031	139	3	-	-	PUNCT
easat-8031	139	4	access	access	NOUN
easat-8031	139	5	article	article	NOUN
easat-8031	139	6	is	be	AUX
easat-8031	139	7	distributed	distribute	VERB
easat-8031	139	8	under	under	ADP
easat-8031	139	9	the	the	DET
easat-8031	139	10	terms	term	NOUN
easat-8031	139	11	and	and	CCONJ
easat-8031	139	12	conditions	condition	NOUN
easat-8031	139	13	of	of	ADP
easat-8031	139	14	the	the	DET
easat-8031	139	15	creative	creative	ADJ
easat-8031	139	16	commons	common	NOUN
easat-8031	139	17	attribution	attribution	NOUN
easat-8031	139	18	(	(	PUNCT
easat-8031	139	19	cc	cc	NOUN
easat-8031	139	20	by	by	ADP
easat-8031	139	21	)	)	PUNCT
easat-8031	139	22	license	license	NOUN
easat-8031	139	23	(	(	PUNCT
easat-8031	139	24	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-8031	139	25	)	)	PUNCT
easat-8031	139	26	.	.	PUNCT
easat-8031	140	1	references	reference	NOUN
easat-8031	140	2	[	[	X
easat-8031	140	3	1	1	NUM
easat-8031	140	4	]	]	PUNCT
easat-8031	140	5	p.	p.	PROPN
easat-8031	140	6	n.	n.	PROPN
easat-8031	140	7	taylor	taylor	PROPN
easat-8031	140	8	,	,	PUNCT
easat-8031	140	9	m.	m.	NOUN
easat-8031	140	10	m.	m.	NOUN
easat-8031	140	11	medici	medici	PROPN
easat-8031	140	12	,	,	PUNCT
easat-8031	140	13	a.	a.	NOUN
easat-8031	140	14	hubalewska	hubalewska	PROPN
easat-8031	140	15	-	-	PUNCT
easat-8031	140	16	dydejczyk	dydejczyk	VERB
easat-8031	140	17	,	,	PUNCT
easat-8031	140	18	and	and	CCONJ
easat-8031	140	19	k.	k.	PROPN
easat-8031	140	20	boelaert	boelaert	PROPN
easat-8031	140	21	,	,	PUNCT
easat-8031	140	22	"	"	PUNCT
easat-8031	140	23	hypothyroidism	hypothyroidism	NOUN
easat-8031	140	24	,	,	PUNCT
easat-8031	140	25	"	"	PUNCT
easat-8031	140	26	the	the	DET
easat-8031	140	27	lancet	lancet	NOUN
easat-8031	140	28	,	,	PUNCT
easat-8031	140	29	vol	vol	NOUN
easat-8031	140	30	.	.	PUNCT
easat-8031	141	1	404	404	NUM
easat-8031	141	2	,	,	PUNCT
easat-8031	141	3	no	no	INTJ
easat-8031	141	4	.	.	NOUN
easat-8031	141	5	10460	10460	NUM
easat-8031	141	6	,	,	PUNCT
easat-8031	141	7	pp	pp	ADJ
easat-8031	141	8	.	.	PUNCT
easat-8031	142	1	1347–1364	1347–1364	NUM
easat-8031	142	2	,	,	PUNCT
easat-8031	142	3	2024	2024	NUM
easat-8031	142	4	.	.	PUNCT
easat-8031	143	1	https://doi.org/10.1016/s0140-6736(24)01614-3	https://doi.org/10.1016/s0140-6736(24)01614-3	ADJ
easat-8031	143	2	[	[	X
easat-8031	143	3	2	2	NUM
easat-8031	143	4	]	]	X
easat-8031	143	5	y.	y.	NOUN
easat-8031	143	6	srivastav	srivastav	PROPN
easat-8031	143	7	,	,	PUNCT
easat-8031	143	8	a.	a.	PROPN
easat-8031	143	9	prajapati	prajapati	PROPN
easat-8031	143	10	,	,	PUNCT
easat-8031	143	11	k.	k.	PROPN
easat-8031	143	12	meera	meera	PROPN
easat-8031	143	13	,	,	PUNCT
easat-8031	143	14	and	and	CCONJ
easat-8031	143	15	k.	k.	PROPN
easat-8031	143	16	madhaw	madhaw	NOUN
easat-8031	143	17	,	,	PUNCT
easat-8031	143	18	"	"	PUNCT
easat-8031	143	19	general	general	ADJ
easat-8031	143	20	overview	overview	NOUN
easat-8031	143	21	of	of	ADP
easat-8031	143	22	the	the	DET
easat-8031	143	23	risk	risk	NOUN
easat-8031	143	24	factors	factor	NOUN
easat-8031	143	25	,	,	PUNCT
easat-8031	143	26	pathogenesis	pathogenesis	NOUN
easat-8031	143	27	,	,	PUNCT
easat-8031	143	28	and	and	CCONJ
easat-8031	143	29	combined	combined	ADJ
easat-8031	143	30	treatments	treatment	NOUN
easat-8031	143	31	for	for	ADP
easat-8031	143	32	hashimoto	hashimoto	NOUN
easat-8031	143	33	’s	’s	PART
easat-8031	143	34	thyroiditis	thyroiditis	NOUN
easat-8031	143	35	(	(	PUNCT
easat-8031	143	36	ht	ht	PROPN
easat-8031	143	37	)	)	PUNCT
easat-8031	143	38	,	,	PUNCT
easat-8031	143	39	"	"	PUNCT
easat-8031	143	40	world	world	NOUN
easat-8031	143	41	journal	journal	NOUN
easat-8031	143	42	of	of	ADP
easat-8031	143	43	current	current	ADJ
easat-8031	143	44	medical	medical	ADJ
easat-8031	143	45	and	and	CCONJ
easat-8031	143	46	pharmaceutical	pharmaceutical	NOUN
easat-8031	143	47	research	research	NOUN
easat-8031	143	48	,	,	PUNCT
easat-8031	143	49	vol	vol	NOUN
easat-8031	143	50	.	.	PROPN
easat-8031	143	51	5	5	NUM
easat-8031	143	52	,	,	PUNCT
easat-8031	143	53	no	no	INTJ
easat-8031	143	54	.	.	NOUN
easat-8031	143	55	5	5	NUM
easat-8031	143	56	,	,	PUNCT
easat-8031	143	57	pp	pp	ADJ
easat-8031	143	58	.	.	PUNCT
easat-8031	144	1	175–189	175–189	NUM
easat-8031	144	2	,	,	PUNCT
easat-8031	144	3	2023	2023	NUM
easat-8031	144	4	.	.	PUNCT
easat-8031	145	1	https://doi.org/10.37022/wjcmpr.v5i5.290	https://doi.org/10.37022/wjcmpr.v5i5.290	PROPN
easat-8031	145	2	[	[	X
easat-8031	145	3	3	3	X
easat-8031	145	4	]	]	X
easat-8031	145	5	h.	h.	PROPN
easat-8031	145	6	jiang	jiang	PROPN
easat-8031	145	7	,	,	PUNCT
easat-8031	145	8	x.	x.	PROPN
easat-8031	145	9	chen	chen	PROPN
easat-8031	145	10	,	,	PUNCT
easat-8031	145	11	x.	x.	PROPN
easat-8031	145	12	qian	qian	PROPN
easat-8031	145	13	,	,	PUNCT
easat-8031	145	14	and	and	CCONJ
easat-8031	145	15	s.	s.	PROPN
easat-8031	145	16	shao	shao	PROPN
easat-8031	145	17	,	,	PUNCT
easat-8031	145	18	"	"	PUNCT
easat-8031	145	19	effects	effect	NOUN
easat-8031	145	20	of	of	ADP
easat-8031	145	21	vitamin	vitamin	NOUN
easat-8031	145	22	d	d	NOUN
easat-8031	145	23	treatment	treatment	NOUN
easat-8031	145	24	on	on	ADP
easat-8031	145	25	thyroid	thyroid	NOUN
easat-8031	145	26	function	function	NOUN
easat-8031	145	27	and	and	CCONJ
easat-8031	145	28	autoimmunity	autoimmunity	NOUN
easat-8031	145	29	markers	marker	NOUN
easat-8031	145	30	in	in	ADP
easat-8031	145	31	patients	patient	NOUN
easat-8031	145	32	with	with	ADP
easat-8031	145	33	hashimoto	hashimoto	NOUN
easat-8031	145	34	's	's	PART
easat-8031	145	35	thyroiditis	thyroiditis	NOUN
easat-8031	145	36	—	—	PUNCT
easat-8031	145	37	a	a	DET
easat-8031	145	38	meta‐analysis	meta‐analysis	NOUN
easat-8031	145	39	of	of	ADP
easat-8031	145	40	randomized	randomized	ADJ
easat-8031	145	41	controlled	control	VERB
easat-8031	145	42	trials	trial	NOUN
easat-8031	145	43	,	,	PUNCT
easat-8031	145	44	"	"	PUNCT
easat-8031	145	45	journal	journal	NOUN
easat-8031	145	46	of	of	ADP
easat-8031	145	47	clinical	clinical	ADJ
easat-8031	145	48	pharmacy	pharmacy	NOUN
easat-8031	145	49	and	and	CCONJ
easat-8031	145	50	therapeutics	therapeutic	NOUN
easat-8031	145	51	,	,	PUNCT
easat-8031	145	52	vol	vol	NOUN
easat-8031	145	53	.	.	PROPN
easat-8031	146	1	47	47	NUM
easat-8031	146	2	,	,	PUNCT
easat-8031	146	3	no	no	INTJ
easat-8031	146	4	.	.	NOUN
easat-8031	146	5	6	6	NUM
easat-8031	146	6	,	,	PUNCT
easat-8031	146	7	pp	pp	ADJ
easat-8031	146	8	.	.	PUNCT
easat-8031	147	1	767	767	NUM
easat-8031	147	2	-	-	SYM
easat-8031	147	3	775	775	NUM
easat-8031	147	4	,	,	PUNCT
easat-8031	147	5	2022	2022	NUM
easat-8031	147	6	.	.	PUNCT
easat-8031	147	7	https://doi.org/10.1111/jcpt.13605	https://doi.org/10.1111/jcpt.13605	X
easat-8031	148	1	[	[	X
easat-8031	148	2	4	4	NUM
easat-8031	148	3	]	]	PUNCT
easat-8031	148	4	a.	a.	NOUN
easat-8031	148	5	weetman	weetman	NOUN
easat-8031	148	6	,	,	PUNCT
easat-8031	148	7	"	"	PUNCT
easat-8031	148	8	an	an	DET
easat-8031	148	9	update	update	NOUN
easat-8031	148	10	on	on	ADP
easat-8031	148	11	the	the	DET
easat-8031	148	12	pathogenesis	pathogenesis	NOUN
easat-8031	148	13	of	of	ADP
easat-8031	148	14	hashimoto	hashimoto	NOUN
easat-8031	148	15	’s	’s	PART
easat-8031	148	16	thyroiditis	thyroiditis	NOUN
easat-8031	148	17	,	,	PUNCT
easat-8031	148	18	"	"	PUNCT
easat-8031	148	19	journal	journal	NOUN
easat-8031	148	20	of	of	ADP
easat-8031	148	21	endocrinological	endocrinological	ADJ
easat-8031	148	22	investigation	investigation	NOUN
easat-8031	148	23	,	,	PUNCT
easat-8031	148	24	vol	vol	NOUN
easat-8031	148	25	.	.	PROPN
easat-8031	148	26	44	44	NUM
easat-8031	148	27	,	,	PUNCT
easat-8031	148	28	no	no	INTJ
easat-8031	148	29	.	.	NOUN
easat-8031	148	30	5	5	NUM
easat-8031	148	31	,	,	PUNCT
easat-8031	148	32	pp	pp	ADJ
easat-8031	148	33	.	.	PUNCT
easat-8031	149	1	883	883	NUM
easat-8031	149	2	-	-	SYM
easat-8031	149	3	890	890	NUM
easat-8031	149	4	,	,	PUNCT
easat-8031	149	5	2021	2021	NUM
easat-8031	149	6	.	.	PUNCT
easat-8031	150	1	https://doi.org/10.1007/s40618-020-01477-1	https://doi.org/10.1007/s40618-020-01477-1	NOUN
easat-8031	151	1	[	[	X
easat-8031	151	2	5	5	X
easat-8031	151	3	]	]	PUNCT
easat-8031	151	4	k.	k.	PROPN
easat-8031	151	5	geetha	geetha	PROPN
easat-8031	151	6	,	,	PUNCT
easat-8031	151	7	g.	g.	PROPN
easat-8031	151	8	sasanka	sasanka	PROPN
easat-8031	151	9	,	,	PUNCT
easat-8031	151	10	s.	s.	PROPN
easat-8031	151	11	pridvineel	pridvineel	PROPN
easat-8031	151	12	,	,	PUNCT
easat-8031	151	13	m.	m.	NOUN
easat-8031	151	14	banu	banu	PROPN
easat-8031	151	15	,	,	PUNCT
easat-8031	151	16	and	and	CCONJ
easat-8031	151	17	t.	t.	PROPN
easat-8031	151	18	rao	rao	PROPN
easat-8031	151	19	,	,	PUNCT
easat-8031	151	20	"	"	PUNCT
easat-8031	151	21	a	a	DET
easat-8031	151	22	review	review	NOUN
easat-8031	151	23	on	on	ADP
easat-8031	151	24	hashimoto	hashimoto	NOUN
easat-8031	151	25	’s	’s	PART
easat-8031	151	26	thyroiditis	thyroiditis	NOUN
easat-8031	151	27	,	,	PUNCT
easat-8031	151	28	"	"	PUNCT
easat-8031	151	29	journal	journal	NOUN
easat-8031	151	30	drug	drug	NOUN
easat-8031	151	31	delivery	delivery	NOUN
easat-8031	151	32	therapeutics	therapeutic	NOUN
easat-8031	151	33	,	,	PUNCT
easat-8031	151	34	vol	vol	NOUN
easat-8031	151	35	.	.	PROPN
easat-8031	151	36	13	13	NUM
easat-8031	151	37	,	,	PUNCT
easat-8031	151	38	no	no	INTJ
easat-8031	151	39	.	.	NOUN
easat-8031	151	40	12	12	NUM
easat-8031	151	41	,	,	PUNCT
easat-8031	151	42	pp	pp	ADJ
easat-8031	151	43	.	.	PUNCT
easat-8031	152	1	250	250	NUM
easat-8031	152	2	-	-	SYM
easat-8031	152	3	254	254	NUM
easat-8031	152	4	,	,	PUNCT
easat-8031	152	5	2023	2023	NUM
easat-8031	152	6	.	.	PUNCT
easat-8031	153	1	https://doi.org/10.22270/jddt.v13i12.6133	https://doi.org/10.22270/jddt.v13i12.6133	NOUN
easat-8031	154	1	[	[	X
easat-8031	154	2	6	6	NUM
easat-8031	154	3	]	]	PUNCT
easat-8031	154	4	u.	u.	PROPN
easat-8031	154	5	saeed	saeed	PROPN
easat-8031	154	6	,	,	PUNCT
easat-8031	154	7	s.	s.	PROPN
easat-8031	154	8	saeed	saeed	PROPN
easat-8031	154	9	,	,	PUNCT
easat-8031	154	10	q.	q.	PROPN
easat-8031	154	11	mehmood	mehmood	PROPN
easat-8031	154	12	,	,	PUNCT
easat-8031	154	13	and	and	CCONJ
easat-8031	154	14	a.	a.	NOUN
easat-8031	154	15	ayyub	ayyub	NOUN
easat-8031	154	16	,	,	PUNCT
easat-8031	154	17	"	"	PUNCT
easat-8031	154	18	a	a	DET
easat-8031	154	19	study	study	NOUN
easat-8031	154	20	of	of	ADP
easat-8031	154	21	plasma	plasma	NOUN
easat-8031	154	22	anti	anti	ADJ
easat-8031	154	23	-	-	ADJ
easat-8031	154	24	thyroperoxidase	thyroperoxidase	ADJ
easat-8031	154	25	antibodies	antibody	NOUN
easat-8031	154	26	and	and	CCONJ
easat-8031	154	27	antithyroglobulin	antithyroglobulin	PROPN
easat-8031	154	28	antibodies	antibodie	VERB
easat-8031	154	29	in	in	ADP
easat-8031	154	30	patients	patient	NOUN
easat-8031	154	31	with	with	ADP
easat-8031	154	32	hypothyroidism	hypothyroidism	NOUN
easat-8031	154	33	,	,	PUNCT
easat-8031	154	34	"	"	PUNCT
easat-8031	154	35	pakistan	pakistan	PROPN
easat-8031	154	36	journal	journal	PROPN
easat-8031	154	37	of	of	ADP
easat-8031	154	38	medical	medical	PROPN
easat-8031	154	39	&	&	CCONJ
easat-8031	154	40	health	health	PROPN
easat-8031	154	41	sciences	sciences	PROPN
easat-8031	154	42	,	,	PUNCT
easat-8031	154	43	vol	vol	NOUN
easat-8031	154	44	.	.	PROPN
easat-8031	155	1	16	16	NUM
easat-8031	155	2	,	,	PUNCT
easat-8031	155	3	no	no	INTJ
easat-8031	155	4	.	.	NOUN
easat-8031	155	5	10	10	NUM
easat-8031	155	6	,	,	PUNCT
easat-8031	155	7	pp	pp	ADJ
easat-8031	155	8	.	.	PUNCT
easat-8031	156	1	153	153	NUM
easat-8031	156	2	-	-	SYM
easat-8031	156	3	153	153	NUM
easat-8031	156	4	,	,	PUNCT
easat-8031	156	5	2022	2022	NUM
easat-8031	156	6	.	.	PUNCT
easat-8031	157	1	https://doi.org/10.53350/pjmhs221610153	https://doi.org/10.53350/pjmhs221610153	VERB
easat-8031	157	2	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-8031	158	1	https://doi.org/10.1016/s0140-6736(24)01614-3	https://doi.org/10.1016/s0140-6736(24)01614-3	ADJ
easat-8031	158	2	https://doi.org/10.37022/wjcmpr.v5i5.290	https://doi.org/10.37022/wjcmpr.v5i5.290	NOUN
easat-8031	158	3	https://doi.org/10.1111/jcpt.13605	https://doi.org/10.1111/jcpt.13605	PRON
easat-8031	158	4	https://doi.org/10.1007/s40618-020-01477-1	https://doi.org/10.1007/s40618-020-01477-1	NOUN
easat-8031	158	5	https://doi.org/10.22270/jddt.v13i12.6133	https://doi.org/10.22270/jddt.v13i12.6133	PROPN
easat-8031	158	6	https://doi.org/10.53350/pjmhs221610153	https://doi.org/10.53350/pjmhs221610153	VERB
easat-8031	158	7	1103	1103	NUM
easat-8031	158	8	edelweiss	edelweiss	PROPN
easat-8031	158	9	applied	apply	VERB
easat-8031	158	10	science	science	NOUN
easat-8031	158	11	and	and	CCONJ
easat-8031	158	12	technology	technology	NOUN
easat-8031	158	13	issn	issn	PROPN
easat-8031	158	14	:	:	PUNCT
easat-8031	158	15	2576	2576	NUM
easat-8031	158	16	-	-	SYM
easat-8031	158	17	8484	8484	NUM
easat-8031	158	18	vol	vol	NOUN
easat-8031	158	19	.	.	PROPN
easat-8031	159	1	9	9	NUM
easat-8031	159	2	,	,	PUNCT
easat-8031	159	3	no	no	INTJ
easat-8031	159	4	.	.	NOUN
easat-8031	159	5	6	6	NUM
easat-8031	159	6	:	:	SYM
easat-8031	159	7	1094	1094	NUM
easat-8031	159	8	-	-	SYM
easat-8031	159	9	1103	1103	NUM
easat-8031	159	10	,	,	PUNCT
easat-8031	159	11	2025	2025	NUM
easat-8031	159	12	doi	doi	NOUN
easat-8031	159	13	:	:	PUNCT
easat-8031	159	14	10.55214/25768484.v9i6.8031	10.55214/25768484.v9i6.8031	NUM
easat-8031	159	15	©	©	PROPN
easat-8031	159	16	2025	2025	NUM
easat-8031	159	17	by	by	ADP
easat-8031	159	18	the	the	DET
easat-8031	159	19	authors	author	NOUN
easat-8031	159	20	;	;	PUNCT
easat-8031	159	21	licensee	licensee	PROPN
easat-8031	159	22	learning	learning	NOUN
easat-8031	159	23	gate	gate	NOUN
easat-8031	160	1	[	[	X
easat-8031	160	2	7	7	NUM
easat-8031	160	3	]	]	X
easat-8031	160	4	b.	b.	PROPN
easat-8031	160	5	małkowski	małkowski	PROPN
easat-8031	160	6	,	,	PUNCT
easat-8031	160	7	z.	z.	PROPN
easat-8031	160	8	serafin	serafin	PROPN
easat-8031	160	9	,	,	PUNCT
easat-8031	160	10	r.	r.	PROPN
easat-8031	160	11	glonek	glonek	PROPN
easat-8031	160	12	,	,	PUNCT
easat-8031	160	13	s.	s.	PROPN
easat-8031	160	14	suwała	suwała	PROPN
easat-8031	160	15	,	,	PUNCT
easat-8031	160	16	r.	r.	PROPN
easat-8031	160	17	łopatto	łopatto	PROPN
easat-8031	160	18	,	,	PUNCT
easat-8031	160	19	and	and	CCONJ
easat-8031	160	20	r.	r.	PROPN
easat-8031	160	21	junik	junik	PROPN
easat-8031	160	22	,	,	PUNCT
easat-8031	160	23	"	"	PUNCT
easat-8031	160	24	the	the	DET
easat-8031	160	25	role	role	NOUN
easat-8031	160	26	of	of	ADP
easat-8031	160	27	18f	18f	PROPN
easat-8031	160	28	-	-	PUNCT
easat-8031	160	29	fdg	fdg	PROPN
easat-8031	160	30	pet	pet	PROPN
easat-8031	160	31	/	/	SYM
easat-8031	160	32	ct	ct	PROPN
easat-8031	160	33	in	in	ADP
easat-8031	160	34	the	the	DET
easat-8031	160	35	management	management	NOUN
easat-8031	160	36	of	of	ADP
easat-8031	160	37	the	the	DET
easat-8031	160	38	autoimmune	autoimmune	ADJ
easat-8031	160	39	thyroid	thyroid	NOUN
easat-8031	160	40	diseases	disease	NOUN
easat-8031	160	41	,	,	PUNCT
easat-8031	160	42	"	"	PUNCT
easat-8031	160	43	frontiers	frontier	NOUN
easat-8031	160	44	in	in	ADP
easat-8031	160	45	endocrinology	endocrinology	NOUN
easat-8031	160	46	,	,	PUNCT
easat-8031	160	47	vol	vol	NOUN
easat-8031	160	48	.	.	PROPN
easat-8031	160	49	10	10	NUM
easat-8031	160	50	,	,	PUNCT
easat-8031	160	51	p.	p.	NOUN
easat-8031	160	52	208	208	NUM
easat-8031	160	53	,	,	PUNCT
easat-8031	160	54	2019	2019	NUM
easat-8031	160	55	.	.	PUNCT
easat-8031	161	1	https://doi.org/10.3389/fendo.2019.00208	https://doi.org/10.3389/fendo.2019.00208	NOUN
easat-8031	161	2	[	[	X
easat-8031	161	3	8	8	NUM
easat-8031	161	4	]	]	PUNCT
easat-8031	161	5	m.	m.	NOUN
easat-8031	161	6	a.	a.	NOUN
easat-8031	161	7	abo	abo	PROPN
easat-8031	161	8	-	-	PUNCT
easat-8031	161	9	zaid	zaid	PROPN
easat-8031	161	10	,	,	PUNCT
easat-8031	161	11	h.	h.	PROPN
easat-8031	161	12	a.	a.	PROPN
easat-8031	161	13	hamdi	hamdi	PROPN
easat-8031	161	14	,	,	PUNCT
easat-8031	161	15	and	and	CCONJ
easat-8031	161	16	n.	n.	PROPN
easat-8031	161	17	f.	f.	PROPN
easat-8031	161	18	elashmawy	elashmawy	PROPN
easat-8031	161	19	,	,	PUNCT
easat-8031	161	20	"	"	PUNCT
easat-8031	161	21	vitamin	vitamin	NOUN
easat-8031	161	22	d	d	NOUN
easat-8031	161	23	and	and	CCONJ
easat-8031	161	24	immunity	immunity	NOUN
easat-8031	161	25	:	:	PUNCT
easat-8031	161	26	a	a	DET
easat-8031	161	27	comprehensive	comprehensive	ADJ
easat-8031	161	28	review	review	NOUN
easat-8031	161	29	of	of	ADP
easat-8031	161	30	its	its	PRON
easat-8031	161	31	impact	impact	NOUN
easat-8031	161	32	on	on	ADP
easat-8031	161	33	autoimmunity	autoimmunity	NOUN
easat-8031	161	34	,	,	PUNCT
easat-8031	161	35	allergy	allergy	NOUN
easat-8031	161	36	suppression	suppression	NOUN
easat-8031	161	37	,	,	PUNCT
easat-8031	161	38	antimicrobial	antimicrobial	ADJ
easat-8031	161	39	defense	defense	NOUN
easat-8031	161	40	,	,	PUNCT
easat-8031	161	41	and	and	CCONJ
easat-8031	161	42	cancer	cancer	NOUN
easat-8031	161	43	inhibition	inhibition	NOUN
easat-8031	161	44	,	,	PUNCT
easat-8031	161	45	"	"	PUNCT
easat-8031	161	46	the	the	DET
easat-8031	161	47	egyptian	egyptian	ADJ
easat-8031	161	48	journal	journal	NOUN
easat-8031	161	49	of	of	ADP
easat-8031	161	50	immunology	immunology	NOUN
easat-8031	161	51	,	,	PUNCT
easat-8031	161	52	vol	vol	NOUN
easat-8031	161	53	.	.	PROPN
easat-8031	161	54	30	30	NUM
easat-8031	161	55	,	,	PUNCT
easat-8031	161	56	pp	pp	ADJ
easat-8031	161	57	.	.	PUNCT
easat-8031	162	1	47	47	NUM
easat-8031	162	2	-	-	SYM
easat-8031	162	3	66	66	NUM
easat-8031	162	4	,	,	PUNCT
easat-8031	162	5	2023	2023	NUM
easat-8031	162	6	.	.	PUNCT
easat-8031	163	1	https://doi.org/10.55133/eji.300406	https://doi.org/10.55133/eji.300406	VERB
easat-8031	163	2	[	[	PUNCT
easat-8031	163	3	9	9	NUM
easat-8031	163	4	]	]	PUNCT
easat-8031	163	5	s.	s.	PROPN
easat-8031	163	6	gašić	gašić	PROPN
easat-8031	163	7	et	et	PROPN
easat-8031	163	8	al	al	PROPN
easat-8031	163	9	.	.	PROPN
easat-8031	163	10	,	,	PUNCT
easat-8031	163	11	"	"	PUNCT
easat-8031	163	12	relationship	relationship	NOUN
easat-8031	163	13	between	between	ADP
easat-8031	163	14	low	low	ADJ
easat-8031	163	15	vitamin	vitamin	NOUN
easat-8031	163	16	d	d	NOUN
easat-8031	163	17	levels	level	NOUN
easat-8031	163	18	with	with	ADP
easat-8031	163	19	hashimoto	hashimoto	NOUN
easat-8031	163	20	thyroiditis	thyroiditis	NOUN
easat-8031	163	21	,	,	PUNCT
easat-8031	163	22	"	"	PUNCT
easat-8031	163	23	srpski	srpski	PROPN
easat-8031	163	24	arhiv	arhiv	PROPN
easat-8031	163	25	za	za	PROPN
easat-8031	163	26	celokupno	celokupno	PROPN
easat-8031	163	27	lekarstvo	lekarstvo	PROPN
easat-8031	163	28	,	,	PUNCT
easat-8031	163	29	vol	vol	NOUN
easat-8031	163	30	.	.	PROPN
easat-8031	163	31	151	151	NUM
easat-8031	163	32	,	,	PUNCT
easat-8031	163	33	no	no	INTJ
easat-8031	163	34	.	.	NOUN
easat-8031	163	35	5	5	NUM
easat-8031	163	36	-	-	SYM
easat-8031	163	37	6	6	NUM
easat-8031	163	38	,	,	PUNCT
easat-8031	163	39	pp	pp	ADJ
easat-8031	163	40	.	.	PUNCT
easat-8031	164	1	296	296	NUM
easat-8031	164	2	-	-	SYM
easat-8031	164	3	301	301	NUM
easat-8031	164	4	,	,	PUNCT
easat-8031	164	5	2023	2023	NUM
easat-8031	164	6	.	.	PUNCT
easat-8031	165	1	https://doi.org/10.2298/sarh220608035	https://doi.org/10.2298/sarh220608035	PROPN
easat-8031	165	2	g	g	PROPN
easat-8031	166	1	[	[	X
easat-8031	166	2	10	10	NUM
easat-8031	166	3	]	]	X
easat-8031	166	4	f.	f.	PROPN
easat-8031	166	5	lebiedziński	lebiedziński	PROPN
easat-8031	166	6	and	and	CCONJ
easat-8031	166	7	k.	k.	PROPN
easat-8031	166	8	a.	a.	PROPN
easat-8031	166	9	lisowska	lisowska	PROPN
easat-8031	166	10	,	,	PUNCT
easat-8031	166	11	"	"	PUNCT
easat-8031	166	12	impact	impact	NOUN
easat-8031	166	13	of	of	ADP
easat-8031	166	14	vitamin	vitamin	NOUN
easat-8031	166	15	d	d	NOUN
easat-8031	166	16	on	on	ADP
easat-8031	166	17	immunopathology	immunopathology	NOUN
easat-8031	166	18	of	of	ADP
easat-8031	166	19	hashimoto	hashimoto	NOUN
easat-8031	166	20	’s	’s	PART
easat-8031	166	21	thyroiditis	thyroiditis	NOUN
easat-8031	166	22	:	:	PUNCT
easat-8031	166	23	from	from	ADP
easat-8031	166	24	theory	theory	NOUN
easat-8031	166	25	to	to	ADP
easat-8031	166	26	practice	practice	VERB
easat-8031	166	27	,	,	PUNCT
easat-8031	166	28	"	"	PUNCT
easat-8031	166	29	nutrients	nutrient	NOUN
easat-8031	166	30	,	,	PUNCT
easat-8031	166	31	vol	vol	NOUN
easat-8031	166	32	.	.	PROPN
easat-8031	166	33	15	15	NUM
easat-8031	166	34	,	,	PUNCT
easat-8031	166	35	no	no	INTJ
easat-8031	166	36	.	.	NOUN
easat-8031	166	37	14	14	NUM
easat-8031	166	38	,	,	PUNCT
easat-8031	166	39	p.	p.	NOUN
easat-8031	166	40	3174	3174	NUM
easat-8031	166	41	,	,	PUNCT
easat-8031	166	42	2023	2023	NUM
easat-8031	166	43	.	.	PUNCT
easat-8031	167	1	https://doi.org/10.3390/nu15143174	https://doi.org/10.3390/nu15143174	PROPN
easat-8031	167	2	[	[	X
easat-8031	167	3	11	11	NUM
easat-8031	167	4	]	]	PUNCT
easat-8031	167	5	j.	j.	PROPN
easat-8031	167	6	li	li	PROPN
easat-8031	167	7	et	et	PROPN
easat-8031	167	8	al	al	PROPN
easat-8031	167	9	.	.	PROPN
easat-8031	167	10	,	,	PUNCT
easat-8031	167	11	"	"	PUNCT
easat-8031	167	12	thyroid	thyroid	NOUN
easat-8031	167	13	antibodies	antibodie	VERB
easat-8031	167	14	in	in	ADP
easat-8031	167	15	hashimoto	hashimoto	NOUN
easat-8031	167	16	’s	’s	PART
easat-8031	167	17	thyroiditis	thyroiditis	NOUN
easat-8031	167	18	patients	patient	NOUN
easat-8031	167	19	are	be	AUX
easat-8031	167	20	positively	positively	ADV
easat-8031	167	21	associated	associate	VERB
easat-8031	167	22	with	with	ADP
easat-8031	167	23	inflammation	inflammation	NOUN
easat-8031	167	24	and	and	CCONJ
easat-8031	167	25	multiple	multiple	ADJ
easat-8031	167	26	symptoms	symptom	NOUN
easat-8031	167	27	,	,	PUNCT
easat-8031	167	28	"	"	PUNCT
easat-8031	167	29	scientific	scientific	ADJ
easat-8031	167	30	reports	report	NOUN
easat-8031	167	31	,	,	PUNCT
easat-8031	167	32	vol	vol	NOUN
easat-8031	167	33	.	.	PROPN
easat-8031	168	1	14	14	NUM
easat-8031	168	2	,	,	PUNCT
easat-8031	168	3	no	no	INTJ
easat-8031	168	4	.	.	NOUN
easat-8031	168	5	1	1	NUM
easat-8031	168	6	,	,	PUNCT
easat-8031	168	7	p.	p.	NOUN
easat-8031	168	8	27902	27902	NUM
easat-8031	168	9	,	,	PUNCT
easat-8031	168	10	2024	2024	NUM
easat-8031	168	11	.	.	PUNCT
easat-8031	169	1	https://doi.org/10.1038/s41598-024-78938-7	https://doi.org/10.1038/s41598-024-78938-7	PUNCT
easat-8031	170	1	[	[	X
easat-8031	170	2	12	12	NUM
easat-8031	170	3	]	]	PUNCT
easat-8031	170	4	m.	m.	NOUN
easat-8031	170	5	babić	babić	NOUN
easat-8031	170	6	leko	leko	NOUN
easat-8031	170	7	,	,	PUNCT
easat-8031	170	8	i.	i.	PROPN
easat-8031	170	9	jureško	jureško	PROPN
easat-8031	170	10	,	,	PUNCT
easat-8031	170	11	i.	i.	PROPN
easat-8031	170	12	rozić	rozić	PROPN
easat-8031	170	13	,	,	PUNCT
easat-8031	170	14	n.	n.	PROPN
easat-8031	170	15	pleić	pleić	PROPN
easat-8031	170	16	,	,	PUNCT
easat-8031	170	17	i.	i.	NOUN
easat-8031	170	18	gunjača	gunjača	PROPN
easat-8031	170	19	,	,	PUNCT
easat-8031	170	20	and	and	CCONJ
easat-8031	170	21	t.	t.	PROPN
easat-8031	170	22	zemunik	zemunik	X
easat-8031	170	23	,	,	PUNCT
easat-8031	170	24	"	"	PUNCT
easat-8031	170	25	vitamin	vitamin	NOUN
easat-8031	170	26	d	d	NOUN
easat-8031	170	27	and	and	CCONJ
easat-8031	170	28	the	the	DET
easat-8031	170	29	thyroid	thyroid	NOUN
easat-8031	170	30	:	:	PUNCT
easat-8031	170	31	a	a	DET
easat-8031	170	32	critical	critical	ADJ
easat-8031	170	33	review	review	NOUN
easat-8031	170	34	of	of	ADP
easat-8031	170	35	the	the	DET
easat-8031	170	36	current	current	ADJ
easat-8031	170	37	evidence	evidence	NOUN
easat-8031	170	38	,	,	PUNCT
easat-8031	170	39	"	"	PUNCT
easat-8031	170	40	international	international	ADJ
easat-8031	170	41	journal	journal	NOUN
easat-8031	170	42	of	of	ADP
easat-8031	170	43	molecular	molecular	ADJ
easat-8031	170	44	sciences	science	NOUN
easat-8031	170	45	,	,	PUNCT
easat-8031	170	46	vol	vol	NOUN
easat-8031	170	47	.	.	PROPN
easat-8031	170	48	24	24	NUM
easat-8031	170	49	,	,	PUNCT
easat-8031	170	50	no	no	INTJ
easat-8031	170	51	.	.	NOUN
easat-8031	170	52	4	4	NUM
easat-8031	170	53	,	,	PUNCT
easat-8031	170	54	p.	p.	NOUN
easat-8031	170	55	3586	3586	NUM
easat-8031	170	56	,	,	PUNCT
easat-8031	170	57	2023	2023	NUM
easat-8031	170	58	.	.	PUNCT
easat-8031	171	1	https://doi.org/10.3390/ijms24043586	https://doi.org/10.3390/ijms24043586	PROPN
easat-8031	171	2	[	[	X
easat-8031	171	3	13	13	NUM
easat-8031	171	4	]	]	X
easat-8031	171	5	h.	h.	PROPN
easat-8031	171	6	mousa	mousa	PROPN
easat-8031	171	7	and	and	CCONJ
easat-8031	171	8	a.	a.	NOUN
easat-8031	171	9	zoori	zoori	PROPN
easat-8031	171	10	,	,	PUNCT
easat-8031	171	11	"	"	PUNCT
easat-8031	171	12	prevalence	prevalence	NOUN
easat-8031	171	13	of	of	ADP
easat-8031	171	14	thyroid	thyroid	NOUN
easat-8031	171	15	disorders	disorder	NOUN
easat-8031	171	16	in	in	ADP
easat-8031	171	17	nasiriya	nasiriya	PROPN
easat-8031	171	18	city	city	PROPN
easat-8031	171	19	,	,	PUNCT
easat-8031	171	20	iraq	iraq	PROPN
easat-8031	171	21	,	,	PUNCT
easat-8031	171	22	"	"	PUNCT
easat-8031	171	23	university	university	NOUN
easat-8031	171	24	of	of	ADP
easat-8031	171	25	thi	thi	PROPN
easat-8031	171	26	-	-	PUNCT
easat-8031	171	27	qar	qar	PROPN
easat-8031	171	28	journal	journal	PROPN
easat-8031	171	29	of	of	ADP
easat-8031	171	30	science	science	NOUN
easat-8031	171	31	,	,	PUNCT
easat-8031	171	32	vol	vol	NOUN
easat-8031	171	33	.	.	PROPN
easat-8031	171	34	10	10	NUM
easat-8031	171	35	,	,	PUNCT
easat-8031	171	36	no	no	INTJ
easat-8031	171	37	.	.	NOUN
easat-8031	171	38	1	1	NUM
easat-8031	171	39	,	,	PUNCT
easat-8031	171	40	pp	pp	ADJ
easat-8031	171	41	.	.	PUNCT
easat-8031	172	1	122	122	NUM
easat-8031	172	2	-	-	SYM
easat-8031	172	3	127	127	NUM
easat-8031	172	4	,	,	PUNCT
easat-8031	172	5	2023	2023	NUM
easat-8031	172	6	.	.	PUNCT
easat-8031	172	7	https://doi.org/10.32792/utq/utjsci/v10i1.1040	https://doi.org/10.32792/utq/utjsci/v10i1.1040	PUNCT
easat-8031	173	1	[	[	X
easat-8031	173	2	14	14	NUM
easat-8031	173	3	]	]	PUNCT
easat-8031	173	4	r.	r.	PROPN
easat-8031	173	5	a.	a.	PROPN
easat-8031	173	6	ighewish	ighewish	PROPN
easat-8031	173	7	,	,	PUNCT
easat-8031	173	8	i.	i.	PROPN
easat-8031	173	9	k.	k.	PROPN
easat-8031	174	1	alshibly	alshibly	ADV
easat-8031	174	2	,	,	PUNCT
easat-8031	174	3	and	and	CCONJ
easat-8031	174	4	k.	k.	PROPN
easat-8031	174	5	c.	c.	PROPN
easat-8031	174	6	hasan	hasan	PROPN
easat-8031	174	7	,	,	PUNCT
easat-8031	174	8	"	"	PUNCT
easat-8031	174	9	role	role	NOUN
easat-8031	174	10	of	of	ADP
easat-8031	174	11	cytokines	cytokine	NOUN
easat-8031	174	12	in	in	ADP
easat-8031	174	13	the	the	DET
easat-8031	174	14	pathogenesis	pathogenesis	NOUN
easat-8031	174	15	of	of	ADP
easat-8031	174	16	thyroid	thyroid	NOUN
easat-8031	174	17	disease	disease	NOUN
easat-8031	174	18	among	among	ADP
easat-8031	174	19	iraqi	iraqi	ADJ
easat-8031	174	20	patients	patient	NOUN
easat-8031	174	21	,	,	PUNCT
easat-8031	174	22	"	"	PUNCT
easat-8031	174	23	plant	plant	NOUN
easat-8031	174	24	archives	archive	NOUN
easat-8031	174	25	,	,	PUNCT
easat-8031	174	26	vol	vol	NOUN
easat-8031	174	27	.	.	PROPN
easat-8031	174	28	20	20	NUM
easat-8031	174	29	,	,	PUNCT
easat-8031	174	30	pp	pp	ADJ
easat-8031	174	31	.	.	PUNCT
easat-8031	174	32	6101–6108	6101–6108	NUM
easat-8031	174	33	,	,	PUNCT
easat-8031	174	34	2020	2020	NUM
easat-8031	174	35	.	.	PUNCT
easat-8031	175	1	[	[	X
easat-8031	175	2	15	15	NUM
easat-8031	175	3	]	]	X
easat-8031	175	4	v.	v.	CCONJ
easat-8031	175	5	calcaterra	calcaterra	INTJ
easat-8031	175	6	et	et	PROPN
easat-8031	175	7	al	al	PROPN
easat-8031	175	8	.	.	PROPN
easat-8031	175	9	,	,	PUNCT
easat-8031	175	10	"	"	PUNCT
easat-8031	175	11	gender	gender	NOUN
easat-8031	175	12	differences	difference	NOUN
easat-8031	175	13	at	at	ADP
easat-8031	175	14	the	the	DET
easat-8031	175	15	onset	onset	NOUN
easat-8031	175	16	of	of	ADP
easat-8031	175	17	autoimmune	autoimmune	ADJ
easat-8031	175	18	thyroid	thyroid	NOUN
easat-8031	175	19	diseases	disease	NOUN
easat-8031	175	20	in	in	ADP
easat-8031	175	21	children	child	NOUN
easat-8031	175	22	and	and	CCONJ
easat-8031	175	23	adolescents	adolescent	NOUN
easat-8031	175	24	,	,	PUNCT
easat-8031	175	25	"	"	PUNCT
easat-8031	175	26	frontiers	frontier	NOUN
easat-8031	175	27	in	in	ADP
easat-8031	175	28	endocrinology	endocrinology	NOUN
easat-8031	175	29	,	,	PUNCT
easat-8031	175	30	vol	vol	NOUN
easat-8031	175	31	.	.	PROPN
easat-8031	175	32	11	11	NUM
easat-8031	175	33	,	,	PUNCT
easat-8031	175	34	p.	p.	NOUN
easat-8031	175	35	229	229	NUM
easat-8031	175	36	,	,	PUNCT
easat-8031	175	37	2020	2020	NUM
easat-8031	175	38	.	.	PUNCT
easat-8031	176	1	https://doi.org/10.3389/fendo.2020.00229	https://doi.org/10.3389/fendo.2020.00229	PROPN
easat-8031	177	1	[	[	X
easat-8031	177	2	16	16	NUM
easat-8031	177	3	]	]	PUNCT
easat-8031	177	4	c.-w	c.-w	PROPN
easat-8031	177	5	.	.	PUNCT
easat-8031	178	1	cheng	cheng	PROPN
easat-8031	178	2	,	,	PUNCT
easat-8031	178	3	w.-f	w.-f	PROPN
easat-8031	178	4	.	.	PUNCT
easat-8031	178	5	fang	fang	PROPN
easat-8031	178	6	,	,	PUNCT
easat-8031	178	7	k.-t	k.-t	PROPN
easat-8031	178	8	.	.	PUNCT
easat-8031	178	9	tang	tang	PROPN
easat-8031	178	10	,	,	PUNCT
easat-8031	178	11	and	and	CCONJ
easat-8031	178	12	j.-d	j.-d	PROPN
easat-8031	178	13	.	.	PUNCT
easat-8031	179	1	lin	lin	PROPN
easat-8031	179	2	,	,	PUNCT
easat-8031	179	3	"	"	PUNCT
easat-8031	179	4	possible	possible	ADJ
easat-8031	179	5	interplay	interplay	NOUN
easat-8031	179	6	between	between	ADP
easat-8031	179	7	estrogen	estrogen	NOUN
easat-8031	179	8	and	and	CCONJ
easat-8031	179	9	the	the	DET
easat-8031	179	10	baff	baff	NOUN
easat-8031	179	11	may	may	AUX
easat-8031	179	12	modify	modify	VERB
easat-8031	179	13	thyroid	thyroid	NOUN
easat-8031	179	14	activity	activity	NOUN
easat-8031	179	15	in	in	ADP
easat-8031	179	16	graves	grave	NOUN
easat-8031	179	17	’	’	PART
easat-8031	179	18	disease	disease	NOUN
easat-8031	179	19	,	,	PUNCT
easat-8031	179	20	"	"	PUNCT
easat-8031	179	21	scientific	scientific	ADJ
easat-8031	179	22	reports	report	NOUN
easat-8031	179	23	,	,	PUNCT
easat-8031	179	24	vol	vol	NOUN
easat-8031	179	25	.	.	PROPN
easat-8031	179	26	11	11	NUM
easat-8031	179	27	,	,	PUNCT
easat-8031	179	28	no	no	INTJ
easat-8031	179	29	.	.	NOUN
easat-8031	179	30	1	1	NUM
easat-8031	179	31	,	,	PUNCT
easat-8031	179	32	p.	p.	NOUN
easat-8031	179	33	21350	21350	NUM
easat-8031	179	34	,	,	PUNCT
easat-8031	179	35	2021	2021	NUM
easat-8031	179	36	.	.	PUNCT
easat-8031	180	1	https://doi.org/10.1038/s41598-021-00903-5	https://doi.org/10.1038/s41598-021-00903-5	NUM
easat-8031	181	1	[	[	X
easat-8031	181	2	17	17	NUM
easat-8031	181	3	]	]	PUNCT
easat-8031	181	4	b.	b.	PROPN
easat-8031	181	5	q.	q.	PROPN
easat-8031	181	6	ameen	ameen	PROPN
easat-8031	181	7	,	,	PUNCT
easat-8031	181	8	r.	r.	PROPN
easat-8031	181	9	jame	jame	PROPN
easat-8031	181	10	,	,	PUNCT
easat-8031	181	11	and	and	CCONJ
easat-8031	181	12	m.	m.	PROPN
easat-8031	181	13	i.	i.	PROPN
easat-8031	181	14	nader	nader	PROPN
easat-8031	181	15	,	,	PUNCT
easat-8031	181	16	"	"	PUNCT
easat-8031	181	17	investigating	investigate	VERB
easat-8031	181	18	the	the	DET
easat-8031	181	19	association	association	NOUN
easat-8031	181	20	between	between	ADP
easat-8031	181	21	vitamin	vitamin	NOUN
easat-8031	181	22	d	d	NOUN
easat-8031	181	23	and	and	CCONJ
easat-8031	181	24	anti	anti	ADJ
easat-8031	181	25	-	-	ADJ
easat-8031	181	26	thyroid	thyroid	ADJ
easat-8031	181	27	peroxidase	peroxidase	NOUN
easat-8031	181	28	antibodies	antibodie	VERB
easat-8031	181	29	in	in	ADP
easat-8031	181	30	hypothyroid	hypothyroid	ADJ
easat-8031	181	31	iraqi	iraqi	ADJ
easat-8031	181	32	patients	patient	NOUN
easat-8031	181	33	,	,	PUNCT
easat-8031	181	34	"	"	PUNCT
easat-8031	181	35	advancements	advancement	NOUN
easat-8031	181	36	in	in	ADP
easat-8031	181	37	life	life	NOUN
easat-8031	181	38	sciences	science	NOUN
easat-8031	181	39	,	,	PUNCT
easat-8031	181	40	vol	vol	NOUN
easat-8031	181	41	.	.	PROPN
easat-8031	181	42	12	12	NUM
easat-8031	181	43	,	,	PUNCT
easat-8031	181	44	no	no	INTJ
easat-8031	181	45	.	.	NOUN
easat-8031	181	46	1	1	NUM
easat-8031	181	47	,	,	PUNCT
easat-8031	181	48	pp	pp	ADJ
easat-8031	181	49	.	.	PUNCT
easat-8031	182	1	76	76	NUM
easat-8031	182	2	-	-	SYM
easat-8031	182	3	83	83	NUM
easat-8031	182	4	,	,	PUNCT
easat-8031	182	5	2025	2025	NUM
easat-8031	182	6	.	.	PUNCT
easat-8031	183	1	https://doi.org/10.62940/als.v12i1.2363	https://doi.org/10.62940/als.v12i1.2363	NOUN
easat-8031	183	2	[	[	X
easat-8031	183	3	18	18	NUM
easat-8031	183	4	]	]	X
easat-8031	183	5	l.	l.	PROPN
easat-8031	183	6	n.	n.	PROPN
easat-8031	183	7	adam	adam	PROPN
easat-8031	183	8	and	and	CCONJ
easat-8031	183	9	a.	a.	NOUN
easat-8031	183	10	m.	m.	NOUN
easat-8031	183	11	abbas	abbas	PROPN
easat-8031	183	12	,	,	PUNCT
easat-8031	183	13	"	"	PUNCT
easat-8031	183	14	thyroid	thyroid	NOUN
easat-8031	183	15	function	function	NOUN
easat-8031	183	16	and	and	CCONJ
easat-8031	183	17	its	its	PRON
easat-8031	183	18	association	association	NOUN
easat-8031	183	19	with	with	ADP
easat-8031	183	20	vitamin	vitamin	NOUN
easat-8031	183	21	deficiencies	deficiency	NOUN
easat-8031	183	22	:	:	PUNCT
easat-8031	183	23	a	a	DET
easat-8031	183	24	case	case	NOUN
easat-8031	183	25	-	-	PUNCT
easat-8031	183	26	control	control	NOUN
easat-8031	183	27	study	study	NOUN
easat-8031	183	28	in	in	ADP
easat-8031	183	29	duhok	duhok	NOUN
easat-8031	183	30	,	,	PUNCT
easat-8031	183	31	"	"	PUNCT
easat-8031	183	32	expert	expert	NOUN
easat-8031	183	33	review	review	NOUN
easat-8031	183	34	of	of	ADP
easat-8031	183	35	endocrinology	endocrinology	NOUN
easat-8031	183	36	&	&	CCONJ
easat-8031	183	37	metabolism	metabolism	NOUN
easat-8031	183	38	,	,	PUNCT
easat-8031	183	39	vol	vol	NOUN
easat-8031	183	40	.	.	PROPN
easat-8031	183	41	20	20	NUM
easat-8031	183	42	,	,	PUNCT
easat-8031	183	43	pp	pp	ADJ
easat-8031	183	44	.	.	PUNCT
easat-8031	184	1	1	1	NUM
easat-8031	184	2	-	-	SYM
easat-8031	184	3	7	7	NUM
easat-8031	184	4	,	,	PUNCT
easat-8031	184	5	2025	2025	NUM
easat-8031	184	6	.	.	PUNCT
easat-8031	185	1	https://doi.org/10.1080/17446651.2025.2469686	https://doi.org/10.1080/17446651.2025.2469686	PROPN
easat-8031	186	1	[	[	X
easat-8031	186	2	19	19	NUM
easat-8031	186	3	]	]	X
easat-8031	186	4	y.	y.	PROPN
easat-8031	186	5	chen	chen	PROPN
easat-8031	186	6	and	and	CCONJ
easat-8031	186	7	h.-y	h.-y	NOUN
easat-8031	186	8	.	.	PUNCT
easat-8031	187	1	tai	tai	PROPN
easat-8031	187	2	,	,	PUNCT
easat-8031	187	3	"	"	PUNCT
easat-8031	187	4	levothyroxine	levothyroxine	NOUN
easat-8031	187	5	in	in	ADP
easat-8031	187	6	the	the	DET
easat-8031	187	7	treatment	treatment	NOUN
easat-8031	187	8	of	of	ADP
easat-8031	187	9	overt	overt	ADJ
easat-8031	187	10	or	or	CCONJ
easat-8031	187	11	subclinical	subclinical	ADJ
easat-8031	187	12	hypothyroidism	hypothyroidism	NOUN
easat-8031	187	13	:	:	PUNCT
easat-8031	187	14	a	a	DET
easat-8031	187	15	systematic	systematic	ADJ
easat-8031	187	16	review	review	NOUN
easat-8031	187	17	and	and	CCONJ
easat-8031	187	18	meta	meta	ADJ
easat-8031	187	19	-	-	PUNCT
easat-8031	187	20	analysis	analysis	NOUN
easat-8031	187	21	,	,	PUNCT
easat-8031	187	22	"	"	PUNCT
easat-8031	187	23	endocrine	endocrine	ADJ
easat-8031	187	24	journal	journal	NOUN
easat-8031	187	25	,	,	PUNCT
easat-8031	187	26	vol	vol	NOUN
easat-8031	187	27	.	.	PROPN
easat-8031	187	28	67	67	NUM
easat-8031	187	29	,	,	PUNCT
easat-8031	187	30	no	no	INTJ
easat-8031	187	31	.	.	NOUN
easat-8031	187	32	7	7	NUM
easat-8031	187	33	,	,	PUNCT
easat-8031	187	34	pp	pp	ADJ
easat-8031	187	35	.	.	PUNCT
easat-8031	188	1	719	719	NUM
easat-8031	188	2	-	-	SYM
easat-8031	188	3	732	732	NUM
easat-8031	188	4	,	,	PUNCT
easat-8031	188	5	2020	2020	NUM
easat-8031	188	6	.	.	PUNCT
easat-8031	189	1	https://doi.org/10.1507/endocrj.ej19-0583	https://doi.org/10.1507/endocrj.ej19-0583	NOUN
easat-8031	190	1	[	[	X
easat-8031	190	2	20	20	NUM
easat-8031	190	3	]	]	X
easat-8031	190	4	t.	t.	PROPN
easat-8031	190	5	durá	durá	PROPN
easat-8031	190	6	-	-	PUNCT
easat-8031	190	7	travé	travé	PROPN
easat-8031	190	8	and	and	CCONJ
easat-8031	190	9	f.	f.	PROPN
easat-8031	190	10	gallinas	gallinas	PROPN
easat-8031	190	11	-	-	PUNCT
easat-8031	190	12	victoriano	victoriano	NOUN
easat-8031	190	13	,	,	PUNCT
easat-8031	190	14	"	"	PUNCT
easat-8031	190	15	autoimmune	autoimmune	ADJ
easat-8031	190	16	thyroiditis	thyroiditis	NOUN
easat-8031	190	17	and	and	CCONJ
easat-8031	190	18	vitamin	vitamin	NOUN
easat-8031	190	19	d	d	NOUN
easat-8031	190	20	,	,	PUNCT
easat-8031	190	21	"	"	PUNCT
easat-8031	190	22	international	international	ADJ
easat-8031	190	23	journal	journal	NOUN
easat-8031	190	24	of	of	ADP
easat-8031	190	25	molecular	molecular	ADJ
easat-8031	190	26	sciences	science	NOUN
easat-8031	190	27	,	,	PUNCT
easat-8031	190	28	vol	vol	NOUN
easat-8031	190	29	.	.	PROPN
easat-8031	191	1	25	25	NUM
easat-8031	191	2	,	,	PUNCT
easat-8031	191	3	no	no	INTJ
easat-8031	191	4	.	.	NOUN
easat-8031	191	5	6	6	NUM
easat-8031	191	6	,	,	PUNCT
easat-8031	191	7	p.	p.	NOUN
easat-8031	191	8	3154	3154	NUM
easat-8031	191	9	,	,	PUNCT
easat-8031	191	10	2024	2024	NUM
easat-8031	191	11	.	.	PUNCT
easat-8031	192	1	https://doi.org/10.3390/ijms25063154	https://doi.org/10.3390/ijms25063154	NOUN
easat-8031	192	2	[	[	X
easat-8031	192	3	21	21	NUM
easat-8031	192	4	]	]	X
easat-8031	192	5	r.	r.	PROPN
easat-8031	192	6	m.	m.	PROPN
easat-8031	192	7	obaid	obaid	PROPN
easat-8031	192	8	,	,	PUNCT
easat-8031	192	9	f.	f.	PROPN
easat-8031	192	10	t.	t.	PROPN
easat-8031	192	11	yaseen	yaseen	PROPN
easat-8031	192	12	,	,	PUNCT
easat-8031	192	13	and	and	CCONJ
easat-8031	192	14	a.	a.	PROPN
easat-8031	192	15	k.	k.	PROPN
easat-8031	192	16	salim	salim	PROPN
easat-8031	192	17	,	,	PUNCT
easat-8031	192	18	"	"	PUNCT
easat-8031	192	19	correlation	correlation	NOUN
easat-8031	192	20	between	between	ADP
easat-8031	192	21	vitamin	vitamin	NOUN
easat-8031	192	22	d3	d3	PROPN
easat-8031	192	23	(	(	PUNCT
easat-8031	192	24	cholecalciferol	cholecalciferol	NOUN
easat-8031	192	25	)	)	PUNCT
easat-8031	192	26	and	and	CCONJ
easat-8031	192	27	thyroid	thyroid	NOUN
easat-8031	192	28	diseases	disease	NOUN
easat-8031	192	29	in	in	ADP
easat-8031	192	30	iraqi	iraqi	ADJ
easat-8031	192	31	patients	patient	NOUN
easat-8031	192	32	,	,	PUNCT
easat-8031	192	33	"	"	PUNCT
easat-8031	192	34	annals	annal	NOUN
easat-8031	192	35	of	of	ADP
easat-8031	192	36	tropical	tropical	ADJ
easat-8031	192	37	medicine	medicine	NOUN
easat-8031	192	38	and	and	CCONJ
easat-8031	192	39	public	public	ADJ
easat-8031	192	40	health	health	NOUN
easat-8031	192	41	,	,	PUNCT
easat-8031	192	42	vol	vol	NOUN
easat-8031	192	43	.	.	PROPN
easat-8031	192	44	23	23	NUM
easat-8031	192	45	,	,	PUNCT
easat-8031	192	46	no	no	INTJ
easat-8031	192	47	.	.	NOUN
easat-8031	192	48	16	16	NUM
easat-8031	192	49	,	,	PUNCT
easat-8031	192	50	pp	pp	ADJ
easat-8031	192	51	.	.	PUNCT
easat-8031	193	1	231	231	NUM
easat-8031	193	2	-	-	SYM
easat-8031	193	3	603	603	NUM
easat-8031	193	4	,	,	PUNCT
easat-8031	193	5	2020	2020	NUM
easat-8031	193	6	.	.	PUNCT
easat-8031	194	1	[	[	X
easat-8031	194	2	22	22	NUM
easat-8031	194	3	]	]	X
easat-8031	194	4	h.	h.	PROPN
easat-8031	194	5	g.	g.	PROPN
easat-8031	194	6	bakr	bakr	PROPN
easat-8031	194	7	and	and	CCONJ
easat-8031	194	8	t.	t.	PROPN
easat-8031	194	9	e.	e.	PROPN
easat-8031	194	10	meawed	meawed	PROPN
easat-8031	194	11	,	,	PUNCT
easat-8031	194	12	"	"	PUNCT
easat-8031	194	13	relevance	relevance	NOUN
easat-8031	194	14	of	of	ADP
easat-8031	194	15	25(oh	25(oh	NOUN
easat-8031	194	16	)	)	PUNCT
easat-8031	194	17	vitamin	vitamin	NOUN
easat-8031	194	18	d	d	NOUN
easat-8031	194	19	deficiency	deficiency	NOUN
easat-8031	194	20	on	on	ADP
easat-8031	194	21	hashimoto	hashimoto	NOUN
easat-8031	194	22	’s	’s	PART
easat-8031	194	23	thyroiditis	thyroiditis	NOUN
easat-8031	194	24	,	,	PUNCT
easat-8031	194	25	"	"	PUNCT
easat-8031	194	26	egyptian	egyptian	ADJ
easat-8031	194	27	journal	journal	NOUN
easat-8031	194	28	of	of	ADP
easat-8031	194	29	immunology	immunology	NOUN
easat-8031	194	30	,	,	PUNCT
easat-8031	194	31	vol	vol	NOUN
easat-8031	194	32	.	.	PROPN
easat-8031	195	1	24	24	NUM
easat-8031	195	2	,	,	PUNCT
easat-8031	195	3	no	no	INTJ
easat-8031	195	4	.	.	NOUN
easat-8031	195	5	2	2	NUM
easat-8031	195	6	,	,	PUNCT
easat-8031	195	7	pp	pp	ADJ
easat-8031	195	8	.	.	PUNCT
easat-8031	196	1	53	53	NUM
easat-8031	196	2	-	-	SYM
easat-8031	196	3	62	62	NUM
easat-8031	196	4	,	,	PUNCT
easat-8031	196	5	2017	2017	NUM
easat-8031	196	6	.	.	PUNCT
easat-8031	197	1	[	[	X
easat-8031	197	2	23	23	NUM
easat-8031	197	3	]	]	X
easat-8031	197	4	g.	g.	PROPN
easat-8031	197	5	chao	chao	PROPN
easat-8031	197	6	,	,	PUNCT
easat-8031	197	7	y.	y.	PROPN
easat-8031	197	8	zhu	zhu	PROPN
easat-8031	197	9	,	,	PUNCT
easat-8031	197	10	and	and	CCONJ
easat-8031	197	11	l.	l.	PROPN
easat-8031	197	12	fang	fang	PROPN
easat-8031	197	13	,	,	PUNCT
easat-8031	197	14	"	"	PUNCT
easat-8031	197	15	correlation	correlation	NOUN
easat-8031	197	16	between	between	ADP
easat-8031	197	17	hashimoto	hashimoto	NOUN
easat-8031	197	18	’s	’s	PART
easat-8031	197	19	thyroiditis	thyroiditis	NOUN
easat-8031	197	20	–	–	PUNCT
easat-8031	197	21	related	relate	VERB
easat-8031	197	22	thyroid	thyroid	NOUN
easat-8031	197	23	hormone	hormone	NOUN
easat-8031	197	24	levels	level	NOUN
easat-8031	197	25	and	and	CCONJ
easat-8031	197	26	25hydroxyvitamin	25hydroxyvitamin	NUM
easat-8031	197	27	d	d	NOUN
easat-8031	197	28	,	,	PUNCT
easat-8031	197	29	"	"	PUNCT
easat-8031	197	30	frontiers	frontier	NOUN
easat-8031	197	31	in	in	ADP
easat-8031	197	32	endocrinology	endocrinology	NOUN
easat-8031	197	33	,	,	PUNCT
easat-8031	197	34	vol	vol	NOUN
easat-8031	197	35	.	.	PROPN
easat-8031	197	36	11	11	NUM
easat-8031	197	37	,	,	PUNCT
easat-8031	197	38	pp	pp	ADJ
easat-8031	197	39	.	.	PUNCT
easat-8031	198	1	1–7	1–7	NUM
easat-8031	198	2	,	,	PUNCT
easat-8031	198	3	2020	2020	NUM
easat-8031	198	4	.	.	PUNCT
easat-8031	199	1	https://doi.org/10.3389/fendo.2020.00004	https://doi.org/10.3389/fendo.2020.00004	PROPN
easat-8031	199	2	[	[	X
easat-8031	199	3	24	24	NUM
easat-8031	199	4	]	]	PUNCT
easat-8031	199	5	b.	b.	PROPN
easat-8031	199	6	ucan	ucan	PROPN
easat-8031	199	7	et	et	PROPN
easat-8031	199	8	al	al	PROPN
easat-8031	199	9	.	.	PROPN
easat-8031	199	10	,	,	PUNCT
easat-8031	199	11	"	"	PUNCT
easat-8031	199	12	vitamin	vitamin	NOUN
easat-8031	199	13	d	d	NOUN
easat-8031	199	14	treatment	treatment	NOUN
easat-8031	199	15	in	in	ADP
easat-8031	199	16	patients	patient	NOUN
easat-8031	199	17	with	with	ADP
easat-8031	199	18	hashimoto	hashimoto	NOUN
easat-8031	199	19	’s	’s	PART
easat-8031	199	20	thyroiditis	thyroiditis	NOUN
easat-8031	199	21	may	may	AUX
easat-8031	199	22	decrease	decrease	VERB
easat-8031	199	23	the	the	DET
easat-8031	199	24	development	development	NOUN
easat-8031	199	25	of	of	ADP
easat-8031	199	26	hypothyroidism	hypothyroidism	NOUN
easat-8031	199	27	,	,	PUNCT
easat-8031	199	28	"	"	PUNCT
easat-8031	199	29	international	international	ADJ
easat-8031	199	30	journal	journal	NOUN
easat-8031	199	31	for	for	ADP
easat-8031	199	32	vitamin	vitamin	NOUN
easat-8031	199	33	and	and	CCONJ
easat-8031	199	34	nutrition	nutrition	NOUN
easat-8031	199	35	research	research	NOUN
easat-8031	199	36	,	,	PUNCT
easat-8031	199	37	vol	vol	NOUN
easat-8031	199	38	.	.	PROPN
easat-8031	199	39	86	86	NUM
easat-8031	199	40	,	,	PUNCT
easat-8031	199	41	no	no	INTJ
easat-8031	199	42	.	.	NOUN
easat-8031	199	43	1	1	NUM
easat-8031	199	44	,	,	PUNCT
easat-8031	199	45	pp	pp	ADJ
easat-8031	199	46	.	.	PUNCT
easat-8031	200	1	9	9	NUM
easat-8031	200	2	-	-	SYM
easat-8031	200	3	17	17	NUM
easat-8031	200	4	,	,	PUNCT
easat-8031	200	5	2016	2016	NUM
easat-8031	200	6	.	.	PUNCT
easat-8031	201	1	https://doi.org/10.1024/0300-9831/a000269	https://doi.org/10.1024/0300-9831/a000269	PROPN
easat-8031	201	2	[	[	X
easat-8031	201	3	25	25	NUM
easat-8031	201	4	]	]	PUNCT
easat-8031	201	5	a.	a.	NOUN
easat-8031	201	6	a.	a.	NOUN
easat-8031	201	7	raeef	raeef	PROPN
easat-8031	201	8	,	,	PUNCT
easat-8031	201	9	m.	m.	PROPN
easat-8031	201	10	j.	j.	PROPN
easat-8031	201	11	al	al	PROPN
easat-8031	201	12	-	-	PUNCT
easat-8031	201	13	shaabani	shaabani	PROPN
easat-8031	201	14	,	,	PUNCT
easat-8031	201	15	and	and	CCONJ
easat-8031	201	16	s.	s.	PROPN
easat-8031	201	17	k.	k.	PROPN
easat-8031	201	18	al	al	PROPN
easat-8031	201	19	-	-	PUNCT
easat-8031	201	20	ani	ani	PROPN
easat-8031	201	21	,	,	PUNCT
easat-8031	201	22	"	"	PUNCT
easat-8031	201	23	the	the	DET
easat-8031	201	24	relation	relation	NOUN
easat-8031	201	25	between	between	ADP
easat-8031	201	26	vitamin	vitamin	NOUN
easat-8031	201	27	d	d	NOUN
easat-8031	201	28	insufficiency	insufficiency	NOUN
easat-8031	201	29	and	and	CCONJ
easat-8031	201	30	thyroid	thyroid	NOUN
easat-8031	201	31	hormones	hormone	NOUN
easat-8031	201	32	in	in	ADP
easat-8031	201	33	iraqi	iraqi	ADJ
easat-8031	201	34	women	woman	NOUN
easat-8031	201	35	living	live	VERB
easat-8031	201	36	in	in	ADP
easat-8031	201	37	al	al	PROPN
easat-8031	201	38	-	-	PUNCT
easat-8031	201	39	khalidiya	khalidiya	PROPN
easat-8031	201	40	,	,	PUNCT
easat-8031	201	41	anbar	anbar	ADJ
easat-8031	201	42	province	province	NOUN
easat-8031	201	43	,	,	PUNCT
easat-8031	201	44	"	"	PUNCT
easat-8031	201	45	journal	journal	NOUN
easat-8031	201	46	of	of	ADP
easat-8031	201	47	biotechnology	biotechnology	NOUN
easat-8031	201	48	research	research	NOUN
easat-8031	201	49	center	center	NOUN
easat-8031	201	50	,	,	PUNCT
easat-8031	201	51	vol	vol	NOUN
easat-8031	201	52	.	.	PROPN
easat-8031	201	53	17	17	NUM
easat-8031	201	54	,	,	PUNCT
easat-8031	201	55	no	no	INTJ
easat-8031	201	56	.	.	NOUN
easat-8031	201	57	1	1	NUM
easat-8031	201	58	,	,	PUNCT
easat-8031	201	59	pp	pp	ADJ
easat-8031	201	60	.	.	PUNCT
easat-8031	201	61	4554	4554	NUM
easat-8031	201	62	,	,	PUNCT
easat-8031	201	63	2023	2023	NUM
easat-8031	201	64	.	.	PUNCT
easat-8031	202	1	https://doi.org/10.24126/jobrc.2023.17.1.700	https://doi.org/10.24126/jobrc.2023.17.1.700	PROPN
easat-8031	202	2	[	[	X
easat-8031	202	3	26	26	NUM
easat-8031	202	4	]	]	PUNCT
easat-8031	202	5	m.	m.	NOUN
easat-8031	202	6	d.	d.	PROPN
easat-8031	202	7	ibrahim	ibrahim	PROPN
easat-8031	202	8	and	and	CCONJ
easat-8031	202	9	s.	s.	PROPN
easat-8031	202	10	e.	e.	PROPN
easat-8031	202	11	i.	i.	PROPN
easat-8031	202	12	d.	d.	PROPN
easat-8031	202	13	el	el	PROPN
easat-8031	202	14	shishtawy	shishtawy	PROPN
easat-8031	202	15	,	,	PUNCT
easat-8031	202	16	"	"	PUNCT
easat-8031	202	17	association	association	NOUN
easat-8031	202	18	between	between	ADP
easat-8031	202	19	vitamin	vitamin	NOUN
easat-8031	202	20	d	d	PROPN
easat-8031	202	21	,	,	PUNCT
easat-8031	202	22	thyroid	thyroid	NOUN
easat-8031	202	23	hormones	hormone	NOUN
easat-8031	202	24	,	,	PUNCT
easat-8031	202	25	calcium	calcium	NOUN
easat-8031	202	26	,	,	PUNCT
easat-8031	202	27	anti	anti	ADJ
easat-8031	202	28	-	-	ADJ
easat-8031	202	29	tpo	tpo	NOUN
easat-8031	202	30	and	and	CCONJ
easat-8031	202	31	tsh	tsh	NOUN
easat-8031	202	32	receptor	receptor	NOUN
easat-8031	202	33	antibodies	antibodie	VERB
easat-8031	202	34	in	in	ADP
easat-8031	202	35	hypothyroid	hypothyroid	ADJ
easat-8031	202	36	patients	patient	NOUN
easat-8031	202	37	,	,	PUNCT
easat-8031	202	38	"	"	PUNCT
easat-8031	202	39	the	the	DET
easat-8031	202	40	medical	medical	ADJ
easat-8031	202	41	journal	journal	NOUN
easat-8031	202	42	of	of	ADP
easat-8031	202	43	cairo	cairo	PROPN
easat-8031	202	44	university	university	PROPN
easat-8031	202	45	,	,	PUNCT
easat-8031	202	46	vol	vol	NOUN
easat-8031	202	47	.	.	PROPN
easat-8031	202	48	92	92	NUM
easat-8031	202	49	,	,	PUNCT
easat-8031	202	50	no	no	INTJ
easat-8031	202	51	.	.	NOUN
easat-8031	202	52	09	09	NUM
easat-8031	202	53	,	,	PUNCT
easat-8031	202	54	pp	pp	ADJ
easat-8031	202	55	.	.	PUNCT
easat-8031	203	1	979987	979987	NUM
easat-8031	203	2	,	,	PUNCT
easat-8031	203	3	2024	2024	NUM
easat-8031	203	4	.	.	PUNCT
easat-8031	204	1	https://doi.org/10.21608/mjcu.2024.390023	https://doi.org/10.21608/mjcu.2024.390023	PROPN
easat-8031	204	2	[	[	X
easat-8031	204	3	27	27	NUM
easat-8031	204	4	]	]	X
easat-8031	204	5	h.	h.	PROPN
easat-8031	204	6	y.	y.	PROPN
easat-8031	204	7	abdulrazaq	abdulrazaq	PROPN
easat-8031	204	8	and	and	CCONJ
easat-8031	204	9	a.	a.	PROPN
easat-8031	204	10	f.	f.	PROPN
easat-8031	204	11	hussein	hussein	PROPN
easat-8031	204	12	,	,	PUNCT
easat-8031	204	13	"	"	PUNCT
easat-8031	204	14	obesity	obesity	NOUN
easat-8031	204	15	and	and	CCONJ
easat-8031	204	16	graves	grave	NOUN
easat-8031	204	17	’	’	PART
easat-8031	204	18	disease	disease	NOUN
easat-8031	204	19	,	,	PUNCT
easat-8031	204	20	possible	possible	ADJ
easat-8031	204	21	association	association	NOUN
easat-8031	204	22	,	,	PUNCT
easat-8031	204	23	"	"	PUNCT
easat-8031	204	24	journal	journal	NOUN
easat-8031	204	25	of	of	ADP
easat-8031	204	26	pharmaceutical	pharmaceutical	ADJ
easat-8031	204	27	negative	negative	ADJ
easat-8031	204	28	results	result	NOUN
easat-8031	204	29	,	,	PUNCT
easat-8031	204	30	vol	vol	NOUN
easat-8031	204	31	.	.	PROPN
easat-8031	204	32	13	13	NUM
easat-8031	204	33	,	,	PUNCT
easat-8031	204	34	pp	pp	ADJ
easat-8031	204	35	.	.	PUNCT
easat-8031	205	1	226–229	226–229	NUM
easat-8031	205	2	,	,	PUNCT
easat-8031	205	3	2022	2022	NUM
easat-8031	205	4	.	.	PUNCT
easat-8031	206	1	https://doi.org/10.47750/pnr.2022.13.s02.32	https://doi.org/10.47750/pnr.2022.13.s02.32	NUM
easat-8031	206	2	[	[	SYM
easat-8031	206	3	28	28	NUM
easat-8031	206	4	]	]	X
easat-8031	206	5	i.	i.	PROPN
easat-8031	206	6	a.	a.	PROPN
easat-8031	206	7	ameen	ameen	PROPN
easat-8031	206	8	,	,	PUNCT
easat-8031	206	9	e.	e.	PROPN
easat-8031	206	10	s.	s.	PROPN
easat-8031	206	11	saleh	saleh	PROPN
easat-8031	206	12	,	,	PUNCT
easat-8031	206	13	and	and	CCONJ
easat-8031	206	14	k.	k.	PROPN
easat-8031	206	15	n.	n.	PROPN
easat-8031	206	16	taha	taha	PROPN
easat-8031	206	17	,	,	PUNCT
easat-8031	206	18	"	"	PUNCT
easat-8031	206	19	serum	serum	X
easat-8031	206	20	ferritin	ferritin	ADJ
easat-8031	206	21	levels	level	NOUN
easat-8031	206	22	for	for	ADP
easat-8031	206	23	iraqi	iraqi	ADJ
easat-8031	206	24	patients	patient	NOUN
easat-8031	206	25	with	with	ADP
easat-8031	206	26	hashimoto	hashimoto	NOUN
easat-8031	206	27	’s	’s	PART
easat-8031	206	28	thyroiditis	thyroiditis	NOUN
easat-8031	206	29	,	,	PUNCT
easat-8031	206	30	"	"	PUNCT
easat-8031	206	31	indian	indian	ADJ
easat-8031	206	32	journal	journal	NOUN
easat-8031	206	33	of	of	ADP
easat-8031	206	34	public	public	ADJ
easat-8031	206	35	health	health	NOUN
easat-8031	206	36	research	research	PROPN
easat-8031	206	37	&	&	CCONJ
easat-8031	206	38	development	development	PROPN
easat-8031	206	39	,	,	PUNCT
easat-8031	206	40	vol	vol	NOUN
easat-8031	206	41	.	.	PROPN
easat-8031	206	42	10	10	NUM
easat-8031	206	43	,	,	PUNCT
easat-8031	206	44	no	no	INTJ
easat-8031	206	45	.	.	NOUN
easat-8031	206	46	10	10	NUM
easat-8031	206	47	,	,	PUNCT
easat-8031	206	48	pp	pp	ADJ
easat-8031	206	49	.	.	PUNCT
easat-8031	207	1	667–671	667–671	NUM
easat-8031	207	2	,	,	PUNCT
easat-8031	207	3	2019	2019	NUM
easat-8031	207	4	.	.	PUNCT
easat-8031	208	1	https://doi.org/10.5958/09765506.2019.02889.4	https://doi.org/10.5958/09765506.2019.02889.4	NOUN
easat-8031	209	1	[	[	X
easat-8031	209	2	29	29	NUM
easat-8031	209	3	]	]	PUNCT
easat-8031	209	4	m.	m.	NOUN
easat-8031	209	5	n.	n.	PROPN
easat-8031	209	6	iqbal	iqbal	PROPN
easat-8031	209	7	and	and	CCONJ
easat-8031	209	8	j.	j.	PROPN
easat-8031	209	9	samanje	samanje	PROPN
easat-8031	209	10	,	,	PUNCT
easat-8031	209	11	"	"	PUNCT
easat-8031	209	12	estimation	estimation	NOUN
easat-8031	209	13	of	of	ADP
easat-8031	209	14	il-8	il-8	NOUN
easat-8031	209	15	,	,	PUNCT
easat-8031	209	16	il-38	il-38	NOUN
easat-8031	209	17	,	,	PUNCT
easat-8031	209	18	vitamin	vitamin	NOUN
easat-8031	209	19	d	d	PROPN
easat-8031	209	20	,	,	PUNCT
easat-8031	209	21	tpo	tpo	PROPN
easat-8031	209	22	ab	ab	PROPN
easat-8031	209	23	,	,	PUNCT
easat-8031	209	24	and	and	CCONJ
easat-8031	209	25	crp	crp	PROPN
easat-8031	209	26	levels	level	NOUN
easat-8031	209	27	in	in	ADP
easat-8031	209	28	iraqi	iraqi	ADJ
easat-8031	209	29	hashimoto	hashimoto	NOUN
easat-8031	209	30	thyroiditis	thyroiditis	NOUN
easat-8031	209	31	patients	patient	NOUN
easat-8031	209	32	,	,	PUNCT
easat-8031	209	33	"	"	PUNCT
easat-8031	209	34	medical	medical	ADJ
easat-8031	209	35	journal	journal	NOUN
easat-8031	209	36	of	of	ADP
easat-8031	209	37	babylon	babylon	PROPN
easat-8031	209	38	,	,	PUNCT
easat-8031	209	39	vol	vol	NOUN
easat-8031	209	40	.	.	PROPN
easat-8031	209	41	21	21	NUM
easat-8031	209	42	,	,	PUNCT
easat-8031	209	43	no	no	INTJ
easat-8031	209	44	.	.	NOUN
easat-8031	209	45	2	2	NUM
easat-8031	209	46	,	,	PUNCT
easat-8031	209	47	pp	pp	ADJ
easat-8031	209	48	.	.	PUNCT
easat-8031	209	49	425	425	NUM
easat-8031	209	50	-	-	SYM
easat-8031	209	51	430	430	NUM
easat-8031	209	52	,	,	PUNCT
easat-8031	209	53	2024	2024	NUM
easat-8031	209	54	.	.	PUNCT
easat-8031	210	1	https://doi.org/10.4103/mjbl.mjbl_1503_23	https://doi.org/10.4103/mjbl.mjbl_1503_23	NOUN
easat-8031	210	2	https://doi.org/10.3389/fendo.2019.00208	https://doi.org/10.3389/fendo.2019.00208	PROPN
easat-8031	210	3	https://doi.org/10.55133/eji.300406	https://doi.org/10.55133/eji.300406	PROPN
easat-8031	210	4	https://doi.org/10.2298/sarh220608035	https://doi.org/10.2298/sarh220608035	NOUN
easat-8031	210	5	g	g	PROPN
easat-8031	210	6	https://doi.org/10.3390/nu15143174	https://doi.org/10.3390/nu15143174	PROPN
easat-8031	210	7	https://doi.org/10.1038/s41598-024-78938-7	https://doi.org/10.1038/s41598-024-78938-7	NUM
easat-8031	211	1	https://doi.org/10.3390/ijms24043586	https://doi.org/10.3390/ijms24043586	PROPN
easat-8031	211	2	https://doi.org/10.32792/utq/utjsci/v10i1.1040	https://doi.org/10.32792/utq/utjsci/v10i1.1040	PART
easat-8031	212	1	https://doi.org/10.3389/fendo.2020.00229	https://doi.org/10.3389/fendo.2020.00229	PROPN
easat-8031	212	2	https://doi.org/10.1038/s41598-021-00903-5	https://doi.org/10.1038/s41598-021-00903-5	NUM
easat-8031	212	3	https://doi.org/10.62940/als.v12i1.2363	https://doi.org/10.62940/als.v12i1.2363	PROPN
easat-8031	212	4	https://doi.org/10.1080/17446651.2025.2469686	https://doi.org/10.1080/17446651.2025.2469686	NOUN
easat-8031	212	5	https://doi.org/10.1507/endocrj.ej19-0583	https://doi.org/10.1507/endocrj.ej19-0583	NOUN
easat-8031	212	6	https://doi.org/10.3390/ijms25063154	https://doi.org/10.3390/ijms25063154	NOUN
easat-8031	212	7	https://doi.org/10.3389/fendo.2020.00004	https://doi.org/10.3389/fendo.2020.00004	PROPN
easat-8031	212	8	https://doi.org/10.1024/0300-9831/a000269	https://doi.org/10.1024/0300-9831/a000269	PROPN
easat-8031	212	9	https://doi.org/10.24126/jobrc.2023.17.1.700	https://doi.org/10.24126/jobrc.2023.17.1.700	PROPN
easat-8031	212	10	https://doi.org/10.21608/mjcu.2024.390023	https://doi.org/10.21608/mjcu.2024.390023	PROPN
easat-8031	212	11	https://doi.org/10.47750/pnr.2022.13.s02.32	https://doi.org/10.47750/pnr.2022.13.s02.32	NUM
easat-8031	212	12	https://doi.org/10.5958/0976-5506.2019.02889.4	https://doi.org/10.5958/0976-5506.2019.02889.4	PROPN
easat-8031	212	13	https://doi.org/10.5958/0976-5506.2019.02889.4	https://doi.org/10.5958/0976-5506.2019.02889.4	PROPN
easat-8031	212	14	https://doi.org/10.4103/mjbl.mjbl_1503_23	https://doi.org/10.4103/mjbl.mjbl_1503_23	NOUN